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ABSTRACT OF THE DISSERTATION 
FCS Analysis of Pore Formation by the Human Protein Bax in Lipid Membranes 
by 
Olena Anatoliyivna Ivashyna 
Abstract 
Bax is a pro-apoptotic member of the BCL-2 protein family and its paramount function 
during apoptosis is to form pores in the mitochondrial outer membrane (MOM). In a 
simplified apoptosis model, upon apoptotic stimulation, Bax is activated via an 
unresolved mechanism, translocates to the MOM, where it changes conformation, inserts 
into the membrane as a monomer, and finally undergoes in-membrane oligomerization to 
form a pore. Once the Bax pore is formed, cytochrome c and other mitochondria-resident 
proteins escape into the cytoplasm where they activate the cascade of caspases, which 
dismantle the cell. To date, the structure of the inactive cytoplasmic form of Bax is 
known; however, the structure of the membrane-integrated, active form of Bax remains 
unsolved. The absence of membrane structure for Bax leaves the mechanism of Bax pore 
formation poorly understood. To investigate the mechanism of Bax pore formation, we 
developed and used approaches to study fluorescently labeled Bax in solution and in lipid 
membranes using single-molecule sensitivity fluorescence techniques based on 
fluorescence correlation spectroscopy – FCS. These single-molecule fluorescence 
techniques provide us with a non-invasive method to study the mechanism of Bax pore 
formation reconstituted in giant unilamellar vesicles (GUVs). Our results show, that in 
the environment of a GUV lipid membrane, Bax can form a complex distribution of 
coexisting pore sizes ranging from 1 nm to 20 µm in diameter. Evidence is provided by 
 xi
 xii
directly examining oligomerization and mobility changes of Bax molecules in GUVs by 
fluorescence cross-correlation spectroscopy (FCCS) and observing the large complexes 
by confocal microscopy. We show that in the presence of Bcl-xL, an inhibitor of Bax pore 
formation, membrane-bound Bax was primarily monomeric. We also show, that in the 
large length-scale format of the GUV, Bax forms mega-pores – structures that reveal its 
affinity for highly curved membranes. Analysis of the line tension in the rim of Bax 
mega-pores indicates that Bax dramatically reduces line tension while stabilizing these 
lipidic pores. Furthermore, our results demonstrate that Bax forms pores by increasing 
membrane surface energy and by changing the curvature of lipid membranes, thus 
manifesting an ability to sculpt lipid bilayers. 
 In addition to studying Bax in lipid membranes, we have investigated the in vitro 
mechanism of Bax activation in detergent micelles, where, due to the formation of large 
hydrodynamic volume protein-detergent micelles, Bax has been proposed to form homo-
oligomers upon activation prior to membrane insertion, which is in contrast to the in vivo 
studies which reported that Bax binds MOM as a monomer and then undergoes homo-
oligomerization.  Our studies using fluorescence intensity distribution analysis (FIDA) 
have shown that Bax is a monomer before, during and after interaction with detergent 
micelles; however, it does form large hydrodynamic volume complexes with detergent 
micelles. The results of our FIDA study establish the connection between the in vitro and 
in vivo mechanism of Bax activation, showing that, prior to the formation of an 
oligomeric pore in a lipid membrane, Bax binds lipid membranes as a monomer. 
  
 
 
 
 
 
 
CHAPTER 1 
“Apoptosis, Bcl-2 Protein Family, and Bax” 
 
 
 
 
 
 
 
 
 
 
 
 
 1
Apoptosis  
In order to maintain homeostasis and survive, multicellular organisms developed 
a mechanism to sacrifice certain cells for the good of others. For example, cells in the 
xylem of plants must die to create a conduction pathway for water; so must do the cells in 
the finger webs of a human embryo as well as the neuron cells which failed to create the 
proper cellular connection1, 2. Therefore, to selectively kill cells, multicellular organisms 
developed a mechanism – apoptosis – which is a morphologically defined form of a 
programmed cell death3-6. The distinctive morphological features of apoptosis include 
nuclear fragmentation, membrane blebbing and the formation of apoptotic bodies. All 
multicellular organisms employ apoptosis; however, the biochemical details of apoptosis 
vary among species. For example, vertebrates, during the mitochondrial pathway of 
apoptosis, rely on the release of cytochrome c from mitochondria to ensure the activation 
of caspases – the family of proteases responsible for cellular demise – while in C. elegans 
only four proteins are involved in apoptosis without the engagement of cytochrome c7. 
Furthermore, some single-celled organism who form surface biofilms, or live in colonies 
(such as yeast), also have been shown to have a mechanism to eliminate single cells in 
the colony to ensure the survival of others8, 9. Thus the need to eliminate old, virus-
infected or otherwise unwanted cells is universal among the various forms of life. 
 Apoptosis plays an important role in mammalian development, especially in the 
nervous system where deficiencies in the execution of the apoptotic program lead to 
severe neurological disorders. Apoptosis also plays an important role in maintaining 
homeostasis, for example, in the immune system where it eliminates unwanted B and T 
cells. Disregulation of apoptosis during the maintenance of homeostasis leads to cancer, 
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as illustrated by B-cell lymphomas. While disregulation or inhibition of apoptosis at 
different stages in the life of vertebrates is detrimental, activation of apoptosis, for 
example, in the cells of the central nervous system upon trauma, or in cardiomyocytes 
deprived of oxygen upon myocardial infarction, also has a deleterious effect onto the life 
expectancy of an organism10, 11.  It is estimated that up to 50% of the cells lost in a heart 
attack or stroke might be saved by pharmacologic inhibition of apoptosis. The latter can 
be accomplished only when we understand the molecular and biophysical mechanisms of 
programmed cell death. 
 
Bcl-2 protein family and apoptosis 
 Apoptosis can occur via two distinct pathways: the extrinsic and intrinsic 
pathways7, 12-15 (Fig. 1-1). The extrinsic pathway, also known as the death-receptor 
pathway, occurs via activation of the death receptors at the cell surface, leading to the 
activation of effector caspase 8, which in turn activates the executioner caspases that 
dismantle the cell. The intrinsic pathway of apoptosis, also known as the mitochondrial 
pathway, occurs when the cell senses internal damage or is deprived of growth factors. 
The mitochondrial pathway of apoptosis is controlled by the Bcl-2 protein family, where 
upon activation, proteins Bax or Bak permeabilize the mitochondrial outer membrane 
(MOM) resulting in the release of cytochrome c and other mitochondria-resident proteins 
into the cytoplasm. In the cytoplasm cytochrome c activates the formation of an 
apoptosome, leading to cell death. The two pathways of apoptosis are connected though 
caspase 8. Caspase 8 can cleave Bid to produce tBid which activates Bax and Bak to 
permeabilize the MOM and release cytochrome c, thus killing a cell.  
 3
 
Figure 1-1. The two pathways of apoptosis. 
 
Sub-groups of the Bcl-2 protein family 
 In humans, twenty-three genes comprise the Bcl-2 protein family and they 
generate both pro- and anti-apoptotic proteins13, 16-21. These two functional protein groups 
are further divided into three structural groups based on the number of conserved Bcl-2 
homology domains (BH1-4) (Fig. 1-2). The first group are the anti-apoptotic 
multidomain proteins which display sequence conservation through BH1-4 domains, and 
they include Bcl-2, Bcl-xL, Mcl1, etc. The other two groups of the Bcl-2 protein family 
are the pro-apoptotic multidomain proteins (Bax, Bak) and the pro-apoptotic BH3-only 
proteins (Bid, Bim, Bad, Noxa, Puma, etc.). Interactions between these three groups of 
the Bcl-2 protein family inform the programmed cell-death decision by altering the  
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 Figure 1-2. The Bcl-2 protein family.  
 
permeability state of the MOM. Alteration of the permeability state of the MOM is done 
by Bax and Bak, which together22 or independently23,  can form oligomeric pores in the 
MOM. The rest of the Bcl-2 family proteins positively and negatively regulate pore 
formation by Bax and Bak. It has been proposed that the anti-apoptotic proteins such as 
Bcl-2 and Bcl-xL inhibit pore formation by Bax and Bak by directly binding these 
proteins in the MOM. However, it has been shown that Bcl-xL can prevent Bax pore 
formation and apoptosis by an independent mechanism where Bcl-xL does not need to 
hetero-oligomerize with Bax or Bak24, 25, though the molecular details of this mechanism 
have yet to be determined.  
The BH3-only proteins, also known as the sentinels of death, transmit the death 
signal sensed internally inside the cell to Bax and Bak26. However, two opposing 
hypothesis for these proteins function have been proposed. The first hypothesis states that 
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all BH3-only proteins can bind directly only to the anti-apoptotic proteins which keep 
Bax and Bak in check. Binding of the BH3-only proteins to the anti-apoptotic proteins 
releases Bax and Bak to form pores12-14, 20, 27-29. The second hypothesis proposes that 
there are two types of the BH3-only proteins: direct activators and de-
repressor/sensitizers7, 21, 30-34. The direct activator proteins, which include only Bid, Bim 
and Puma, activate Bax and Bak by directly binding these proteins, while de-
repressor/sensitizer proteins, which include the rest of the BH3-only proteins, initiate 
apoptosis by binding the anti-apoptotic proteins, preventing them from interacting with 
the activator BH3-proteins as well as Bax and Bak. However, Puma have been 
characterized by some groups as a direct activator while by others as a de-
repressor/sensitizer21, 31. 
One of the interesting questions about the Bcl-2 protein family in vertebrates is 
why the family needs to have so many members (over twenty), while in other 
multicellular organisms, for example, C. elegans there are only two homologues of the 
Bcl-2 protein family (Egl-1 and Ced-9)35. A possible answer to this question comes from 
the tissue-specific expression of the Bcl-2 proteins in vertebrates. For example Bax and 
Bak are expressed in most tissues while the BH3-only proteins have tissue-specific 
expression patterns. Additionally, BH3-only proteins receive apoptotic signals from 
various sources. For example, protein Bim is sequestered to the cytoskeletal structures via 
association with dynein light chain LC8, and is released form this interaction upon the 
induction of apoptosis. Free Bim translocates to the mitochondria where it serves as a 
direct activator of Bax and Bak36, 37. Another example is the cytoplasmic protein Bid, 
which upon cleavage by caspases 8 translocates to the MOM where it serves as a direct 
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activator of Bax and Bak38-40. Puma, another BH3-only protein, is a cytoplasmic protein 
which is known to interact with p53, a tumor-suppressor protein involved in the 
regulation of the cell cycle41. Upon interaction with p53, Puma influences the activation 
of Bax and Bak. Therefore, it has been proposed that the reason for the expansion of the 
number of protein in the Bcl-2 family is the based on three points: (i) a need for 
redundancy; (ii) a need for functional specialization due to the higher number of tissues 
in vertebrates compare to invertebrates; (iii) and a need for compensatory regulation35.  
 
Discovery of the Bcl-2 protein family: retrospective history 
 The Bcl-2 family of proteins was discovered during a quest to understand the 
molecular origins of cancer. In the 1940s in the US, an increase in the incidents of cancer 
was observed and this increase continues. As a result massive research effort has been 
undertaken to understand the origins of cancer. In 1970s the first viral oncogene, src, was 
discovered42. In 1989 Bishop and Varmus were awarded the Nobel Prize in Medicine for 
the discovery of viral oncogenes, and in particular the src oncogene. The discovery of src 
showed that there is a connection between the DNA content of a cell and cancer, and thus 
opened new avenues of research. As a result it has been shown that a number of non-
hereditary cancers are associated with chromosomal translocations43-45. For example, it 
has been shown that translocation from chromosome 14 to chromosome 18, t(14:18), is 
commonly detected in poorly differentiated lymphocytic lymphomas44. However, the 
state of technology at the time did not allow sequencing of these translocations. In 1980 it 
became possible to sequence chromosomal DNA at the translocation points and in 1985 
three unrelated research groups published independently their results on cloning the gene 
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located at the t(14:18)46-49. This gene was called bcl-2, abbreviating the name of cancer 
cells from which it was cloned – B cell lymphoma. The translocation t(14:18) has 
coupled the immunoglobulin heavy chain locus from chromosome 14 to the bcl-2 gene 
on chromosome 18, thus leading to over-expression of this gene. However, it was unclear 
how the over-expression of a gene can cause cancer. 
In 1988 Vaux et al has shown that the over-expression of the Bcl-2 protein results 
in reduced cell death and the locking of cells in the G0 state50. This observation became 
the first proof that bcl-2 was an oncogene which promoted cancer not due to the mutation 
in the gene, but due to the over-expression of the normal gene. After that point the quest 
for detailed understanding of the Bcl-2 protein function began. As a result it has been 
discovered that Bcl-2 is involved in the control of apoptosis. Additionally, it was found 
that there are a number of proteins which share sequence homology with the Bcl-2 
protein, which consequently became the members of the Bcl-2 protein family. These 
proteins include Bax51, Bcl-xL52, Bcl-w53, Mcl154, Bik55, Bid40, Bim56 and others.  
In 1993 protein Bax was discovered by coimmunoprecipitation with Bcl-xL51 and 
later on it has been shown that to prevent apoptosis, Bcl-2 has to hetero-dimerize with 
Bax57, 58. It has also been shown that during apoptosis the release of cytochrome c is 
required to initiate the mitochondrial pathway of apoptosis and that Bax and Bak are 
involved in this process59. 
The biochemical function of the Bcl-2 protein family was revealed after the 
structure for Bcl-xL was solved60. This structure showed a remarkable similarity in fold 
with the pore-forming subunits of collicin A and diphtheria toxin61, 62. Later on the 
structures of Bid63, Bax64 and Bcl-265 have been determined and they showed the same 
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resemblance in protein fold to Bcl-xL and collicin A. Thus, based on this similarity in 
protein fold, it has been proposed and later proved that proteins of the Bcl-2 family can 
form pores in lipid membranes66-72. 
Since the over-expression of the anti-apoptotic proteins has been implicated in 
causing cancer, an attempt has been made to develop pharmacologic inhibitors of the 
anti-apototic proteins73. As a result, anti-cancer drugs such as ABT-747 and ABT-263 
have been developed74-77. These drugs have been engineered to bind the hydrophobic 
pocket on the surface of Bcl-2 and Bcl-xL, where normally the BH3 proteins would bind, 
thus allowing the BH3 proteins to activate Bax and Bak resulting in the cell death.  
Another avenue for the development of anti-cancer drugs would be to develop 
small molecules able to activate the pro-apoptotic members of the Bcl-2 family, such as 
Bax and Bak. In addition, development of small molecules which can inhibit the 
activation of Bax and Bak would be tremendously beneficial in the prevention of 
apoptosis in the central nervous system after trauma or apoptosis of cardiomyocytes after 
myocardial infarction. However, all of the above scenarios of activation and inhibition of 
Bax and Bak are still on hold, since the mechanism of the activation of Bax and Bak is 
not clear. This demonstrates the need for more basic research to be applied to the problem 
of understanding the molecular mechanism of action of the proteins of the Bcl-2 family, 
and in particular of the protein Bax. 
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Structure and function of protein Bax 
Bax is a 21 kDa protein (192 amino acids). According to the solution NMR 
structure, Bax consists of nine α-helices with 61 % α-helical content64 (Fig. 1-3). This 
structure represents the conformation of inactive solution Bax. In contrast to inactive 
Bax, active Bax is bound to a lipid membrane and has a different protein conformation 
(Fig. 1-4). It has been shown by cysteine scanning of Bax that in the active membrane 
bound conformation of Bax has three helices inserted into the lipid membrane78. These 
are helices 5, 6 and 9 (Fig. 1-4, shown in blue and yellow). To achieve such conformation 
the molecule of Bax needs to be “flexible”. The flexibility in changing from one protein 
conformation to another is possible due to the presence of multiple glycines in the loops 
connecting the helices of Bax (Fig. 1-5). Glycines constitute 11 % of all amino acids in 
Bax and 60 % of them are found in the connecting loops.  
In order to permeabilize the MOM, Bax needs to translocate from the cytosole to 
the MOM and undergo a conformational change which is associated with its activation 
and can be detected by the conformation specific antibodies. In particular, 6A7 antibody 
against the N-terminus of Bax is used as a “gold standard” for showing the activation of 
Bax79, 80. However, the molecular mechanism of Bax activation is a matter of active 
debate21, 28, 81. In fact, it has been recognized as a “holy grail of apoptosis research”7.  
It has been shown in in vitro assays that Bax can be directly activated by a 
number of BH3 peptides82, and by the full-length BH3-only proteins21, 41, 83-86. In 
addition, it has been shown that Bax can be directly activated by heat87, by the direct 
interaction with p5388, by elevated pH89 and by incubation with detergents79, 80, 90, 91.  
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Figure 1-3.  Structure of the human Bax protein, alpha isoform64. See Appendix I for 
protein sequence. 
 
 
Figure 1-4.  Schematic of the protein conformation of Bax in a lipid membrane. 
 
 
Figure 1-5. Position of glycine and proline amino acids in the Bax protein 
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Currently, two structural models of Bax activation are being proposed. The first 
model suggests that the homo- and hetero-oligomerization of Bax with other Bcl-2 family 
members occurs via a hydrophobic groove on the surface of Bax (formed by domain 
BH1-3) which in the inactive protein conformation is occupied by the C-terminus of Bax. 
This model of Bax activation is not supported by the structural studies on Bax, i.e. 
currently there is no solved structure of Bax where this hydrophobic groove is occluded 
by the BH3 domain. However, this hypothesis of C-terminus displacement by the BH3 
peptides was proposed based on the structural studies with the anti-apoptotic proteins92 
which share a similar fold with Bax. The second model of Bax activation by the BH3 
peptides has been proposed by Gavathiotis et al, who has shown that the stapled BH3 
peptide of Bim binds to Bax at a binding site formed by helices 1 and 6 of Bax93. This 
site is on the opposite side of the Bax protein from the hydrophobic groove occupied by 
the C-terminus. However, it is possible that in vivo both of these binding sites on Bax are 
used in the homo- and heterotypic interactions.   
The importance of various residues and sequences of residues in Bax has been 
explored in a large number of studies.  As a result, it has been shown that the removal of 
the BH3 domain in Bax renders it inactive in vivo94  and that BH3 domain is important 
for hetero-and homo-oligomerization among proteins of the Bcl-2 family95, 96. It was also 
shown that the N-terminal end of Bax contains the mitochondrial-targeting sequence97, 98 
and that the C-terminus of Bax, together with helices 5 and 6, is involved in membrane 
binding70, 78, 99, while the rest of the helices of Bax play an important role in the activation 
of Bax by the BH3-only proteins and in the homo-oligomerization of Bax93, 100, 101. 
Therefore, when considering a strategy for the fluorescent labeling of Bax for FCS 
 12
studies discussed in Chapter 7, we did not label Bax with GFP (however, it has been 
done102) but instead we labeled Bax with small fluorescent dyes (~0.5 kDa) via 
genetically engineered cysteine. A similar fluorophore labeling strategy of Bax has been 
used by Lovell  et al, where Bax was used in a FRET study84. 
 
 
Bax pore formation mechanism 
According to a simplified apoptosis model, Bax is found in the cytoplasm of non-
dying cells and upon the initiation of the mitochondrial pathway of apoptosis Bax is 
activated. Then it translocates from the cytoplasm to the mitochondrial outer membrane, 
where it inserts into the membrane as a monomer and then undergoes self-
assembly/oligomerization to form a pore through which cytochrome c and other 
mitochondria-resident proteins can escape into the cytoplasm103-105 (Fig. 1-6).  
 
 
Figure 1-6. Schematic of the mechanism of Bax binding, conformational change, 
integration, and pore formation in a lipid membrane. 
 
The formation of Bax pores in MOM has not been observed by high resolution 
electron microscopy. Instead it was shown that Bax was accumulated at the fission site of 
mitochondria during apoptosis106. In addition, it has been shown that disruption of 
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mitochondrial fission results in the inhibition of apoptosis thus establishing a connection 
between the function of Bax and that of the proteins involved in mitochondrial fission107-
110. However, the electrophysiology measurements of membrane conductance in isolated 
mitochondria from apoptotic cells revealed the existence of a mitochondrial apoptosis-
induced channel (MAC). The exact protein composition of a MAC is not clear but it is 
clear that Bax is its major component111, 112. It has been shown that MAC activity is not 
present in Bax-/-, Bak-/- cells, but is present in cells expressing one or both of these 
proteins112. Additionally, it has been shown that the conductivity of a MAC in proteo-
liposomes formed from mitochondrial membranes is similar to the conduction properties 
of the channels formed by the recombinant activated Bax, however, the two do not match 
exactly. On the other hand, in vitro Bax has been shown to form pores in artificial lipid 
membranes, and its ability to release cytochrome c and other macromolecules from 
liposomes via the formation of a pore is clearly documented39, 68, 83, 104, 105, 113. Therefore, 
the existence of a MAC in mitochondria during apoptosis and the ability of recombinant 
Bax to form pores in artificial lipid bilayers indicate that the permeabilization of the 
OMM during apoptosis must occur via the formation of a Bax-containing pore. Dispite 
this indication the opponents of this hypothesis do exist. 
Studies of the kinetics of liposome poration by Bax revealed that Bax forms pores 
of various diameters starting with a dimer pore of 1 nm in diameter, continuing to a  
tetramer pore of 4 nm in diameter104 (this pore is wide enough for cytochrome c to go 
though), and continuing to larger pores up to 100 nm in diameter83, 113, 114. This 
heterogeneity in the sizes of pores formed by Bax was assumed to be a controversy, 
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however, later on it has been shown that the size of a Bax-containing pore in MOM 
changes with time111, thus unifying all previous results.  
In Chapter 6 of this dissertation we present data showing that Bax is able to form 
even larger pores with diameter of 5-20 µm. We named these pores as Bax mega-pores 
and they are wide enough to allow multiple mitochondria to diffuse through them. In all 
of the observed Bax mega-pores Bax was concentrated at the rim of the pore, however, in 
GUVs, where the mega-pore was observed to close, no trace of large visible aggregates 
of Bax was left on the membrane surface of a GUV. This observation indicates that Bax 
is accumulated at the pore edge, but it does not form tight contacts with neighboring 
monomers of Bax thus allowing for fast disassembly of the pore. This brings us to the 
discussion about the type of the pore formed by Bax. 
The pore forming proteins and peptides can form two types of pores in lipid 
membranes – barrel-stave and toroidal pores115 (Fig. 1-7). The interior of the barrel-stave 
pore is outlined by protein components, while the interior of the toroidal pore has lipid 
headgroups outlining the pore interior. Because of its unique structure toroidal pore is 
occasionally called a lipidic pore since the two leaflets of the lipid bilayer are connected 
 
Figure 1-7.  Schematic of a cross section for a barrel-stave and for a toroidal pore. 
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at the pore site. The example of a peptide forming barrel-stave pore is alamethicin116, 
while magainin peptide serves as an example of a peptide forming toroidal pores117.  
In case of Bax both models of the pore has been proposed and still are being 
proposed118-121. However, overwhelming number of arguments suggest that Bax forms a 
toroidal type of pore. The first argument is that Bax accelerates the rate of lipid mixing 
between the two leaflets of a lipid bilayer85, 119. Normally such lipid mixing or transfer 
has an extremely low rate and can be accelerated only when the two leaflets are 
connected, for example through a lipidic pore. The second argument comes from the 
neutron scattering experiments where lipid bilayers treated with pore-forming helix 5 of 
Bax shows formation of a lipidic pore structure121. As a control in these experiments 
alamethicin was used to show the neutron scattering pattern for a bona fide barrel-stave 
pore forming peptide. The third argument is based on the experiments where the addition 
of positive intrinsic curvature promoting lipids (such as lyso-lipids), which energetically 
favor being in the rim of a lipidic pore, accelerated Bax pore formation, while addition of 
lipids with negative intrinsic curvature (such as DOPE or cholesterol) inhibited the pore 
formation by Bax67, 86. In addition to this argument, it has been shown that activated Bax 
can crosslink liposomes to form cuboidal structures – sponge-like structures (unpublished 
data).  
 The above-mentioned review of the pore-formation mechanism of Bax together 
with the enigma of Bax activation, also discussed above, clearly indicates that the 
mechanism of Bax pore formation is poorly understood and needs to be studied in greater 
detail. The experiments discussed in this dissertation attempt to answer some of the 
questions about the mechanism of Bax action. 
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“In vitro Systems to Study Protein Bax” 
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Introduction 
Due to the complexity of cellular systems and due to the size limitations of mitochondria, 
which represent the “battle ground” for the proteins of the Bcl-2 family, it has been 
recognized that model in vitro systems which mimic mitochondria can provide crucial 
information about the function of Bax and the other Bcl-2 family proteins. In this chapter 
four model in vitro systems used to study Bax are discussed (Fig. 2-1). These in vitro 
systems are introduced in the order of simplicity of preparation, starting with detergent 
micelles, continuing to large unilamellar vesicles (100-200 nm in diameter), and giant 
unilamellar vesicles (5-100 µm in diameter), and finishing with supported lipid bilayers. 
In addition, previous use of these in vitro systems and the utility of these systems to the 
study of the mechanism of Bax pore formation in lipid membranes are discussed. 
 
Figure 2-1. In vitro systems used to study Bax pore formation. Adopted with permission 
from Mariana Ruiz Villarreal. 
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Detergent micelles 
After the discovery of the various members of the Bcl-2 family, a number of 
studies have been done to determine the cellular localization of these proteins prior to and 
during apoptosis. These studies have shown that, for example, the Bcl-2 protein is found 
primarily in the membrane compartment of cells1-3, while Bax and Bcl-xL changed 
localization from cytosolic to membrane during the induction of apoptosis4. In these 
studies, detergents were used to extract Bax and other Bcl-2 family proteins from the 
membrane compartment, and it has been discovered that certain detergents can promote 
homo- and hetero-dimerization of the Bcl-2 family proteins4, 5. In particular, it has been 
found that certain detergents can lead to the conformational change in Bax which is 
associated with its activation5. As a result, Antonsson et al. tested a number of detergents 
for their ability to activate Bax, allowing it to form pores in liposomes6.  The results of 
this study have shown that Bax can be activated by incubation with detergents such as n-
octylglucoside, dodecylmaltoside, Nonidet P-40 and Triton X-100 but not with CHAPS. 
This discovery has led to a number of studies where Bax was activated by incubation 
with detergents, primarily n-octylglucoside7-13. However, before we discuss the important 
results of the studies of Bax in detergent micelles, it is important to discuss the basic 
properties of detergent micelles and detergent molecules comprising these micelles.  
Detergents are amphipathic molecules which self-assemble into micelles in 
aqueous solution (Fig. 2-2)14, 15. The critical concentration at which detergent molecules 
start to self-assemble into micelles is known as critical micelles concentration (CMC). 
The size and shape of detergent micelles together with the CMC depend on the chemical 
structure of detergent molecules (Table 2-1). In addition, based on their chemical  
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 Figure 2-2. a. Schematic of a detergent molecule consisting of a hydrophobic tail and a 
hydrophilic headgroup. b. Schematic cross-section of a spherical detergent micelle16.  
 
structure detergents are subdivided into two major groups: non-ionic and ionic detergents 
(Table 2-1). In addition to showing that a range of detergents can activate Bax to form 
pores in lipid membranes, Antonsson et al. has also shown using analytical gel filtration 
that Bax, when incubated with these activating detergent micelles, eluted together with a 
high molecular weight marker with the molecular weight larger than the combined weight 
of one Bax monomer and one detergent micelle6. Based on this observation together with 
the knowledge that Bax oligomerizes in the MOM during apoptosis17, it was proposed 
that detergents promote homo-oligomerization of Bax and these homo-oligomers 
represent active Bax. As a result Bax activated by incubation with detergent micelles was 
named oligomeric Bax, OG-Bax13, 18. In addition to these biochemical studies, Suzuki et 
al. while determining the solution structure of inactive Bax, attempted to determine the 
structure of Bax in an n-octylglucoside micelle19, showing that Bax does form large  
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Table 2-1. Characteristics of various detergents. 
Name MW CMC, M 
at 25 °C 
Aggregation 
number 
Structure 
Non-ionic detergents 
Dodecylmaltoside 510 0.15 mM 98 
 
n-octylglucoside 292 20-25 mM 84 
 
CHAPS 615 6 mM 10 
 
cholic acid 430 14 mM 10 
 
Triton X-100 625 0.2-0.9 mM 100-155 
 
Tween 20 1228 0.06 mM  
 
Ionic detergents 
Sodium lauryl 
sulfate, SDS 
288 7-10 mM 62  
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molecular weight complexes in the presence of n-octylglucoside micelles. These n-
octylglucoside/Bax complexes had very large hydrodynamic volume, preventing the 
NMR based determination of the structure of active Bax.  
In Chapter 4 of this dissertation, similar studies were undertaken with the 
fluorescently labeled truncated form of Bax, BaxΔC, with the purpose of determining the 
number of Bax monomers in the OG-Bax complex11. These studies show that indeed 
BaxΔC, incubated with detergent micelles, forms large macromolecular complexes, but 
with only one BaxΔC monomer present per complex. This result shows that Bax is able 
to change the structure of detergent micelles and indicates that the molecular mechanism 
of Bax activation by detergents is not well understood. 
Cholic acid is a naturally occurring bile salt able to activate Bax5, 11 but without 
the occurrence of large molecular weight Bax complexes. The latter fact makes cholic 
acid an interesting candidate for the study of Bax activation. 
Detergent micelles were recognized initially as in vitro platforms providing a 
hydrophobic environment for the study of Bax activation. However, it turned out that 
when present in detergent micelles, Bax has a transformative effect on the detergent 
micelle structure. For this reason the activation effect of detergents on Bax have been 
employed widely. However, it is conceivable that in the future, detergents such as cholic 
acid can be used to determine the protein conformation of active Bax. 
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Large unilamellar vesicles 
Large unilamellar vesicles (LUVs) are widely used as a well characterized, easily 
manipulated in vitro system to study the mechanism of Bax pore formation (Fig. 2-3).  
LUVs have been used in a wide variety of in vitro Bax-related studies: (i) the 
stoichiometry of Bax pore formation20; (ii) the kinetics of Bax pore formation in various 
conditions such as presence of activating detergents, or activating proteins (such as cBid 
and Bim), or low pH 6, 7, 9, 13, 20-22; (iii) the kinetics of Bax binding to lipid membranes10, 
23; (iv) the morphological changes of lipid membranes upon Bax binding 24; (v) the effect 
of curvature-producing and charged lipids on Bax pore formation7, (vi) the interaction of 
Bax with other Bcl-2 family proteins 7, 22, 23, 25; (vii) the ability of Bax to promote mixing 
of lipids between the internal and external LUV leaflets26; (viii) the conformational 
changes in Bax structure upon membrane binding27 etc. 
 The LUVs used in the majority of the aforementioned studies are 200 nm in 
diameter (similar to the smallest cross-section diameter of mitochondria28) and are most 
commonly composed of a lipid mixture containing combinations of either of following 
lipids: DOPC, POPC, DOPE, DOPA, DOPG or cardiolipin – lipids which are commonly 
found in the contact sites of mitochondria29. The contact sites in mitochondria are the 
sites where the outer and inner mitochondrial membranes are in contact. The two most 
common methods of LUV preparation are the freeze-thaw method30  and the reverse-
phase method10, 11, 31-33 (See Appendix II for a detailed protocol).  
The utility of LUVs to study the mechanism of Bax pore formation is clear, 
however this in vitro system has a number of important limitations: (i) lipid composition 
of LUVs cannot be 100% identical to the lipid composition of the MOM; (ii) LUVs lack 
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other mitochondrial proteins present in the MOM during Bax insertion and pore 
formation which may affect the ability of Bax to form pores; (iii) due to their size, LUVs 
cannot be used to study the in-membrane diffusion of Bax monomers and the oligomeric 
Bax pores (GUVs can be used for this purpose). 
 
 
 
Figure 2-3. Transmission electron microscopy 
micrograph of LUVs. Scale bar is 200 nm. 
Adopted from Soman et al.34 
 
 
Giant unilamellar vesicles 
 Giant unilamellar vesicles (GUVs) are another example of a model in vitro system 
used to study the mechanism of Bax pore formation (Fig. 2-4). GUVs have been used 
successfully to study Bax pore using a patch clamp technique18, or to study the dye 
release from a GUV though a single Bax pore using fluorescence microscopy9. Due to 
their size, 5-100 µm in diameter, GUVs can be observed by light microscopy, unlike 
LUVs, and they can be used to study protein diffusion and oligomerization in a lipid 
membrane using FCS35-39 as well as to study the morphological changes in GUVs upon 
protein binding40-42. The use of GUVs to study the diffusion and homo-oligomerization of 
Bax in lipid membranes using FCS is discussed in Chapter 5. 
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 Figure 2-4. Giant unilamellar vesicles: confocal microscopy images.  
a. Confocal 3D reconstruction of a field of GUVs (view from the top). One large GUV 
dominates the field. b. Multilamellar giant vesicle. c. Cross-section image of a field of 
GUVs. d. Multilamellar GUVs prepared from a lipid mixture of DOPC and cardiolipin 
(80:20 mol %). Scale bar in each image is 20 µm. All GUVs were prepared by the 
electroformation method43. 
 
GUVs can be prepared by three methods: “gentle hydration” method44, 45, reverse-
phase method46, and by the electroformation method43, 47-50. In the “gentle hydration” 
method, as the name implies, GUVs are formed by the hydration of dried lipid film 
 35
deposited on a glass or Teflon surface. In this method, GUVs are formed by the swelling 
of the lipid film into lipid vesicles. It generally takes up to12 hours to produce GUVs by 
this method while the electroformation and the reverse-phase methods take up to 2 hours 
(depending on the lipid composition). In the reverse-phase method, GUVs are made by 
mixing lipids dissolved in a mixture of diethyl ether and chloroform with aqueous buffer 
solution forming an emulsion of water in ether/chloroform which is transformed into 
GUVs after the slow evaporation of ether and chloroform. In the electroformation 
method, lipids are dried on the surface of two parallel platinum wires43 or on the surface 
of two parallel ITO-coated cover glass plates48, which are then transferred into an 
aqueous solution (usually 300 mM sucrose) and connected to an AC generator (See 
Appendix III for detailed protocol). The AC generator generates an alternating electric 
field between the two electrodes (in this case platinum wires or ITO-coated glass plates) 
resulting in the swelling of lipid bilayers from the substrate in the form of GUVs.  
The electroformation method of GUV preparation is used most commonly due to 
the relative simplicity of the preparation protocol51, and it was used to prepare the GUVs 
described in Chapters 5 though 7. However, this method has a number of drawbacks, 
such as the difficulty of forming GUVs in solutions containing physiologic salt 
concentrations51, the inability to prepare GUVs with heterogeneous lipid distribution 
between the two lipid leaflets (which would be desirable, since most cellular membranes 
have asymmetric lipid distribution among the two leaflets), and the artifacts associated 
with the heterogeneous lipid distribution among the GUVs in the same preparation (Fig. 
2-5). In GUVs prepared from a mixture of more than three lipids, it is common to see 
heterogeneous lipid distribute among the GUVs as shown by arrow and asterisk on 
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Figure 2-5. Heterogeneity of lipid distribution among the GUV prepared by the 
electroformation method. GUVs with prominent heterogeneity of lipid distribution are 
indicated with an arrow and an asterisk. Scale Bar 20 µm.  
 
Figure 2-5, where lipidic dyes DiO and DiD are unevenly redistribute among the GUVs. 
Another example of heterogeneous lipid distribution is illustrated by the simultaneous 
formation of unilamellar and multilamellar giant vesicles, electroformed from a lipid 
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mixture of DOPC:cardiolipin (80:20 mol %) (Fig. 2-4d). This effect will be discussed in 
greater detail in Chapter 5 of this dissertation.  
 
Lipid bilayers 
Lipid bilayers are another example of an in vitro system which can be used to 
study the mechanism of Bax pore formation. Based on the preparation method, lipid 
bilayers can be divided into supported lipid bilayers (SLBs), which are prepared on a 
mica surface, and free-standing lipid bilayers which are mostly used in electrophysiology. 
SLBs can be further subdivided into dry and hydrated lipid bilayers. All three types of 
lipid bilayers have been used to study the mechanism of Bax pore formation. For 
example, hydrated SLBs have been used to study by AFM the effect of full length Bax 
protein and the pore-forming helices of Bax (helices 5 and 6) on hydrated SLB52, 53 while 
dry SLBs were used in neutron-scattering experiments to determine whether the pore-
forming helix of Bax (helix 5) forms toroidal or barrel-staved type pores54. The result of 
the latter study showed that helix 5 of Bax forms toroidal pores in lipid membranes. Use 
of free-standing lipid bilayers in the electrophysiology experiments allowed conductance 
measurements to be performed on Bax pores. It was shown that Bax pores are non 
selective and can have a variety of diameters18, 21, 55, 56. In addition, using free standing 
lipid bilayers, Basanez et al. have shown that upon insertion into the lipid bilayer, Bax 
reduces the line tension in the bilayer55, which was further confirmed by Garcia-Saez et 
al. in a study using AFM on a hydrated SLB exposed to the pore forming helix 5 of 
Bax57. These line tension studies together with the measurements presented in Chapter 6 
of this dissertation suggest the ability of Bax to stabilize a lipid edge, and provide further 
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support for the hypothesis that Bax forms lipid stabilized toroidal pores in lipid 
membranes.  
We have also attempted to use hydrated SLBs to study the diffusion and 
oligomerization of Bax in lipid membranes using FCS (Fig. 2-6). However, because of 
the hindrance of lipid diffusion in SLBs due to mica-lipid bilayer interaction we reasoned 
that free-standing bilayers where lipid diffusion in not hindered by the interaction with 
mica would provide a better model system for studies of the in-membrane diffusion of 
Bax. Therefore, we have used GUVs as a source of free-standing lipid bilayers in the 
FCS studies on Bax (Chapter 5).  
 
BaxΔC lipidic dye DiD overlay 
 
Figure 2-6. Bax binding to a supported lipid bilayer.  Lipid bilayer was prepared from 
a lipid mixture of DOPC:Sphingomeyelin:Cholesterol = 2:2:1 mol%. BaxΔC labeled with 
Bodipy FL was used in these experiments. Scale bar is 5µm. 
 
Previous studies of Bax in lipid bilayers have shown that this model in vitro 
system is instrumental in the study of the mechanism of Bax pore formation. However, 
the limited number of studies utilizing this system to study Bax shows that this model 
system is under-exploited. One of the potential uses of this model system can be 
combining it with the use of total internal reflection (TIRF) microscopy. Use of hydrated 
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SLBs in combination with single-molecule TIRF microscopy can be employed to study 
the sequence of interactions among the Bax and other Bcl-2 family proteins leading to or 
preventing pore formation by Bax.    
 
Other in vitro systems  
A description of model in vitro systems used to study Bax would not be complete 
without mentioning a less commonly used model such as lipid monolayers and lipid 
bicelles. Lipid monolayers have been used to study binding and incorporation of Bax and 
tBid58 (Fig. 2-7 a) where it has been shown that upon binding tBid increases pressure in 
lipid monolayers 12 times higher than the pressure produced by Bax, indicating that tBid 
has higher binding affinity to lipid membranes than Bax. The results of this study have 
been recently corroborated by the kinetic measurements of the fluorescent Bax and tBid 
insertion into lipid membranes23.  
 Lipid bicelles present another possible model in vitro system for studying the 
structure of active Bax. Lipid bicelles are discoidal lipid aggregates formed from long-
chain phospholipids and either detergents or short-chain phospholipids(Fig. 2-7 b). 
Bicelles are  
 
 
Figure 2-7. Schematic representation of a lipid monolayer and a bicelle. 
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most commonly used in NMR to study the structure-function relationship of membrane 
associated and membrane-integrated proteins59, 60. Therefore, they can be used to 
determine the structure of Bax in lipid membranes. 
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 This Chapter provides an overview of single-molecule sensitivity fluorescence 
techniques and the description of liposome permeability assay, which was used to asses 
the functionality of all proteins used in the experiments described in this dissertation. 
 
Single-Molecule Sensitivity Fluorescence Techniques  
 Single-molecule sensitivity fluorescence techniques provide a powerful non-
invasive tool to study biological processes in vivo and in vitro and have been used 
extensively in a number of experiments described in this dissertation. The following 
section provides a background on the physical basis of fluorescence and the background 
of the three single-molecule sensitivity fluorescence techniques: fluorescence correlation 
spectroscopy (FCS)1, fluorescence cross-correlation spectroscopy (FCCS)2, and 
fluorescence intensity distribution analysis (FIDA)3. 
 
Physical principles of fluorescence 
 Luminescence is a physical process of the emission of a photon by a molecule 
during the transition between the electronic energy states4, 5. Depending on the nature of 
the excited electronic energy states between which the transition occurs, luminescence is 
divided into two categories – fluorescence and phosphorescence. Fluorescence occurs 
during the transition from a singlet energy states to the ground state (for example, 
S1→S0), while phosphorescence occurs during the transition from a triplet state to the 
ground state (for example, T1→S0). The electron in a triplet state has the same spin 
orientation as the electron in the ground state, and therefore, according to the principles 
of quantum mechanics transitions between these energy states are forbidden; however, 
they do occur but with lower probability. Based on the low probability of the T1→S0 
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transition, the lifetime of an electron in the triplet state, T1, is longer than its life time in 
the excited singlet state, S1, and therefore, the lifetime of a fluorescence process is 
generally on the order of 10-9 seconds, while the lifetime of a phosphorescence is on the 
order of 10-6 seconds.  
The electronic energy states and the transitions among them can be summarized 
by the Jablonski diagram (Fig. 3-1). On this diagram the excited electronic energy states 
and the ground state are shown with thick horizontal lines, while the vibrational energy 
states of each energy state are shown with thinner horizontal lines. According to this 
diagram, in the absence of excitation the molecule is in the ground electronic energy 
state, S0. Upon absorption of a photon with the energy of Ah , the molecule is excited 
into the higher electronic energy state S1 or S2. Transition between the energy states is 
shown by vertical lines. Once in the S2 state, the molecule rapidly relaxes to the lowest 
vibrational level of S1 via internal conversion mechanism. Next, molecule transitions to 
the ground energy state by emitting a photon with the energy of Fh  or by transfering 
energy via a non-radiative pathway (for example, collision with other molecules). 
Alternatively, molecules in the S1 energy state can undergo an intersystem crossing to the 
triplet state T1. Such transitions are forbidden by the principles of quantum mechanics but 
do occur with a low probability. Once in the T1 state, a molecule undergoes T1→S0 
transition by emitting a photon with energy Ph or by the mechanism of non-radiative 
energy transfer.  
 Excitation into higher vibrational energy states followed by the decay into various 
vibrational ground states results in the lower energy of emitted fluorescence photons than 
the energy of the adsorbed photon. The difference in the energy of adsorbed and emitted  
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Figure 3-1. Jablonski diagram of the electronic energy states of a molecule. 
 
 
 
 
Figure 3-2. Excitation and emission spectra for two fluorophores: Alexa Fluor 488 
maleimide and Atto 655 maleimide. These excitation and emission spectra illustrate the 
phenomenon of a Stokes’ shift. 
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photons is translated into respectively shorter and longer wavelength of the adsorbed and 
emitted photons which is also known as a Stokes’ shift, and is used to separate the 
excitation photons from the emission photons in the FCS experiments with the use of 
dichroic mirrors and filters (Fig. 3-2). 
 
Fluorophores 
Fluorophores, or fluorescent dyes, are molecules which can emit fluorescent light 
when excited4-6. The major characteristics of fluorophores include excitation and 
emission spectra, extinction coefficient, quantum yield, singlet-to-triplet quantum yield 
and photobleaching. Excitation and emission spectra of a fluorophore define the 
excitation wavelength of a laser and the combination of a dichroic mirror and filters in 
the FCS experiment (Fig. 3-2). Extinction coefficient defines the efficiency of the 
fluorophore molecules to absorb excitation light, while the quantum yield of a 
fluorophore is defined as a ratio of the number of emitted photons per unit of time to the 
number of absorbed photons. Alternatively, the quantum yield of a fluorophore is defined 
as  
    
nrr
r
kk
k
      (Eqn. 1) 
where,  is the rate of radiative energy transfer defined as the transition rate of singlet to 
the ground state, and  is the rate of all non-radiative de-excitation processes.  
rk
nrk
 Photobleaching of a fluorophore is a process of irreversible destruction of a 
fluorophore. For each fluorophore type there is a characteristic number of photons 
emitted before the dye undergoes photobleaching. For example, Alexa Fluor 488 is more 
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photostable than carboxyfluorescein, while both of these fluorophores have identical 
excitation and emission spectra. Photobleaching in the FCS experiment can be controlled 
by the illumination levels7, 8.  
 For use in FCS experiments fluorophores should have high extinction coefficient, 
high fluorescence quantum yield, low singlet-to-triplet quantum yield and low 
photobleaching7, 8. However, the majority of biological molecules do not posses such 
fluorescence properties (GFP would be an exception from this statement). Therefore, in 
order to study the biological molecules, a number of synthetic fluorophores were 
developed. These fluorophores are bright and photostable and have engineered reactive 
groups which allow for their attachment to the biological molecules of interest. In case of 
Bax we used maleimide reactive group which forms a covalent bond with an engineered 
cysteine. Examples of chemical structure for some synthetic FCS-compatible 
fluorophores used in the experiments presented in this dissertation are shown in Figure 3-
3. Depending on the chemical structure fluorophores can be used in a variety of 
applications. For example, small dyes like Alexa Fluor 488, Atto 655 and Bodipy FL can 
be used to label proteins and nucleic acids, while lipophilic dyes like DiO and DiD are 
used to visualize lipid membranes.  
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Alexa Fluor 488 c5 maleimide 
 
Atto 655 
 
BODIPY® FL N-(2-aminoethyl)maleimide 
 
 
 
DiO 
DiD 
 
Figure 3-3. Chemical structures for selected FCS-compatible fluorophores. All of these 
fluorophores were used in the experiments described in Chapters 7 through 7. 
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FCS and autocorrelation analysis 
Fluorescence correlation spectroscopy (FCS)1 is a single-molecule sensitivity 
technique uniquely suited for study of biological processes in the 3D space of solution1, 7, 
9-14, in the 2D space of a lipid membrane15-22, or in 1D space, in the case of the directed 
flow of fluorophores8. It is based on detecting fluorescence intensity fluctuations within a 
small observation volume (<1 fl) which is achieved by the use of a confocal microscope 
(Fig. 3-4). Temporal analysis of these fluorescence intensity fluctuations allows 
determination of the concentration and diffusion coefficients of the fluorophores passing 
through the observation volume. 
 
Development of FCS: historic prospective 
 The theoretical basis of FCS has been developed by Madge D., Elson E. and 
Webb W.W. in 197223. However, due to technical limitations, it did not gain wide use 
until two decades later; when in 1993, Rigler et al implemented FCS in the scheme of a 
confocal microscope and showed a number of implementation of the technique in 
biochemistry and biology9, 24-28.  Since then, FCS has seen a renaissance in its 
development based on the number of its various implementations such as fluorescence 
cross-correlation spectroscopy2, 12, 29, photon-counting histogram (PCH) also known as 
fluorescence intensity distribution analysis (FIDA)3, 30-32, high-order correlation FCS 
(HO-FCS)33-36, image-correlation spectroscopy37-40, total internal reflection FCS (TIR-
FCS)41, stimulated emission depletion FCS (STED-FCS)42-44, FCS with UV fluorophores 
(UV-FCS)26, 45, implementation of the FCS in vivo12, 14, 17, 18, 46-49, two-photon FCS50, 51, 
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supercritical angle FCS52, multiple variation of scanning FCS17, 53-58, FCS in lipid 
membranes19-21, 32, 55, 56, 59-62 etc.  
 
The auto-correlation function 
In a generic FCS experiment, excitation light from a laser is focused into a small 
volume (also known as observation volume) in a solution sample with the use of a 
dichroic mirror and a high numerical aperture objective (Fig. 3-4 a). Here, for the sake of 
simple explanation, we assume that the sample consists of a dilute solution of freely 
diffusing non-interacting fluorophores (Fig. 3-4 b). Each time a fluorophore passes 
through the observation volume, it is excited and emits fluorescence, a portion of which 
is collected by the objective and directed through the dichroic mirror and a filter to a 
pinhole positioned in front of the avalanche photo diode (APD) used as a highly sensitive 
detector in the FCS setup. Pinhole does not allow photons generated outside the 
observation volume to reach the APD, thus only the photons generated by the 
fluorophores present in the observation volume are registered and give rise to the 
fluorescence intensity fluctuations trace (Fig. 3-4 c). From this intensity trace, the 
autocorrelation function can be calculated as1, 8 
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where  is the autocorrelation function,  is the fluorescence intensity as a function of 
time, 
G F
  is the correlation time (also known as the “lag time”) and the angular brackets 
refer to time averaging, while )()()( tFtFtF   and  
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 Figure 3-4. Principles of FCS. a. Schematic of the FCS setup. b. schematic 
representation of the FCS observation volume. c. Time trace of the fluorescence intensity 
fluctuations is used to calculate the auto-correlation curve, which measures the self-
similarity of the signal. d.  Fitting of the experimental auto-correlation curve allows 
determination of the parameters of interest such as diffusion coefficient and the number 
of fluorescent particles in the observation volume. See next section for the description of 
selected the fitting correlation functions. 
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The auto-correlation function measures the self similarity of the fluorescence 
signal with time by comparing the signal at time t  with the signal at time t  (the 
product carries out this comparison) and averaging over all times (Fig. 3-4 c). During the 
short lag times  the fluorophore has not moved out from the observation volume and 
signal intensity would not change much, thus resulting in high value of the auto-
correlation function. For the longer lag times  the fluorophore would move out from the 
observation volume resulting in a significance change in the signal intensity and low 
values for autocorrelation function which decay to zero at long lag times.  
 The auto-correlation function is characterized by the two major parameters: the 
diffusion time D  and the height of the curve,  (Fig. 3-4 d). The diffusion time )0(G D  
represents the average time the fluorophore spends in the observation volume and is 
connected to the diffusion coefficient, , of the fluorophore D
     DxyD 4
2      (Eqn. 3) 
where xy is the waist of the observation volume. The heights of the auto-correlation 
curve, , is proportional to the average number of particles in the observation 
volume. If we set 
)0(G
0 in the equation 2 and assume the fluorescence intensity to be 
proportional to the number of particles in the observation volume, then we find N
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because the number of particles in the observation volume follows a Poisson distribution. 
 The fluctuations of the fluorescence intensity in the observation volume arise not 
only due to the Brownian diffusion of fluorophores through the volume, but also due to 
photophysical fluctuations, internal dynamics, rotation of fluorophores and 
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photobleaching which lead to the variation in excitation probabilities. Additionally, 
fluctuations in the excitation power or detection geometry can result in an unwanted 
change of the fluorescence intensity and thus lead to the distortion of the auto-correlation 
curve. Therefore, additional controls should be used to account for these possible sources 
of fluorescence fluctuations. 
 Once the correlation curve is obtained, it is fitted with a mathematical function 
which models the fluorescence intensity fluctuations in the observation volume according 
to the characteristics of the system under study (for example, 3D versus 2D diffusion). IN 
the fitting function some of the fitting parameters are the concentration of particles and 
their diffusion coefficient.  
 
Fitting correlation functions 
In order to extract meaningful information about the system under study the 
experimental auto-correlation function needs to be fitted to the fitting correlation function 
which is derived from the fundamental physical principles. In the case of the Brownian 
diffusion of a fluorophore in a 3D space the fitting correlation function is defines as 
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where is the average number of fluorescent particles in the observation volume, N
SCN 0
23  , is the concentration of fluorophores and C xy is the waist radius of the 
laser focus. The structural parameter xyzS  measures the aspect ratio of observation 
volume which is assumed to have Gaussian shape. Detailed derivation of the Equation 5 
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can be found in references 1 and 3. However, it is important to point out that this 
equation was derived using the diffusion equation describing free Brownian diffusion: 
    ),(),( 2 trCD
t
trC 
    (Eqn. 6) 
where ),( trC  is the concentration of the fluorophores at various positions r  inside the 
observation volume at a time point . t
 Additionally, equation 5 should take into account the photodynamic state of a 
fluorophore while it is present in the observation volume, since the timescale of these 
photodynamic changes is comparable to the diffusion time of a fluorophore. For example, 
the diffusion time D  of the Alexa Fluor 488 is aqueous solution is 30±5 µsec, while the 
triplet time is 4.7±1.9 µsec (mean±s.d., n=3, measured with the Confocor 2 instrument). 
Therefore, accounting for the triplet-state population (T ) of the fluorophore is done by an 
additional factor: 
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where T  is the lifetime of the triplet state of the fluorophore and T is the fraction of 
fluorophores in the triplet state. 
In case of FCS measurement in a lipid membrane, a fitting correlation function 
that models the 2D motion of fluorescently labeled particles in the plane perpendicular to 
the laser beam path is: 
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where is the lipid membrane area found in the observation volume, C  is the 
concentration of the fluorophores (in molecules per unit area), and 
effA
D  is calculated using 
equation 3. In many examples of the FCS measurements of lipid and protein diffusion in 
lipid membranes, the diffusion time D  is on the order of milliseconds and is at least two 
orders of magnitude longer that the triplet time of the fluorophore. Therefore, those cases 
the contribution of the triplet state of the fluorophore is not considered. 
 In case of the active transport of molecules though the observation volume with 
velocity v  the fitting auto-correlation function is defined as8, 63: 
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FCCS and cross-correlation analysis 
FCS is a powerful technique which allows determination of the diffusion 
coefficients and concentrations of fluorophores. However, in many biochemical and 
biological processes this information is insufficient, since the fluorescently labeled 
molecules of interest undergo chemical reactions such as association (or binding). If the 
two molecules of interest associate and have similar diffusion coefficient (i.e. similar 
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molecular weight), then FCS would not be able to differentiate between the hetero-dimer 
and the individual monomer molecules. To solve this problem FCCS was developed2.  
In FCCS experiments the two molecules of interest are labeled with spectrally 
different fluorophores and excited with overlapping laser beams (Fig.3-5). Example of 
the FCCS-compatible pair of fluorophores, Alexa Fluor 488 and Atto 655, is shown in 
Figure 3-2 and 3-3.  
In the FCCS experiment the fluorescence fluctuations are detected in two 
channels with signals  and (Fig. 3-5b). If the labeled species interact, they 
will diffuse as one particle through the observation volume, resulting in simultaneous 
fluorescence signal in both channels and positive cross-correlation (Fig. 3-5c). The 
spectral cross-correlation curve is obtained from the cross-correlation analysis of the 
fluorescence fluctuations in the two channels: 
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The degree of binding or percentage of cross-correlation ( ) can be calculated by 
comparing the amplitude  from the auto- and cross-correlation curves: 
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Here , and  correspond to the concentrations of bound species rgC rC gC rg , and the 
unbound form r  and g  respectively.  
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Figure 3-5. Principles of FCCS. a. FCCS setup for measurement in solution and in a 
lipid membrane of a GUV. b. Fluorescence intensity traces for the red and green 
channels. c. Examples for the auto-correlation curves for the red and green channels and 
the cross-correlation between the two channels (blue line). 
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FCCS is prone to artifacts and care must be taken to avoid them. The two main 
artifacts in FCCS measurements are spectral cross-talk, which leads to false-positive 
cross-correlation, and imperfect overlap between the detection volumes, which leads to 
decreased cross-correlation11, 12, 29. Spectral cross-talk can be corrected by using 
alternative excitation or alternative pair of fluorophores, while the imperfect overlap 
between the detection volumes is more difficult to correct. One of the approaches used to 
account for imperfect overlap between the detection volumes uses measurement of the 
maximum possible cross-correlation for the instrument (for examples, by using double-
labeled DNA) and then correcting all consecutive measurements for the value of this  
maximum signal. 
 
Two-focus scanning FCCS 
  Two-focus scanning FCS was developed specifically for the FCS 
measurement in the lipid membranes of GUVs which tend to undergo multiple 
undulations (spatial fluctuations) during the time of the measurement (Fig. 3-6).  
Presence of membrane undulations introduces additional fluctuations in the fluorescence 
intensity signal which can be incorrectly interpreted as the presence of slowly diffusing 
molecules64. In addition to the possible contribution of membrane undulations to the 
auto-correlation curve, photobleaching is another problem encountered in FCS in lipid 
membranes. In a lipid membrane molecules diffuse slower than in solution and thus 
require longer FCS measurement time which increases the probability of photobleaching. 
Use of scanning FCS reduces photobleaching during the measurement without shortening 
the measurement time. 
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          a. 
 
  b.
 
Figure 3-6. Confocal microscopy image of the cross-section of a GUV which a. 
undergoes large membrane undulations due to loss of tension which occurred due to the 
permeabilization of the GUV by Bax; b. tensed GUV which does not have significant 
membrane undulations.  
 
Before continuing the description of the formalism of the two-focus scanning FCS, it is 
important to mention the two approaches of performing FCS experiments in GUVs. FCS 
in GUVs can be done in two spatial positions: at the top or bottom of GUV20, 47, 61, or in 
the membrane segment in the equatorial section of a GUV16, 18, 19, 55 which is used in the 
two-focus scanning FCS (Fig. 3-7a).  In two-focus scanning FCS, the observation volume 
is scanned perpendicularly through the equatorial section of a GUV along two lines 
separated by distance  in alternating fashion. Intersection of each scanning line with the 
GUV membrane creates a detection area on the GUV surface. Scanning of the 
observation volume is up to 1000 times faster than the diffusion time of a protein or lipid 
molecule in the lipid membrane, thus allowing sampling of the fluorescent protein or 
lipid many time before it leaves the observation volume. In addition, scanning of the 
observation volume through the GUV membrane reduces the photobleaching in the 
detection each membrane detection area by reducing the residency time of the laser beam 
   
d
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Figure. 3-7. Principles of two-focus scanning FCS. a. Schematic of the position of a laser 
beam with respect to GUV in two types of FCS measurements. b. Confocal image of an 
equatorial cross section of a GUV. c-f. Schematic of data analysis in two-focus scanning 
FCS.  g. Normalized auto- and cross correlation curve for Bax-G in a lipid membrane 
measured by two-focus scanning FCS. 
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 in the detection areas. Once the scanning is done, a map of change in the fluorescence 
intensity with time for each of the two detection areas is constructed (Fig. 3-7c) and 
further processed by software to eliminate the contribution of membrane undulations to 
the fluorescence intensity trace (Fig. 3-7d). Next, the fluorescence intensity trace for each 
detection area is auto-correlated and fitted to  
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while the cross-correlation of the fluorescence intensity traces of the detection areas is 
fitted to 
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The cross-correlation curve fitted to this equation shows a maximum at a characteristic 
lag time, which is the time it takes a fluorophore to move from one detection area to the 
other. Once the distance between the two detection areas is known, diffusion coefficient 
 and the structure parameter can be determined directly by fitting to equation 10. A 
global fit of the two auto-correlation functions (one for each detection area) and the 
cross-correlation function improves the accuracy. Example of  the auto- and cross-
correlation curves obtained by the two-focus scanning FCS is shown in Figure 3-7g. 
D S
 Due to the alternating data collection between the two foci the resulting cross-
correlation curve is shifted by the delay time . If this delay time is comparable to the 
diffusion time 
dt
D  of the fluorophores, then the shift needs to be taken into account. 
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However, in our two-focus FCS experiments on Bax in GUV membranes the delay time 
was much smaller than the diffusion time and thus was not taken into account. 
 
Two-color two-focus scanning FCCS 
 Two-color two-focus scanning FCCS is used to study the formation of in-
membrane complexes by molecules labeled with two spectrally different fluorophores 
(similar to the discussed above FCCS in solution). Data analysis for this technique 
includes calculation of the auto- and cross-correlation functions for each spectral channel. 
 In case of perfect overlap between the detection volumes for each spectral channel 
and negligible cross-talk, the concentrations of the unbound molecules and and of 
molecules in a complex  is calculated from the amplitudes of the correlation functions 
in following way 
rC gC
rgC
   rgreffr CCAG 
1)0( ,   rggeffg CCAG 
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     rggrgreff rgrgcross CCCCA
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G )0(    (Eqn. 11) 
 
Fluorescence intensity distribution analysis 
Fluorescence intensity distribution analysis (FIDA) is an extension on the FCS 
technique3. While FCS analyzes the temporal characteristics of the fluorescence 
fluctuations allowing determinations of the concentration and diffusion properties of the 
fluorophores, FIDA analyzes the instantaneous values of the fluorescence intensity 
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fluctuations, thus providing information about the distribution of the aggregation states of 
the fluorophores (Fig. 3-8).  
FIDA and FCS share similar experimental setup which is based on confocal 
microscope (3-4). In this setup fluorophores diffusing thought the observation volume 
and emit photons, a portion of which is transmitted though the optics of the microscope to 
the APD. It is estimated that up to 105 photons per second can be detected by the APD 
from a fluorophore passing through the observation volume. The observation volume in 
FCS is approximated to have Gaussian shape, while in FIDA the shape of the observation 
volume can not be described by Gaussian and is more complex due to interference caused 
by diaphragms and aberrations. The observation volume in FIDA is described by the 
 
Figure 3-8. FIDA and FCS use the same signal of the fluorescence intensity fluctuations. 
FIDA utilizes the values for the instantaneous brightness of the fluctuations while FCS 
utilizes the temporal distribution of the fluorescence fluctuations. On the figure n  
represents the number of photon counts.  
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three-dimensional spatial brightness function )(rB , which is instrument specific and can 
be calculated using a calibration measurement with a single dye of known brightness (for 
example, Alexa Fluor 488 or rhodamine 6G).  
Distribution of photon counts, ,  arising from the observation volume carries 
information about the specific brightness and concentration of all fluorescent species 
present in the volume and is calculated according to the Mandel formula3, 65 which is 
expressed as  
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where is the concentration of species with specific brightness of , is the length 
of the counting period, i is the summation index representing the number of fluorescent 
species,  is summation index representing total number of molecules inside the 
observation volume, n  is summation index representing the number of photon counts. 
Equation 12 is a double Poissonian first part of which represent the Poisson distribution 
of the number of molecules within small portion of the observation volume, , while 
the second part of the equation represent the Poisson distribution of the number of photon 
counts detected from the molecules inside the observation volume. It is stated by Kask et 
al that FIDA can differentiate up to five various fluorescent species in a single 
experiment. 
ic iq countT
m
dV
In FIDA two major assumptions are used: (i) the coordinates of the molecules do 
not change significantly during the counting period  which means that the counting 
period should be shorter than the average time a fluorophore spends inside the 
observation volume (i.e. 
countT
DcountT  ); and (ii) brightness of each molecule can be 
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expressed as the product of a spatial brightness function )(rB  and specific brightness q , 
which is characteristic to each fluorescent species. Example of FIDA for monomeric 
fluorescently labeled BaxΔC and for fluorescently labeled  BaxΔC bound to liposomes is 
shown in Figure 3-9. Furthermore, use of FIDA to determine the oligomeric state of Bax 
in detergent micelles is discussed in Chapter 4. 
a 
 
b 
 
Figure 3-9. Fl-BAXΔC(G40C) bound to liposomes: FCS and FIDA results. a. Results of 
the FIDA fitting for monomeric free fl-BAXΔC(G40C) in solution (squares) and the fl-
BAXΔC(G40C)-liposome mixture (circles). According to the single-component FIDA 
fitting the molecular brightness of free fl-BAXΔC(G40C) monomers in solution was 
5.4±0.1 kHz, while two-component FIDA fitting for fl-BAXΔC(G40C)-liposome mixture 
produced  the values for the molecular brightness of 5.4 kHz (fixed component) and 
51.7±10.7 kHz which correspond to 9.57±1.99 fl-BAXΔC(G40C) molecules bound per 
LUV. FIDA analysis was done based on at least six 100 seconds measurements. b. 
Autocorrelation curves (not fitted) for free fl-BAXΔC(G40C) in solution ( D =91.3±4.3 
µsec) (filled squares) and for fl-BAXΔC(G40C)-LUV mixture ( 1D =91.3 µsec, 
2D =1.12±0.2 msec) (empty circles). 
 
 The general idea for analysis of the photon counts have been proposed by Qian 
and Elson66, 67 in 1990, while the formalism and experimental implementation of FIDA 
has been presented by Kask et al3 in 1999. Currently a number of variation of FIDA have 
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been developed and they include two-dimensional FIDA (2D-FIDA)68, fluorescence 
intensity and lifetime analysis (FILDA)69, fluorescence intensity multiple distributions 
analysis (FIMDA)70. In contrast to FIDA, 2D-FIDA uses two detectors to differentiate 
between the various dyes, while FILDA and FIMDA perform simultaneous determination 
of the fluorescence brightness (as done by FIDA) together with fluorescence lifetime or 
diffusion time respectively.  
 
Assay of liposome permeability 
 Assay of liposome permeability is used to study the kinetics of the pore formation 
by Bax and other pore-forming proteins and peptides71. For this assay large unilamellar 
liposomes (100-200 nm in diameter) containing high concentration of a fluorescent dye 
are prepared (See Appendix II for a detailed protocol). As a fluorescent dyes in this assay 
carboxyfluorescein or calcein are most commonly used16, 72. These dyes are self-
quenched and thus do not fluoresce at 20-50 mM concentration and become fluorescent 
when diluted to µM concentration. 
 In a generic liposome permeability assay unilamellar liposomes with encapsulated 
dye have very low background fluorescence signal ( ) (Fig. 3-10). When the pore 
forming agent is added (for example, activated Bax), the dye molecules are released from 
liposomes, becomes diluted and the increase in the fluorescence signal ( ) is detected. 
Maximum dye release from liposomes ( ) is achieved by the addition of detergent 
(for example, 0.1% w/v Triton X-100) which results in the solubilization of all liposomes 
present in the assay. The curve representing the kinetics of dye release from liposomes is 
calculated as 
)0(F
)(tF
maxF
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)0(
)0()()(
max FF
FtFtR 
     (Eqn. 13) 
In many instances the curve of dye release is exponential and can be used to gain 
quantitative information about the kinetics of the release73, 74 by fitting to equation  
   tmtAFtR
release
 ))exp(1()0()( 1   (Eqn. 14) 
where,  is the size of exponential component, 1A release  is the time constant of the 
exponential component,  is the slope of the linear component of the release curve 
which is occasionally present in release experiments due to the background leakage of 
dye from liposomes. Saito et al used equation 14 to calculate the 
m
release  values for the 
various concentrations of activated Bax and then used these values in a Hill plot analysis 
to determine the stoichiometry of the initial pores formed by Bax73. This analysis showed 
that Bax forms dimer and then tetramer pores. However, due to the small size of the 
encapsulated dye (0.5 kDa) the formation of higher in stoichiometry Bax pores has not 
been detected. However, later experiment with liposomes encapsulating larger dye 
molecules (for example 10 and 70 kDa dextran labeled with carboxyfluorescein) have 
shown that Bax can form pores large enough to release these dyes75, 76.  
In addition to using self-quenching effect of carboxyfluorescein and calcein in 
some applications it is advantageous to encapsulate into liposomes dyes together with a 
quencher. Examples of such quencher-dye pair are Tb/DPA and ANTS/DPX76-78. 
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 Figure 3-10. Principles of the assay of liposome permeability. 
 
The assay of liposome permeabilization has a number of advantages over other 
techniques measuring the pore formation in lipid membranes (for example, the 
electrophysiology methods).  These advantages include relative ease of sample 
preparation (liposomes can be prepared in 30 min and then used within 1 week), fast data 
acquisition and analysis, and the ability to measure multiple samples at in one experiment 
by using 96-well format in a fluoremeter. However, the major disadvantage of the 
technique is that it measures the permeabilization of a population of liposomes and thus 
doe not allow characterization of individual pores. 
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Abstract* 
BAX is a pro-apoptotic member of the BCL-2 protein family. At the onset of apoptosis, 
monomeric, cytoplasmic BAX is activated and translocates to the outer mitochondrial 
membrane, where it forms an oligomeric pore. The chemical mechanism of BAX 
activation is controversial and several in vitro and in vivo methods of its activation are 
known. One of the most commonly used in vitro methods is activation with detergents, 
such as n-octylglucoside. During BAX activation with n-octylglucoside, it has been 
shown that BAX forms high molecular weight complexes which are larger than combined 
molecular weight of BAX monomer and one detergent micelle. These large complexes 
have been ascribed to the oligomerization of BAX prior to its membrane insertion and 
pore formation. This is in contrast with the in vivo studies which suggest that active BAX 
inserts into the outer mitochondrial membrane as a monomer and then undergoes 
oligomerization. Here, to simultaneously determine the molecular weight and the number 
of BAX proteins per BAX-detergent micelle during detergent activation we have used an 
approach which combines two single-molecule sensitivity techniques – fluorescence 
correlation spectroscopy (FCS) and fluorescence-intensity distribution analysis (FIDA). 
We have tested a range of detergents: n-octylglucoside, dodecylmaltoside, Triton X-100, 
Tween 20, CHAPS and cholic acid. With these detergents we observe that BAX is a 
monomer before, during and after interaction with micelles. We conclude that detergent 
activation of BAX is not congruent with oligomerization and that in physiologic buffer 
conditions BAX can assume two stable monomeric conformations: one inactive and one 
active.  
* This research was originally published in Journal of Biological  Chemistry  Ivashyna, O., A.J. Garcia-
Saez, J. Ries, E.T. Christenson, P. Schwille, and P.H. Schlesinger. 2009. Detergent activated BAX protein 
is a monomer. 284(36):23935-23946.  © the American Society for Biochemistry and Molecular Biology. 
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Introduction 
BAX is a pro-apoptotic member of the BCL-2 protein family. In a simplified 
apoptosis model, monomeric inactive BAX is localized in the cytoplasm of healthy non-
dying cells1. During apoptosis BAX is activated, and translocates to the OMM2 where it 
inserts as a monomer3, undergoes oligomerization4 and forms a pore through which 
cytochrome c and other apoptotic factors are released into the cytoplasm. Once in the 
cytoplasm, these apoptotic factors induce the activation of the effector caspases which 
execute the cell death process. This mechanism, which is generally correct, requires that 
soluble BAX becomes integrated into the mitochondrial membrane where it forms a 
functional oligomeric pore capable of cytochrome c release. However, the molecular 
mechanism of BAX activation remains controversial5, 6.  
It has been understood for some time, but frequently ignored, that activity of the 
BCL-2 family proteins are exhibited in cells when these proteins are associated with the 
hydrophobic environment of membranes. Therefore, it has always seemed that attention 
to the effect of hydrophobic environments on the BCL-2 family proteins would be 
rewarding. It has been shown that BAX can be directly activated by treatment with non-
ionic detergents such as n-octylglucoside, dodecylmaltoside, and Triton X-1001, 7. During 
activation by non-ionic detergents, in order to gain the ability to form pores in a bilayer 
membrane, BAX needs to undergo a major conformational transition from a globular 
protein with two pore-forming alpha-helices 5 and 6 hidden in the protein core8 to a 
conformation in which these two helices are exposed and inserted into a lipid membrane3, 
5, 9. The nature of this active conformation of BAX is important for the understanding of 
the death decision in cells. Most proposals suggest that in a cell this activated form of 
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BAX protein is initiated and maintained by the interactions with other proteins, such as 
tBID, or by BAX itself as a homo-oligomer7, 10. 
Non-ionic detergents have been commonly used to activate BAX for in vitro 
studies because they are reliably effective and simple to employ. However, little is known 
about the detailed molecular mechanism of BAX activation by these detergents and its 
comparability with in vivo activation of BAX. What is known is that concentrations of 
detergent above their critical micelle concentration (CMC) are necessary for BAX 
activation. This suggests that, in order to be activated, BAX needs to interact with 
detergent micelles instead of monomeric detergent molecules. For example, in the case of 
BAX activation by n-octylglucoside, it has been shown that n-octylglucoside 
concentration should be 1 % (w/v)7, which is well above the CMC for this detergent (0.6 
% w/v)11. In addition, it has also been shown that above their individual CMC 
concentrations most BAX activating detergents produce a change in BAX conformation 
which can be detected by a conformation-sensitive 6A7 antibody against BAX1, 12, 13. In 
cellular experiments this feature of BAX reactivity to 6A7 antibody is commonly 
associated with the onset of apoptosis14, 15. However, CHAPS does not generate the 
antibody detected conformational change or the activation of BAX. The small micelle 
size of this detergent (10 kDa) suggests that perhaps BAX can not adopt an activated 
state with this detergent. However, cholic acid with even smaller micelle size (4 kDa) can 
partially activate BAX1.  
Many important detergent properties are associated with micelles. The formation 
of detergent micelles in solution is concentration dependent beginning at the CMC. The 
CMC value for a detergent has a practical importance since in most cases only monomers 
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of detergent can be removed by dialysis, and therefore, it is easier to remove detergent 
monomers for a detergent with high CMC value than for a detergent with low CMC11. 
For BAX this same consideration applies to its activation with n-octylglucoside 
(CMC~23 mM) as compared to its activation with Triton X-100 (CMC~0.25 mM).  The 
ease of dialysis is why, in most cases, OG is used to activate BAX in vitro. 
It has been shown by analytical gel filtration that, when incubated with n-
octylglucoside, BAX creates complexes with molecular weight larger than the combined 
size of a BAX monomer (21 kDa) and an n-octylglucoside micelle (~26 kDa)7, 11. It has 
also been shown that in defined liposomes BAX pore formation requires 
oligomerization16. These data combined with the knowledge that oligomerization is 
important for the biological function of BAX led to a hypothesis that BAX oligomerizes 
during its detergent activation prior to membrane insertion7. However, it has been shown 
that in vivo activated BAX inserts into the OMM as a monomer3 and in order to create a 
pore, BAX undergoes oligomerization in this membrane4. This discrepancy between the 
oligomeric state of active BAX prior to its insertion into a lipid membrane in vivo 
(monomer) and in vitro (possibly hexamer or octamer) led us to study the oligomerization 
state of BAX in detergent micelles. The important issue is whether BAX activation 
requires protein oligomerization or whether active BAX conformation can be generated 
from a single protein monomer. To solve this issue we used two single-molecule 
sensitivity techniques: fluorescence correlation spectroscopy (FCS)17 and fluorescence-
intensity distribution analysis (FIDA)18. Combined use of FCS and FIDA allows 
simultaneous determination of the apparent molecular weight and the number of 
fluorescently labeled BAX monomers per protein-detergent micelle. Our results are 
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consistent with previously established results in which BAX forms high molecular weight 
protein-detergent micelles with n-octylglucoside4 and show that BAX is present as a 
monomer in these complexes. In addition, we determined the apparent molecular weight 
and the number of BAX proteins bound per protein-detergent micelles formed by BAX 
and micelles of five additional detergents (dodecylmaltoside, Triton X-100, Tween 20, 
cholic acid and CHAPS). Our data show that BAX is a monomer before, during and after 
interaction with the micelles of all tested detergents. 
 
Results 
Detergent-activated fluorescently labeled BAX∆C can release cytochrome c from 
isolated mitochondria.  
For the FCS and FIDA experiments, we prepared recombinant, fluorescently-
labeled, human BAX∆C containing a fluorophore at a single cysteine residue (Fig. 1.A, 
B). Human BAX∆C contains two indigenous cysteines (C62 and C126) which we 
considered inappropriate for fluorophore conjugation due to structural and functional 
reasons8. Previously full-length BAX with G40C, C62A and C126A mutations has been 
reported to be functional in vivo3. Therefore, we removed cysteines, C62 and C126, by 
mutation to alanine and added an additional cysteine residue in place of glycine 40 
creating BAX∆C(G40C) (Fig. 4-1.A). BAX∆C(G40C) labeled with Bodipy FL 
maleimide fluorophore became fluor-BAX∆C. 
To check the biological activity of the fluor-BAX∆C protein, we studied its 
ability to release cytochrome c using mitochondria isolated from HeLa cells (Fig. 4-1.C). 
Our results show that fluor-BAX∆C activated with 2% (w/v) n-octylglucoside releases  
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 Figure 4-1.  A. Schematic structure of human BAXΔC(G40C). Introduced mutations and 
their relative position with respect to the helices and BH domains are indicated with 
arrows. B. SDS-PAGE of purified recombinant proteins: Protein standards with 
molecular weight indicated (lane 1), human BAXΔC(G40C) (lane 2), human BAXΔC 
(lane 3), human fluor-BAXΔC (lane 4). C. Cytochrome c release from mitochondria 
isolated from HeLa cells. Mitochondria isolated from HeLa cells were incubated for 20 
min at 37 °C with 100 nM of the indicated recombinant protein. Where indicated, protein 
was activated by incubation with 2% (w/v) n-octylglucoside for 1 hour at 4°C after which 
protein/detergent mixture was diluted to obtain final detergent concentration of 0.5% 
(w/v) and the 100 nM protein concentration used in the assays. Cytochrome c content of 
each fraction was normalized for the basal release of cytochrome c in mitochondria 
samples with only detergent added and in mitochondria samples without detergent or 
protein added. Error-bars were calculated based on three independent experiments.  
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cytochrome c from isolated mitochondria similar to BAXΔC but with slightly lower 
efficiency. For both proteins significant cytochrome c release required detergent 
activation, suggesting that the detergent activation of fluor-BAXΔC was comparable to 
the detergent activation of the BAXΔC7, 12, 19. In each cytochrome c release experiment 
final concentration of n-octylglucoside was 0.005% (w/v) or lower, which is well below 
the CMC for this detergent (0.6% w/v)11, so that detergent micelles played no role in the 
release of cytochrome c or the maintenance of the active BAXΔC conformation during 
the assay. 
 
Surface plasmon resonance studies of membrane binding and integration by 
BAX∆C and fluor-BAX∆C.  
Direct analysis of the membrane binding and integration by detergent activated 
fluor-BAXΔC was compared to that of BAXΔC using surface plasmon resonance (SPR) 
as previously described20 (Fig. 4-2). SPR has been applied to the study of membrane 
binding and integration of a number of pore forming proteins and peptides21, 22 including 
BAX20. Using this technique it is not necessary to label or chemically modify the protein 
under study. Therefore, we could use this method to determine the effect of the mutations 
and the added fluorophore on fluor-BAXΔC membrane binding and integration by 
comparison with the same properties of BAXΔC. 
These SPR experiments were done using cardiolipin-containing liposomes 
(DOPC:DOPA:cardiolipin 70:20:10 mol%) immobilized on the SPR-chip surface and the 
protein of interest were injected over this surface. Both BAXΔC and fluor-BAXΔC 
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required n-octylglucoside activation to generate significant interaction with liposomes 
membrane (Fig. 4-2.A, B).  
To determine the concentration-dependence of BAX integration into the liposome 
membranes, we sequentially injected increasing concentrations of BAX over the same 
liposome-covered surface and determined the amount of BAX integrated into the lipid 
membrane based on sensorgram response after 300 seconds of washing. Our results show 
that, when activated with n-octylglucoside, fluor-BAXΔC and BAXΔC have comparable 
integration into the liposome membrane (Fig. 4-2.C). This similarity in membrane 
integration suggests that the slight decrease in cytochrome c release by fluor-BAXΔC 
(Fig. 4-1.C) is not the result of reduced membrane retention of the labeled protein, but 
possibly a result of reduced stability of the in-membrane open pore conformation. 
However, despite a possible reduction in the stability of fluor-BAXΔC pores, the 
cytochrome c release experiments (Fig 4-1.C) together with the SPR binding data (Fig. 4-
2) suggest that both BAXΔC and fluor-BAXΔC, when activated with n-octylglucoside, 
follow a similar mechanism of membrane interaction and pore formation.  
 
Analytical gel filtration of BAX∆C(G40C) with n-octylglucoside or CHAPS present.  
To show that fluor-BAXΔC interacts with detergent micelles of n-octylglucoside and 
CHAPS comparably to BAXΔC, we performed analytical gel filtration following a 
procedure of Antonsson et al.7 We carried out our analytical gel filtration studies using 
BAX∆C(G40C) incubated with either 2% (w/v) of n-octylglucoside or CHAPS (Fig. 4-
3). The obtained results show that in the absence of detergents BAX∆C(G40C) eluted as 
a monomer with molecular weight of slightly less than 25 kDa (Fig. 4-3.A), while in the 
 89
presence of 2% (w/v) n-octylglucoside, protein eluted at a molecular weight slightly 
below 440 kDa (Fig. 4-3.C). In contrast, when BAX∆C(G40C) was incubated with and 
eluted in the presence of 2% (w/v) CHAPS in the column, protein eluted mostly (73%) as 
a monomer in a broad peak (Fig. 4-3.B). These results are consistent with previously 
reported analytical gel filtration of BAX∆C (7) and show that mutant BAX∆C(G40C) 
interacts with micelles of n-octylglucoside and CHAPS similarly as BAX∆C.  
 
 
 
Figure 4-2. Surface plasmon resonance data of fluor-BAXΔC and BAXΔC binding to 
cardiolipin-containing liposomes (200 nm in diameter; DOPC:DOPA:CL 70:20:10 
mol%). Increasing concentrations of protein activated with 2% (w/v) n-octylglucoside 
was flowed over immobilized on surface liposomes A. Data for fluor-BAXΔC binding. 
B. Data for BAXΔC binding. C. Results of concentration-dependence analysis of protein 
integration into liposomes for BAXΔC (squares) and fluor-BAXΔC (triangles). 
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 Figure 4-3. Analytical gel filtration of BAXΔC(G40C) incubated with indicated 
detergents. BAXΔC(G40C) was incubated with 2% (w/v) of indicated detergent for 1 
hour at 4 °C. BAXΔC(G40C) incubated with detergent was passed through a Superdex-
200 column equilibrated with 10 mM HEPES/KOH, pH 7.0, 300 mM KCl buffer 
containing 2% (w/v) of the same detergent in which BAX was incubated. The Superdex-
200 column was calibrated with two protein standards. A. BAXΔC(G40C) without 
detergents. B. BAXΔC(G40C) + 2% (w/v) CHAPS. C. BAXΔC(G40C) + 2% (w/v) n-
octylglucoside. D. Standards (chymotrypsinogen, 25 kDa, and ferritin, 438.7 kDa).  
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Activation of BAX with non-ionic detergents.  
Compared to the amount of protein required for the analytical gel filtration 
studies, the amount of fluor-BAXΔC required for the FCS and FIDA analyses is at least 
100 times lower. Therefore, we decided to extend the range of the detergents used in our 
study. We chose n-octylglucoside, CHAPS, Triton X-100, dodecylmaltoside and Tween 
20 since these detergents have specific and known effects on  BAX∆C activity7, 19. We 
also chose cholic acid due to its similarity in structure to CHAPS, because it is a 
physiologic detergent and because it can activate BAX1. In all cases the 2% (w/v) 
concentration of the detergent was well above the CMC11.  
Before proceeding to the FCS and FIDA studies, we first tested the ability of all 
chosen detergents to activate BAXΔC using an assay of carboxyfluorescein release from 
liposomes (Fig. 4.A)20. For these experiments we used recombinant human BAXΔC 
purified from E. coli cells without detergent. This BAXΔC protein was monomeric (23 ± 
4 kDa as determined by dynamic light scattering) and had very low (<10%) 
carboxyfluorescein release activity. Upon 1 hour incubation at 4°C with selected non-
ioninc detergents (n-octylglucoside, dodecylmaltoside, Triton X-100 and Tween 20) 
BAXΔC released carboxyfluorescein from liposomes (Fig. 4-4.A), indicating that protein 
became activated. Incubation with cholic acid, an ionic detergent, also resulted in 
activation of BAXΔC. However, upon similar 1 hour incubation at 4°C with CHAPS 
(detergent known for its inability to activate BAX) no significant carboxyfluorescein 
release was observed. Similar carboxyfluorescein release results were obtained for 
BAXΔC(G40C) incubated with all six detergents (Fig. 4-4.B). Comparison of the 
maximum carboxyfluorescein release values for both proteins after 90 min presents two 
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instructive observations (Fig. 4-4.C). First, upon incubation with all detergents BAXΔC 
has almost 20% higher carboxyfluorescein releasing activity than its mutant, 
BAXΔC(G40C). Second, for both proteins incubation with Triton X-100 resulted in the 
most activated form of BAX followed by n-octylglucoside, dodecylmaltoside, cholic acid 
and Tween 20, while CHAPS failed to activated either of the two proteins.  
 
CD spectroscopy on BAXΔC in detergent micelles.  
Circular dichroism measurements were performed to determine whether any 
significant secondary structure changes occur in BAXΔC during interaction with 
detergent micelles. BAXΔC without detergent produced CD spectra with strong α-helical 
pattern (Fig. 4-5). In the presence of micelles of Triton X-100, Tween 20 or cholic acid 
no significant changes in the BAXΔC spectra were observed. However, in the presence of 
micelles of n-octylglucoside or dodecylmaltoside slight increase in the alpha-helical 
content of BAXΔC CD spectra was observed. The CD spectra of BAXΔC in the presence 
of CHAPS were not collected because of high CD signal from CHAPS (due to presence 
of amide bond in CHAPS structure).  
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Figure 4-4. Release of carboxyfluorescein (CF) from liposomes by the detergent 
activated BAXΔC and BAXΔC(G40C). A. Monomeric inactive BAXΔC was incubated 
for 1 hour at 4°C with 2% (w/v) n-octylglucoside (OG), 0.6% (w/v) dodecylmaltoside 
(DM), 0.076% (w/v) Triton X-100 (TX), 0.038% (w/v) Tween 20 (Tw), 2% (w/v) 
CHAPS, or 2% (w/v) cholic acid (ChA). During this incubation the concentration of each 
detergent was above the CMC while protein concentration was 70 µM. Before addition to 
liposomes protein was diluted to 50 nM. Total lipid mass in each assay was 175 µg. 
Liposomes composition was DOPC:DOPA 70:30 mol%. Final detergent concentration in 
the release assays was below the CMC for each detergent. Releases were normalized to 
carboxyfluorescein release by 20% Triton X-100 and corrected for basal 
carboxyfluorescein release by each detergent. Each release curve represents an average of 
at least three independent experiments. B.  Release of carboxyfluorescein from liposomes 
by detergent activated BAXΔC(G40C). Protein was treated the same way as BAXΔC in 
panel A. C. Single point comparison of the carboxyfluorescein release values at 90 
minutes for BAXΔC and BAXΔC(G40C) activated with indicated detergents. 
Representative error bars are shown for each release curve. 
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Figure 4-5. CD spectroscopy of BAXΔC in the presence of detergent micelles in 10 mM 
HEPES, pH 7.0, 100 mM KCl. A. Comparison of the CD spectra for BAXΔC alone and 
in the presence of either 0.08% Triton X-100 (TX), or 0.04% Tween 20 (Tw), or 2% 
cholic acid (ChA). B. Comparison of the CD spectra for BAXΔC alone and in the 
presence of either 2% n-octylglucoside (OG), or 0.6% dodecylmaltoside (DM). 
 
FCS detection volume is not affected by the presence of detergents.  
The maintenance of consistent detection volume is critical for accurate 
comparison of FCS characteristics of different particles. Size and shape of the FCS 
detection volume depend on a number of parameters, one of which is the refractive index 
of solution23, 24. The latter can be affected by the presence of detergents leading to the 
distortion of the FCS detection volume.  
Commonly AlexaFluor 488 dye is used for calibration of the FCS detection 
volume24, 25. During this calibration procedure the diffusion time ( D ) of the dye 
molecules and the structure parameter of the FCS detection volume ( ) are obtained by 
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fitting the measured autocorrelation curve using Equation 1. Using such analysis for 
AlexaFluor 488 diffusing freely in solution in the absence of detergent we get following 
values: D =22.7±0.9 µsec,  =5.5±0.8. To determine whether presence of detergent has 
an effect on our FCS measurements we determined D and   values for AlexaFluor 488 
in solution containing increasing concentrations of n-octylglucoside detergent (Fig. 4-6). 
The results of these experiments show that over the range of 0% to 5% (w/v) of n-
octylglucoside the diffusion time of the dye and the structure parameter of the detection 
volume do not change indicating that the FCS detection volume is not affected by the 
detergent presence. Similar experiments were done with the rest of the detergents and 
they yielded analogous results (data not shown). 
 
Figure 4-6. Effect of detergent on the shape and size of the FCS detection volume. 
Measurement of the diffusion time ( D ) of Alexa Fluor 488 and the structure parameter 
of the detection volume ( ) at various detergent concentrations. N-octylglucoside was 
used as a detergent of choice, while buffer composition was 10 mM HEPES, pH 7.2, 100 
mM KCl. Error bars were calculated based on nine 10 sec measurements. For some data 
points error bars are smaller than the symbol. 
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FCS characterization of fluor-BAX∆C in detergent micelles.  
We used fluorescence correlation spectroscopy to confirm the detergent 
dependent change in the apparent molecular weight of BAXΔC protein as seen by 
analytical gel filtration. The diffusion characteristics of fluor-BAXΔC were studied in the 
absence and in the presence of 2% (w/v) of selected detergents (Fig. 4-7, Table 4-1). The 
FCS diffusion times were obtained by fitting the autocorrelation curves (Fig. 4-7) and are 
shown in Table 1. Fluor-BAX∆C incubated with 2% (w/v) of either n-octylglucoside, 
dodecylmaltoside, Triton X-100 or Tween 20 had a significant increase in diffusion time, 
D , compared with the diffusion time of fluor-BAX∆C monomer in the absence of 
detergent. In contrast, the diffusion time of fluor-BAX∆C in the presence of 2% (w/v) 
CHAPS or cholic acid did not increase significantly (Table 4-1).  
Using Equation 6 and the diffusion time of the fluorescent particles we calculated 
the apparent molecular weight (MW) of the BAXΔC-detergent micelle complexes for 
each detergent (Table 4-1). The apparent MW of fluor-BAXΔC in the presence of n-
octylglucoside and CHAPS calculated from the FCS data are the same as the MW 
obtained by analytical gel filtration of BAX in the presence of these detergents (Fig. 4-3). 
The large MW complexes of BAX generated in the presence of n-octylglucoside, 
dodecylmaltoside and Triton X-100 detergents were significantly larger than the sum of 
BAX and micelle of the respective detergents. 
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 Figure 4-7. Normalized FCS autocorrelation curves of fluor-BAXΔC incubated with 
various detergents, as indicated (OG - n-octylglucoside, DM – dodecylmaltoside, TX-100 
– Triton X-100). For each autocorrelation experiment protein was incubated in 10 mM 
HEPES/KOH, pH 7.2, 100 mM KCl, with 2% (w/v) of indicated detergent at 4 °C for 1 
hour.  In each graph: normalized autocorrelation curve for fluor-BAXΔC in the absence 
of detergent (dashed line), normalized autocorrelation curve for fluor-BAXΔC incubated 
with 2% (w/v) of the indicated detergent (solid line), and normalized autocorrelation 
curve for fluor-BAXΔC after detergent was diluted to the concentration below its CMC 
(dotted line). Raw data for each autocorrelation curve are shown with thin jagged line. 
See Table 1 for the numerical results of the analysis of these autocorrelation curves. 
 
 
 98
To determine the size of fluor-BAX∆C after interaction with detergent micelles 
we removed micelles by diluting detergent concentration below CMC. In most cases this 
resulted in dissociation of the protein-detergent micelles as well as of the detergent 
micelles in solution. Each measurement of fluor-BAXΔC size after detergent dilution was 
done at least one hour after dilution to allow dissociation of the detergent micelles bound 
to the protein. In all cases the diffusion time of fluor-BAXΔC decreased significantly 
upon detergent dilution (Table 4-1, Fig. 4-7). For all detergents, except Triton X-100, the 
diffusion time decreased close to that of fluor-BAXΔC monomer. These observations 
indicate that upon detergent dilution the molecular weight of the protein-detergent 
micelle complexes is reduced, and for most of the detergents this molecular weight is 
reduced to that of a fluor-BAXΔC monomer. In addition, it should be mentioned that n-
octylglucoside treated fluor-BAX∆C used in the FCS dilution experiments was used with 
similar dilution as in the cytochrome c release experiments (Fig. 4-1.C). 
 
Table 4-1. Results of the FCS studies with fluor-BAX∆C-detergent micelles.  
The molecular weight of the fluor-BAX∆C-detergent micelles was calculated using Equation 6. 
 
 Detergent concentration 2% 
(w/v) 
After detergent dilution 
Sample: 
fluor-BAXΔC+ D , µsec Molecular weight, kDa Detergent concentration, 
% (w/v) 
D , µsec Molecular 
weight, kDa 
no detergent 91 ± 4  0 91 ± 4  
n-octylglucoside 223 ± 5 280 ± 12 0.003 100 ± 5 25±1 
Triton X-100 366 ± 8 1236 ± 223 0.003 158 ± 4 99±2 
dodecylmaltoside 262 ± 21 453 ± 31 0.003 90 ± 4 18±1 
CHAPS 115 ± 4 38 ± 1 0.004 87 ± 3 17±1 
cholic acid 124 ± 5 48 ± 1 0.003 86 ± 2 17±1 
Tween 20 161 ± 12 105 ±2 0.003 112 ± 3 35±1 
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Fluorescence intensity distribution analysis of fluor-BAX∆C in detergent micelles.  
Analysis of the distribution of the photon counts in the FCS data sets was used to 
determine the number of fluor-BAX∆C molecules per protein-detergent micelle formed 
with micelles of all tested detergents. This analysis used the FIDA algorithm developed 
by Kask et al.26  Using FIDA we determined fluorescence brightness of BAX molecules 
before, during and after interaction with detergent micelles. Comparison of these 
fluorescence brightness values shows that BAX is a monomer in all cases (Table 4-2). 
However, in case of dodecylmaltoside and Triton X-100 the calculated values of 
fluorescence brightness per protein-detergent micelle were 90% higher than the 
fluorescence brightness of the fluor-BAXΔC monomer. It is possible that BAX is 
dimerized in micelles of these detergents. Interestingly, in the presence of cholic acid or 
Tween 20 protein fluorescence brightness decreased by 36% and 15% respectively, while 
in the presence of the rest of the detergents protein fluorescence brightness increased or 
stayed the same as in the absence of detergents. Therefore, since protein fluorescence 
brightness was clearly affected by the detergent we studied this effect directly. 
For three detergents where micelle size was significantly increased by the 
addition of BAX (n-octylglucoside, dodecylmaltoside and Triton X-100) we varied the 
degree of protein to detergent ratio while holding either detergent or protein 
concentration constant. First, we varied the concentration of the fluor-BAXΔC from 25 
µM to 3 µM while keeping detergent concentration constant at 2% (w/v). We reasoned 
that, if fluor-BAXΔC forms oligomers in micelles, then decrease in protein concentration 
while keeping detergent concentration constant would lead to a change, e.g. reduction, of 
the oligomeric state of protein in detergent micelles. Such change in the oligomeric state 
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of protein with increasing detergent concentration has been previously demonstrated for 
some transmembrane peptides in detergent micelles27. In this case there was no 
significant change in the fluorescence brightness of the fluor-BAXΔC-detergent micelles 
(Table 4-2).  
 
 
Table 4-2. Analysis of the fluorescence-intensity distribution of the fluor-BAX∆C 
protein detergent-micelle complexes. Protein (at concentration indicated in the table) 
was preincubated with detergent for 1 hour at 4 °C. Upon incubation with detergent, the 
protein was diluted below 0.5 µM into a solution containing identical detergent 
concentration as during activation. The measurements were done immediately upon this 
dilution. Mean and standard deviations of the brightness values were calculated based on 
9 measurements 50 seconds each. 
 
 Detergent concentration 2% (w/v) After detergent dilution 
Sample: 
fluor-BAXΔC+ 
Fluorescence 
brightness for 25 
µM BAX, kHz 
Fluorescence 
brightness for 3 
µM BAX, kHz 
Detergent 
concentration, 
% (w/v) 
Fluorescence 
brightness, 
kHz 
no detergent   0 5.5 ± 0.1 
n-octylglucoside 7.4 ±0.2 7.2 ±0.3 0.003 4.7 ± 0.2 
Triton X-100 10.5 ± 0.1 10.4 ± 0.1 0.003 7.1 ± 0.1 
dodecylmaltoside 8.5 ± 0.1 10 ± 0.1 0.003 5.0 ± 0.1 
CHAPS 5.9 ± 0.1 5.8 ± 0.1 0.004 5.6 ± 0.1 
cholic acid 3.49 ± 0.06  0.003 4.71 ± 0.09 
Tween-20 4.70 ± 0.24  0.003 5.41 ± 0.06 
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Second, we measured the effect of increasing detergent concentration on the 
fluorescence brightness of fluor-BAXΔC at constant protein concentration. If protein 
fluorescence brightness increases due to the presence of detergent, then the total 
fluorescence intensity of the sample containing constant protein concentration will 
increase with increasing detergent concentration. As shown in Fig. 4-8.A (empty circles), 
for constant protein concentration in the presence of increasing n-octylglucoside 
concentrations total fluorescence intensity increases. Furthermore, fluorescence 
brightness per particle of protein-detergent micelles determined by single-component 
fitting of resulting FCS auto-correlation curves also increased (Fig. 4-8.A. filled squares). 
The ratio of the total fluorescence intensity to the fluorescence brightness per particle 
(a.k.a. cpp) represents average number of particles in the FCS observation volume. As 
expected, this number stayed constant for all n-octylglucoside concentrations clearly 
showing that increase in n-octylglucoside concentration leads to increase in protein 
fluorescence brightness. For n-octylglucoside the FCS and FIDA yield similar protein 
fluorescence brightness values (Table 4-2, Fig. 4-8). Such an agreement between FCS 
and FIDA results further shows that fluor-BAXΔC is present as a monomer in n-
octylglucoside micelles.  
Analogous detergent titration experiments were performed for the rest of the 
detergents giving the same result that protein fluorescence brightness of the fluor-
BAXΔC is changing with increasing concentration of detergent (Fig 4-8.C). In addition, 
in the n-octylglucoside titration experiment gradual increase in the protein diffusion time 
was observed together with increase in protein fluorescence brightness. This observation 
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suggests that with increasing n-octylglucoside concentration protein-detergent micelles 
grow in size (Fig 4-8.B).  
 
 
Figure 4-8. Enhancement of the fluor-BAXΔC fluorescence intensity upon interaction 
with detergents. A. Constant concentration (3 µM) of fluor-BAXΔC was incubated with 
increasing concentrations of n-octylglucoside for 1 hour at 4 °C. The fluorescence 
intensity of the protein samples incubated with detergent was measured using ConfoCor 3 
(Zeiss, Germany). For each measurement the protein incubated with detergent was 
diluted to a final concentration of 24 nM in EB buffer containing the same detergent 
concentration as in the protein sample. All measurements were done at 22 °C. Counts per 
particle (cpp) values were determined using single-component fit of the FCS 
autocorrelation curves. B. Increase in the apparent molecular weight of BAXΔC upon 
interaction with micelles of n-octylglucoside. MW values were calculated using Equation 
6. C. Change in the cpp value of fluor-BAXΔC with increasing detergent concentration. 
Samples were prepared and measurements were done similar to the Fig. 6.A. Detergent 
abbreviations are similar to Fig. 5.  
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For all tested detergents after micelle removal by dilution the fluorescence 
brightness of the fluor-BAXΔC returned to that of a protein monomer. However, upon 
removal of Triton X-100 protein fluorescence brightness decreased but was still 29% 
higher than that for the protein monomer in the absence of the detergent. This result 
suggests incomplete dissociation of the Triton X-100 molecules from BAX and is in 
accordance with the FCS diffusion time which shows that upon Triton X-100 dilution 
below CMC, the apparent MW of the fluor-BAXΔC was higher than that of a protein 
monomer.  
 
FCCS analysis of BAXΔC in detergent micelles.  
To show the absence of BAX oligomerization in detergent micelles fluorescence 
cross-correlation (FCCS) analysis was used. FCCS is a variation of the FCS which allows 
determination of the degree of interaction between two fluorescent molecules or 
macromolecular assemblies. In these experiments we used two types of fluorescently 
labeled BAX: fluor-BAXΔC and Bodipy 630/650 maleimide-BAXΔC. The degree of 
interaction between these two proteins in detergent micelles is proportional to the cross-
correlation value which is determined by FCCS analysis. The results of these FCCS 
experiments show low cross-correlation values between two fluorescent forms of 
BAXΔC compared to the theoretically predicted cross-correlation value of BAXΔC 
dimer. These FCCS results suggest absence of interaction between the two fluorescent 
variants of BAXΔC in detergent micelles of all tested detergents (Fig. 4-9). 
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Figure 4-9. Results of the FCCS experiments with fluor-BAXΔC (50% labeled)  and 
Bodipy 630/650 maleimid-BAXΔC (80% labeled) in the presence of indicated 
detergents: lane 1 - cross correlation standard (double-stranded RNA with Alexa Fluor 
488, Cy5 labels); lane 2 - no detergent present; lane 3 - + 2% n-octylglucoside; lane; 4 - + 
2% Triton X-100; lane 5 - + 2% CHAPS; lane 6 - + 2% Cholic acid; lane 7- + 2% Tween 
20; lane 8 - + 2% dodecylmaltoside; lane 9 – maximum expected cross-correlation value 
for a formation of protein dimer from a mix of 50 % and 80 % labeled protein.  
Experiments were done in 10 mM HEPES, pH 7.2, 100 mM KCl buffer at 22 °C. All 
detergent concentrations are given in % of w/v. 
 
Discussion 
Fluorescently labeled BAXΔC is active.  
In order to apply FCS to the study of BAX we generated a soluble form of the 
protein. We employed the BAXΔC in these solution studies of the protein activity and 
oligomerization because we found that it remained in solution and could be activated by 
detergent throughout all the manipulations that were used in these studies. In order to 
label this protein with a fluorophore we substituted endogenous cysteines with alanine 
(C62A, C126A) and converted glycine 40 in an unstructured region of BAX to a cysteine. 
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The position of these changes in the BAXΔC protein are shown not to interfere with the 
function of the full-length BAX in vivo3 and the resulting protein was well expressed by 
bacteria. The added cysteine was exposed in the engineered protein and formed disulfide 
cross linked BAXΔC(G40C) dimers at high concentrations (data not shown). After 
substitution with the fluorescent probe the disulfide formation did not occur. Therefore, 
further characterization of the activity of the engineered protein was performed on the 
fluor-BAXΔC. 
To assess the functional capability of fluor-BAXΔC we tested its ability to 
promote cytochrome c release from isolated mitochondria as compared to that of 
BAXΔC. Since our engineered BAXΔC was based upon the human protein we used 
mitochondria isolated from HeLa cells to study cytochrome c release28. In these 
experiments we observed that activated with n-octylglucoside fluor-BAXΔC releases 
71±15 % of the mitochondrial cytochrome c while BAXΔC releases 100±30 % (Fig. 4-1). 
Based on this result we conclude that mutation and fluorophore labeling of BAXΔC alter 
pore forming activity of this protein but only in a minor way. In addition, to these 
experiments we also studied the ability of various detergents to activate BAXΔC and its 
mutant in liposomes (Fig. 4-4). Again we saw a reduction in pore activation by the 
mutant protein. However, it is clear that the reduction is consistent across the range of 
tested detergents (Fig 4-4.C). Finally, we compared the integration of BAXΔC and its 
mutant into lipid membranes using SPR. We have recently developed methods to 
quantitatively study binding and integration of BAX to membranes using SPR20. In those 
studies protein integration into lipid membranes was critical for pore formation and only 
occurred after protein incubation with n-octylglucoside. In the SPR comparison mutant of 
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BAXΔC, BAXΔC(G40C), was fully functional and integrated into lipid membranes as 
well as BAXΔC (Fig. 4-2). Taken together these studies indicate that BAXΔC(G40C) is 
fully functional but its specific activity for pore formation is slightly lessened by the 
introduced mutations, possibly due to lower oligomerization rate or changed pore 
topology. 
Fluor-BAXΔC forms high MW protein-detergent micelles with most activating 
detergents.  BAXΔC has been shown to form high molecular weight complexes with n-
octylglucoside but not with CHAPS7. To show that our mutated BAX, BAXΔC(G40C), 
can form high molecular weight complexes with n-octylglucoside and not with CHAPS 
we performed analytical gel filtration studies similar to those in reference 7. The results 
of these analytical gel filtration experiments show that in the presence of 2% (w/v) of n-
octylglucoside BAXΔC(G40C) elutes at molecular weight slightly below 440 kDa , while 
in the presence of 2% (w/v) CHAPS this protein elutes mostly as a monomer (73%). 
These results are similar to the previously published results for BAXΔC (7) indicating 
that mutations introduced into BAXΔC do not interfere with formation of high molecular 
weight complexes of this protein with n-octylglucoside. 
Next we proceeded to measure the molecular weight of fluor-BAXΔC in the 
presence of n-octylglucoside and CHAPS using FCS. In the FCS experiments we 
measured the diffusion time, D , of fluor-BAXΔC molecules in the presence of 2% (w/v) 
of these detergents. Then using Equation 6 we calculated the molecular weight of the 
fluor-BAXΔC protein-detergent micelle complexes (Table 4-1). The molecular weight of 
BAXΔC protein-detergent micelle complexes determined by FCS and analytical gel 
filtration were fairly similar, further demonstrating that mutagenesis and fluorescent 
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labeling of BAXΔC does not affect the interactions of this protein with n-octylglucoside 
and CHAPS. This result also shows that FCS can be used to determine apparent 
molecular weight BAXΔC with other detergents. Therefore, we extended the range of 
detergents used in our study to dodecylmaltoside, Triton X-10, Tween 20 and cholic acid. 
As a result of these FCS studies we determined that fluor-BAXΔC forms high molecular 
weight complexes in the presence of activating non-ionic detergents (n-octylglucoside, 
dodecylmaltoside, Triton X-100, Tween 20). However, in the presence of cholic acid, 
activating ionic detergent, fluor-BAXΔC does not form high molecular weight 
complexes. Fluor-BAXΔC also did not form high molecular weight complexes with 
CHAPS, a zwitter-ionic detergent known for its inability to activate BAXΔC. In addition, 
all of the tested activating detergents did not induce significant secondary structure 
changes in the BAXΔC protein (Fig. 4-5).  
For the studies of BAXΔC pore-formation in lipid membranes it is desirable that 
detergent is removed after BAXΔC activation since detergent at concentrations above the 
CMC can alter the integrity of lipid membranes. Therefore, it is important to know the 
molecular weight of BAXΔC after interaction with detergent micelles. To determine the 
latter, excess detergent was removed from fluor-BAXΔC by dilution below the CMC.  
After removal of detergent micelles the molecular weight of fluor-BAXΔC decreased to 
that of the fluor-BAXΔC monomer for the most of the detergents (Table 4-1). The results 
for fluor-BAXΔC treated with Triton X-100 were an exception. Upon Triton X-100 
dilution the molecular weight of fluor-BAXΔC was five times larger than that of fluor-
BAXΔC monomer. There are two possible explanations of this result. The first 
explanation is based on incomplete dissociation of Triton-X-100 molecules bound to 
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fluor-BAXΔC upon detergent dilution, while the second explanation is possible 
formation of fluor-BAXΔC homo-oligomers. To differentiate between these two 
explanations and to determine the stoichiometry of fluor-BAXΔC before, during and after 
interactions with detergent micelles we performed FIDA. 
 
BAXΔC is present as a monomer in protein-detergent micelles.  
To further investigate the stoichiometry of the fluor-BAXΔC-detergent micelles 
we performed FIDA on the FCS data (Table 4-2). The fluorescence brightness of the 
individual protein-detergent micelles varied approximately 90% as a function of the 
detergent used, but all of them contained one BAX protein molecule. The reason for such 
variation of the fluorescence brightness of the protein monomer in various detergents was 
due to the enhancement or quenching of the Bodipy FL fluorophore brightness upon 
transfer into hydrophobic environment of a detergent micelle. Similar effect of the 
fluorophore brightness enhancement were reported previously for the fluorescently-
labeled diphtheria toxin T-domain interacting with detergent micelles29. In our case there 
appears to be an enhancement of the fluorescence brightness of fluor-BAXΔC in the 
presence of n-octylglucoside, dodecylmaltoside, Triton X-100 detergents and decrease in 
protein fluorescence brightness in the presence of cholic acid and Tween 20. Studies of 
detergent titration into constant protein concentration show that this effect is due to the 
enhancement of the fluorophore brightness and not due to protein oligomerization (Fig. 
4-8).  In addition, detergent dilution studies show that upon detergent dilution, which 
leads to the dissolution of the fluor-BAXΔC-detergent micelles, the fluorophore 
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brightness of the protein returns to that of the protein monomer prior to the interaction 
with detergent micelles (Table 4-2).   
The FIDA results mean clearly that before, during, and after interaction with 
detergent micelles the fluor-BAXΔC protein is a monomer. This observation suggests 
that BAXΔC interaction with micelles is fundamentally different from the interaction 
which it establishes in bilayer membranes. In a bilayer membrane BAXΔC assumes 
conformation which allows assembly of homo-oligomers resulting in pore formation. In 
contrast, in a detergent micelle BAXΔC assumes conformation which in case of non-
ionic detergents leads to a dramatic enlargement of resulting protein-detergent micelle 
without necessary protein homo-oligomerization (Table 4-1, Fig. 4-3). Since this increase 
in size can no longer be attributed to additional BAX molecules per micelle, it must be 
due to the incorporation of additional detergent. 
To study the interaction of the fluor-BAXΔC with detergent micelles we used 
detergents at 2% (w/v) concentration which is well above the CMC for all tested 
detergents. If expressed in molar units, this detergent concentration will be on the order 
of mM for all tested detergents (n-octylglucoside – 68 mM, Triton X-100 – 32 mM, 
CHAPS – 33 mM; dodecylmaltoside – 40 mM). In contrast, in all of the experiments the 
concentration of fluor-BAXΔC during incubation with detergent was 20-30 µM. Solution 
containing 20-30 µM protein and >30 mM detergent has an excess of detergent micelles 
over the number of protein molecules. Fleming et al. have shown that an excess of 
detergent micelles moves the protein to a more dissociated state27. Fleming et al. also 
show that for a glycophorin A transmembrane α-helix, 40% of dimers of this α-helix are 
detected for a 40 times lower mole ratio of protein to detergent than was used in our 
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experiments. This demonstrates that if fluor-BAXΔC is forming oligomers in detergent 
micelles, then we would not have been prevented from detecting them. The above 
outlined argument together with the FCCS results (Fig. 4-9) lead us to a conclusion that 
fluor-BAXΔC is present as a monomer in detergent micelles. 
The outcome of this conclusion is that during and after detergent activation 
BAXΔC is a monomer. Therefore this protein has two stable monomeric conformations 
in physiological buffer conditions: one inactive and one active. Second this implies that 
the detergent-activated species of BAX is a monomeric protein and the large molecular 
weight in the presence of the micelles of non-ionic detergents is a result of the detergent 
component of the complex. 
 
Consequences for the physiological activation of BAX.  
These studies suggest that detergent activation of BAX is not merely a mimicry of 
the physiologic BAX activation. The characteristics of the detergent activation indicate 
two intriguing characteristics which may concern in vivo activation of BAX. First, since 
BAX remains active after we effectively remove the detergent substrate upon which it 
has activated, there must be two stable conformations of monomeric solution BAX, one 
active and the other inactive. Since this activation requires a large template and is distinct 
from the oligomer-competent conformation which BAX assumes in membranes, we can 
consider the possibility that BAX is activated as a soluble protein and then integrates into 
the membrane. Second, the existence of a soluble active form of BAX suggests that this 
process can be reversed which is a potential therapeutic approach.  
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Conclusion 
In this work we studied in detail the process of BAXΔC activation by non-ioninc 
detergents. Based on the results of our study we conclude that BAXΔC is a monomer 
before, during and after interaction with detergent micelles. In this study we used 
fluorescently labeled analogue of BAXΔC in combination with two single-molecule 
sensitivity techniques (FCS and FIDA). Since the determination of the oligomeric state of 
proteins in detergent micelles is important for structural and functional studies of integral 
membrane proteins30, 31, we are hopeful that the method presented here can be used  for 
other proteins. 
 
Experimentals 
All chemicals used in this paper were from Sigma-Aldrich, St. Louis, USA, unless 
otherwise stated. All lipids were obtained from Avanti Polar Lipids, USA. Fluorescent 
dyes for protein labeling were purchased from Molecular Probes, USA. 
 
Protein constructs, protein purification and protein labeling.  
The cDNA for human BAX with 19 amino acid truncation on the C-terminus (BAXΔC) 
was fused to the C-terminal intein/chitin-binding domain of pTYB1 vector (New England 
BioLabs, USA)8. Three mutations (G40C, C62A, C126A) were introduced into each of 
the DNA plasmids using a QuikChange mutagenesis kit (Stratagene) and presence of 
mutations was confirmed by sequencing. Resulting construct and purified protein was 
dubbed as BAXΔC(G40C). All proteins (human BAXΔC and human BAXΔC(G40C)) 
were purified from BL21(DE3) E. coli cells without detergent. Briefly, bacterial cultures 
were grown at 37 °C in Terrific Broth32 to an OD600 of 1.5-2.0, then the cultures were 
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induced with 0.1 mM IPTG (RPI, Illinois, USA) and the temperature was dropped to 25 
°C. After 12-15 hours, bacteria were collected via centrifugation, the resulting pellet 
resuspended in lysis buffer (PBS, pH 7.2, 1mM EDTA, 0.25 mM PMSF), and cells 
broken by four passages through a Microfluidizer (Microfluidics, USA) at 1000 bar. 
Lysate was clarified by centrifugation and the supernatant containing BAX incubated 
with chitin affinity resin (New England BioLabs, USA) overnight at 4°C on a rocker. 
Resin was subjected to a high salt wash then equilibrated in cleavage buffer (10 mM 
HEPES/NaOH, pH 8.0, 100 mM NaCl, 50 mM DTT) and incubated for 48 hours at 4ºC. 
The purity of the proteins were assessed by SDS-PAGE. BAXΔC(G40C) was labeled 
with Bodipy FL c5-maleimide (Molecular Probes, USA) according to the manufacturer’s 
protocol. Labeled protein was separated from the free dye using a Sephadex G-25 
column. The degree of protein labeling was determined using a NanoDrop 
spectrophotometer (Thermo Scientific) by measuring absorbance at 280 nm (for protein 
concentration) and 504 nm (for Bodipy FL concentration). Resulting protein was ~ 80 % 
labeled and was stored in EB buffer (10 mM HEPES/KOH, pH 7.2, 100 mM KCl) at 4ºC.  
 
Incubation of BAX with detergent micelles.  
Prior to FCS studies, cytochrome c and carboxyfluorescein release experiments, 
fluorescently labeled BAXΔC(G40C) or BAXΔC (20-30 µM) were incubated with 2% 
(w/v) of indicated detergent in EB buffer for 1 hour at 4 °C. For FCS studies of the fluor-
BAX∆C in detergent micelles, after incubation with detergent, protein was diluted to a 
concentration below 0.5 µM in a solution containing the same detergent concentration as 
the activated protein. This dilution was done to insure that the fluorescent signal emitted 
by the protein sample is within the dynamic range of the detector in the ConFocor 3  
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(Zeiss, Germany). To remove detergent micelles for the cytochrome c release and for the 
FCS studies of post-micelle-activated fluor-BAX∆C, the BAX-detergent mixture was 
diluted below the CMC of each particular detergent. The disappearance of micelles 
occurred at different rates (< 1 minute for OG and longer but <60 minutes for TX-100) 
but was allowed to finish before further studies on the sample (cytochrome c release or 
FCS) proceeded.  
 
Cytochrome c release assay.  
Mitochondria from HeLa cells were isolated using previously published procedure33. 
Isolated mitochondria were resuspended in 10 mM HEPES/KOH, pH 7.4, 100 mM KCl, 
1 mM EGTA, 200 mM sucrose. For the cytochrome c release assay isolated mitochondria 
were incubated with 100 nM of protein that was detergent activated but micelle diluted as 
described in the preceding section or inactive protein at 37 °C for 20 min. After the 
incubation with BAX protein or detergent control solutions, mitochondria were spun 
down at 10,000 g for 10 min at 4 °C, then pellet and supernatant fractions were collected 
and stored at -20 °C. For the cytochrome c release assay we used 0.5 µg of mitochondria 
in 30 µl volume. Protein concentration in the preparation of isolated mitochondria was 
determined by Bio-Rad Protein Assay (Bio-Rad Laboratories, USA).  Cytochrome c 
content in the pellet and supernatant fractions was determined using TiterZyme EAI 
human cytochrome c Enzyme Immunimetric Assay Kit (Assay Designs, USA) in 
combination with Synergy HT plate reader (Bio-Tek Instruments, Inc., USA). 
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Surface plasmon resonance studies of BAX binding to liposomes.  
These studies were done using Biacore X instrument (Biacore Division of GE Healthcare, 
Sweden) at ambient temperature of 25 °C. Liposome with lipid composition of 
DOPC:DOPA: bovine heart cardiolipin (70:20:10 mol %) were prepared using the 
reverse-phase evaporation method34 following procedure described in detail in20. The 
buffer was EB unless otherwise noted. The rest of the experimental conditions, 
experimental protocol and data analysis were the same as described in (20).  
 
Analytical gel filtration.  
Analytical gel filtration experiments were performed on a Superdex 200 HR 10/30 
column (GE Healthcare, UK) equilibrated with 20mM Hepes/KOH pH 7.5, 300mM KCl, 
0.2mM dithiothreitol. In the corresponding samples, 2% (w/v) of the indicated detergent 
was included in the equilibration buffer. Prior to loading the sample on the column 2.5 
nmol of BAX∆C(G40C) were incubated in 2% (w/v) of the corresponding detergent for 
1h at 4° C. Then, samples were loaded into the column and run at 0.5 ml/min. 
BAX∆C(G40C) elution was detected by light absorption at 280 nm. 
 
Carboxyfluorescein release assay. 
Liposomes containing 50 mM carboxyfluorescein (CF) were prepared following 
procedure described in (20). Incubation with detergents protein was diluted into wells in a 
black bottom 96 well-plate (NUNC, Denmark) using EB buffer. Liposomes (200 nm in 
diameter, DOPC:DOPA 70:30 mol%) were added to the wells last. Immediately upon 
addition of liposomes measurement of CF fluorescence was done using Synergy HT plate 
reader (Bio-Tek Instruments, Inc., USA).  CF releases for all protein samples containing 
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detergent were corrected for the baseline CF release in the presence of detergents without 
protein. Data were analyzed in Origin 6.1 (OriginLab Corp. USA). 
 
Circular dichroism spectroscopy.  
Samples for circular dichroism (CD) spectroscopy were prepared at 5 µM protein 
concentration in 10 mM potassium phosphate buffer, pH 7.0. Detergents (n-
octylglucoside (2% w/v), dodecylmaltoside (0.6% w/v), Triton X-100 (0.08%), Tween 20 
(0.04% w/v), cholic acid (2% w/v)) were added to protein samples 1 hour prior to 
measurements and stored at 4 °C.  Samples were measured at 20 °C on Jasco J-715 
spectrapolarimeter using a 1 mm path-length cell. Data were collected every 0.1 nm at 50 
nm/min scan speed from 260 to 200 nm, and results were averaged from five scans. Due 
to high CD signal from Triton X-100 at 200 nm for samples containing this detergent 
data were collected from 240 to 205 nm. Spectra for all protein samples containing 
detergent were corrected for the baseline of detergents in the absence of protein. 
 
FCS, FCCS and FIDA analyses: instrumentation and measurements.  
LSM 510 ConfoCor 3 system coupled with Zeiss Axiovert 200M inverted microscope 
(Zeiss, Germany) was used for FCS and FIDA experiments. A water immersion C-
Apochromat 40x objective (Zeiss, Germany) focused the excitation light to a diffraction-
limited spot. The pinhole size was set to 70 µm for 488 nm excitation laser light.  The 
excitation light of a 25 mW 488 nm Argon laser was set at 1% of the acusto-optical 
tunable transmission. Laser power in the sample was 7 µW. In front of the detector LP 
530 nm filter was used. For the FCS and FIDA analyses each sample was measured at 
least nine times for 50 seconds. The detection volume was previously calibrated with free 
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Bodipy FL maleimide in solution (diffusion time 22.6 ± 0.5 µsec, structure parameter 5.0 
± 0.4). 
 
FCS analysis. 
FCS measurements provide three characteristic parameters for interpretation: D  - the 
diffusion time of a fluorescent particle (i.e. the average time a particle spends in the 
detection volume), N  - the number of fluorescent particles in the detection volume, and 
the counts per particle (cpp) or the average fluorescent intensity per particle. These 
parameters are extracted by performing a fit of FCS auto-correlation data to one 
component diffusion model which takes into account photophysical dynamics of 
fluorophores 
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In this formula )(G is auto-correlation function, τ is the lag time, T is the fraction of 
molecules in the triplet state, T  triplet decay time,   is the structure parameter (aspect 
ratio) of the Gaussian detection volume. Fitting of the FCS auto-correlation curves was 
done using Equation 1 with software written in MATLAB (Mathworks, NA) using a 
weighted non-linear least squares fitting algorithm. 
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Calculation of protein-detergent micelle molecular weight based on FCS diffusion 
time.  
For a particle in solution the diffusion time is inversely proportional to the diffusion 
coefficient  
DD 4
2 
   (Eq. 2) 
 In general protein molecules diffusing in solution are assumed to approximate a 
spherical shape permitting the Einstein-Stokes relationship to be used in evaluating the 
diffusion constant 
R
TkD B6    (Eq. 3) 
where, Bk  is the Boltzmann constant, T  is temperature in degrees Kelvin,   is viscosity 
of solution in which particle is diffusing, and R is the radius of the spherical particle. The 
radius of diffusing particle depends on the molecular weight of the particle 
(   3/1MWR  ). Under these conditions a relationship can be established between the 
FCS diffusion time of a particle and its molecular weight  
R
TkB
D   64
2
  (Eq. 4) 
  3/12 6
4
MW
TkB
D  
 (Eq. 5) 
In case of BAXΔC, we know diffusion time of a BAXΔC monomer, monomerD , , and its 
molecular weight, monomerMW = 19 kDa. We also know the diffusion time of BAXΔC 
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protein-detergent micelle, oligomerD, . Using Equation 5 we can determine the apparent 
molecular weight of the BAXΔC protein-detergent micelle 
3
,
,




monomerD
oligomerD
monomeroligomer MWMW 

 (Eq. 6) 
 FCCS analysis. Fluorescence cross-correlation spectroscopy (FCCS) employing BAX 
labeled with dyes having non-overlaping fluorescence spectra and two channel collection 
of data, was used to determine the presence or absence of BAX homo-oligomers in 
detergent micelles (23,24). Using Bodipy FL maleimide-BAXΔC and Bodipy 630/650 
maleimid-BAXΔC we studied cross-correlation in micelle associated protein. The cross-
correlation value, a ratio of the number of the fluorescent complexes containing both 
proteins of interest to the number of the fluorescent species of one of the proteins, was 
used to estimate the micelles with more than one BAX molecule. As a positive control 
and as a calibration sample the 21 base pair long double-stranded RNA labeled with 
Alexa Fluor 488 and Cy5 on each 3'-end was used35. 
 
Fluorescence intensity distribution analysis, FIDA.  
Analysis of the fluorescence brightness of a particle can provide an additional measure of 
the number of fluorescent proteins associated with a detergent micelle. The particle 
fluorescence brightness determined by FIDA is extracted by fitting the distribution of the 
number of photon counts and is similar to the cpp value determined by FCS for a 
monodisperse fluorophore solution. Determination of the particle brightness of the BAX-
detergent micelle and comparison with particle brightness of monomeric BAX molecules 
estimates the number of BAX molecules in detergent micelles. FIDA was performed 
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according to Kask et al.18. The raw data of photon arrival times was binned to 20 µs and 
photon counting histograms were constructed. Parameters describing the detection 
volume were determined in a solution of fluor-BAXΔC in absence of detergent.  As 
indicated, histograms were fitted to model functions for one or two components, 
described in Kask et al.18 subtracting a background of 310 Hz for the buffer solution.   
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CHAPTER 5 
“Effect of Bax onto the Morphology of GUVs: Imaging Study” 
 
 
 
 
 
 
 
 
 
 
 
 
 124
Abstract 
 This Chapter provides an overview of the various effects of Bax onto GUV 
morphology, permeabilization and collapse as studied by the confocal microscopy with 
the use of fluorescently labeled Bax. In addition, to establishing the effects of Bax 
binding and pore formation in GUVs, the confocal microscopy experiments described in 
this chapter establish a time frame for the FCCS measurements on Bax presented in 
Chapter 7. Furthermore, using the confocal microscopy we compare the ability of Bax to 
transform the morphology of GUVs to the similar ability of detergents, thus establishing 
that Bax has a detergent-like effect onto the morphology of GUVs. In this chapter, we 
also show that the fluorescently labeled full-length Bax used in this and the following two 
chapters is functional. 
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Introduction 
 Upon binding and pore formation, Bax changes the physical properties of lipid 
membranes such as line tension and surface tension1-3, which in place would lead to 
changes in the morphology of lipid bilayers. Therefore, before proceeding to the FCCS 
studies of Bax diffusion and self-assembly in GUV membranes we used confocal 
microscopy to characterize the morphological changes in GUVs upon, during and after 
Bax binding and pore formation. These confocal microscopy studies allow us to establish 
the time frame for the FCCS experiments which is defined by the span of time during 
which there is sufficient amount of the fluorescently labeled Bax in a GUV membrane 
and the GUV is not deformed. As a result of these studies, we determined the optimal 
concentration of Bax for the FCCS experiments and the time frame for the FCCS 
experiments. We also have found that the ability of Bax to transform the morphology of 
GUVs is similar to that of detergent n-octylglucoside suggesting that Bax and n-
octylglucoside disrupt lipid bilayer coupling in a similar fashion. 
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Results and Discussion 
Fluorescently labelled Bax is active 
FCCS is a fluorescence-correlation technique with the sensitivity to detect the co-
diffusion of single molecules which need to be labeled with distinct fluorophores4.  For 
our FCCS and imaging experiments human full-length Bax with a single cysteine residue 
engineered at position 4 and the two endogenous cysteines, C62 and C126, mutated to 
serine and alanine respectively was produced in E. coli without use of detergent as 
described in Appendix V. This protein was labeled with Alexa Fluor 488 dye (Bax-G) or 
with Atto 655 dye (Bax-R). The activity of both fluorescently labeled proteins was 
checked using assay of carboxyfluorescein release from liposomes5, 6 (also described in 
Chapter 3). In this assay cBid was used to activate the pore formation by Bax. However, 
without the addition of cBid, Bax produced a slow release of carboxyfluorescein from 
liposomes (Fig 5-1).  Interestingly, addition of Bcl-xL, an inhibitor of Bax pore formation, 
inhibited only the cBid activation of Bax but not the auto-activation of Bax7 (Fig. 5-1b). 
However, the auto-activation of Bax was inhibited by Bcl-xL when both proteins were 
added simultaneously to liposomes.  
 Another check of the ability of the fluorescently labelled Bax to form pores was 
done using GUVs (Fig. 5-2). In these experiments Bax-R (25 nM), Bax-G (25 nM), cBid 
(4 nM) and free dye Alexa 546 (1 µM) were added to the GUVs and the time series of 
images were taken to follow the GUV permeabilization. As a result Bax bound and 
permeabilized GUVs (Fig 5-2). Bax binding to the GUVs can be seen from the time-
dependent increase in the fluorescence in the GUV membranes while permeabilization of 
GUVs can be seen from the filling of GUV lumen with free dye and with Bax (Fig. 5-2).  
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 Figure 5-1. Assay of liposomes permeabilization by Bax. a. Kinetics of the 
carboxyfluorescein release from the liposomes. Each release curve is normalized and 
represents an average of three independent measurements.  b. End point measurement of 
the % release 60 minutes after addition of indicated proteins to liposomes filled with 
carboxyfluorescein. 
 
However, GUVs presented on Fig. 5-2 were not permeabilized simultaneously reflecting 
the stochastic nature of the Bax pore formation. Nevertheless, all the GUVs in the well 
were permeabilized by 45 min after addition of proteins to GUVs. Without activator 
protein, cBid, fluorescently labeled Bax did bind to GUVs but much weaker than in the 
presence of cBid (Fig. 5-3h). This result of low Bax-R and Bax-G binding to GUVs is 
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consistent with an observation of slow release of carboxyfluorescein from liposomes (Fig 
5-1) suggesting that the fluorescently labeled Bax has some intrinsic activity7. 
We have also tested the effect of Bcl-xL on Bax binding and permeabilization of 
GUVs (Fig. 5-3). In these experiments as expected Bcl-xL prevented pore formation by 
Bax without inhibiting the ability of Bax to bind GUV membranes (Fig. 5-3f). However, 
when liposomes were initially preincubated with Bcl-xL and cBid for one hour and then 
Bax was added no Bax binding to GUVs was observed, suggesting that Bcl-xL when 
present in a lipid membrane inhibits Bax binding to the membrane8. Taken together, these 
results show that both fluorescently labelled Bax proteins can bind lipid membranes and 
form pores in liposomes and thus behave similarly to the wild-type full length Bax. 
 
Figure 5-2. GUV permeabilization by Bax-R and Bax-G activated with cBid. Alexa 546 
was used as a small soluble 0.5 kDa dye to follow the GUV permeabilization. Time 
stamps indicate time after protein addition to GUVs. Scale bar is 20 µm. 
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 Figure 5-3. f. Bax binding to GUVs in the presence of Bcl-xL (50 nM) and cBid (4 nM). 
Bax-R and Bax-G total concentration is 50 nM. g. Bax does not bind GUVs preincubated 
for 60 minutes with 50 nM Bcl-xL and 4 nM cBid. h. Bax-R and Bax-G binding to GUVs 
in the absence of the activator cBid protein. In all images scale bar is 20 µm.  
 
Bax changes morphology of GUVs 
The ability of Bax to from pores in GUVs has been reported previously but not 
with the fluorescent protein or with the intent to characterize the evolution of membrane 
morphology upon prolonged interaction with Bax protein9, 10. Here, we used confocal 
microscopy to establish the effect of the fluorescently labeled Bax on GUVs and to 
establish the time window for the FCCS measurements. We determined that incubation 
with 50 nM Bax and 4 nM cBid allowed us to simultaneously observe the accumulation 
of fluorescent Bax in the GUV membrane and permeabilization of this membrane (Fig. 5-
2) and that the GUVs were stable for 7 to 8 hours allowing FCCS measurements.  
However, after 24 hours this preparation became a mass of collapsed GUV remnants 
reflecting the multiple effects of Bax on membrane structure.  After one hour of 
incubation with this Bax concentration, 100 % of GUVs were permeabilized and had 
homogeneous distribution of labelled Bax on the bilayer membrane. At the same time, in 
these experiments, Bax did not bind to all GUVs equally producing variation in the 
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fluorescence of Bax in GUV membranes representing a variation of Bax concentration in 
these membranes (Fig. 5-5). We hypothesize that this heterogeneity of Bax binding to 
GUVs results from the variation in cardiolipin content of the GUVs which is known to 
affect the Bax and cBid binding11, 12 (See next section for discussion). After 3-4 hours of 
incubation with Bax and cBid the heterogeneity of Bax binding to GUVs was no longer 
visible suggesting Bax saturation in the lipid membrane of GUVs (Fig. 5-5a). Prolonged 
incubation of GUVs with these concentrations of Bax and cBid leads to major 
morphology changes in the GUVs (Fig. 5-3a-d). GUVs change their shape from spherical 
to potato-like and tubule-like shape reflecting the Bax induced changes in the elastic 
coupling to lipid bilayer forces in membranes. Additionally, we observed formation of 
gigantic Bax mega-pores (See Chapter 6) and other large visible Bax aggregates in GUV 
membranes (Fig. 5-4b). During incubation with Bax occasional GUVs rupture onto 
smaller liposomes (Fig. 5-4e) and by the 24 hours of incubation with Bax almost no 
GUVs are left in the observation chamber.  This clearly defined the time period when 
these GUVs could be studied by FCCS. The Bax binding to GUVs and consequent 
deformation and rupture of GUVs is dependent upon the Bax concentrations 
demonstrating that mass action and thermodynamics governs this process. Although all of 
the GUVs were permeabilized by one hour, the membrane density of Bax particles was 
not sufficient for the FCCS measurements until 30 to 40 minutes, and, therefore, the early 
pore formation was not accessible to these studies. 
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Figure 5-4. Bax binding to GUVs: confocal microscopy images. a. ….b. Aggregates of 
Bax in GUV membranes. c. Agglomeration of GUVs after four hours of incubation with 
Bax. d. Formation of tubule-like lipid membrane structures after 7-8 hours of incubation 
with Bax. e. Rupture and collapse of GUVs upon Bax addition. Time steps represent the 
time after Bax addition. In all images scale bar is 20 µm.  
 
Heterogeneity of Bax binding to GUVs 
For all the experiments presented in Chapters 5, 6 and 7 of this dissertation, the 
lipid composition of GUV was DOPC:bovine heart cardiolipin (80:20 mol%). Assuming 
homogeneous distribution of lipids among GUVs during electroformation we expected 
homogeneous Bax binding to GUVs. However, we observed wide variation in the amount 
of Bax binding to GUVs electroformed from the same lipid mixture (Fig. 5-5a). We 
hypothesize that the heterogeneity of Bax binding to GUVs is based on the heterogeneity 
of lipid distribution among GUVs during the electroformation (See Appendix IV for the 
detailed description of the method). In particular, we hypothesize that the heterogeneity 
comes from un-equal distribution of cardiolipin among the GUVs. Cardiolipin is known 
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for its ability to promote non-lamellar lipid bilayer formation (i.e. lipid bilayers with high 
curvature) and in our GUV preparations with 80:20 mol% of DOPC:cardiolipin we 
observe formation of both unilamellar and multilamellar vesicles (Fig. 5-5b), with the 
multilamellar vesicles showing high curvature regions. We hypothesize that these multi-
lamellar vesicles contain higher concentration of cardiolipin than the rest of the vesicles 
from the same GUV preparation. However, we do not have a direct way to measure the 
cardiolipin concentration in these vesicles.  
 
Figure 5-5. Heterogeneity of Bax binding to GUVs.  GUVs were prepared by 
electroformation from DOPC:CL (80:20 mol%) and added to the solution containing 
Bax-R (50 nM), Bax-G (50 nM) and cBID (10 nM). The confocal image was taken 
approximately 30 minutes after mixing. The confocal image is an overlay of red and 
green channels corresponding respectively to Bax-R and Bax-G. a. Confocal image of the 
field view of multiple GUVs with the fluorescently labeled Bax bound. Scale bar is 50 
µm. b. Confocal image of a giant multilamellar vesicle containing high concentration of 
the bovine heart cardiolipin which resulted in the production of high curvature in the 
portions of this vesicle.   Scale bar is 20 µm. Images a and b were taken in the same 
chamber, indicating that these vesicles were from the same preparation and were exposed 
to the same concentration of the fluorescent Bax and cBid. 
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Bax and detergents produce similar morphological changes in GUVs. 
 In addition to permanent transformations of GUV morphology shown in Figure 5-
4, we have observed transient changes in GUV morphology upon Bax binding (Fig. 5-6). 
These transient morphological changes included endocytosis like events, where 
thransforamtion of the GUV membrane resulted in the formation of smaller daughter 
vesicles inside the original vesicle (Fig. 5-6a), and fission like events, where GUV 
disintegrated into a number of smaller vesicles (Fig. 5-6b). Similar morphological 
transformations have been observed when sub-CMC concentration of n-octylglucoside 
detergent was added to GUVs (Fig. 5-7). This apparent similarity in the shape 
transformation of GUVs in the presence of detergents and in the presence of Bax, which 
have never been exposed to detergents, suggests that Bax acts as a detergent during 
binding to lipid membranes. When detergents bind lipid membranes changes in the 
mechano-elastic properties of membranes have been observed, thus we can stipulate that 
Bax can change mechano-elastic properties of lipid membranes similar to detergents.  
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Figure 5-6. Transformation of GUV shapes upon Bax binding.  
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 Figure 5-7. Transformation of GUV shapes upon the addition of n-octylglucoside 
detergent. Time stamps indicate time since the beginning of the observation, which 
occurred 10-15 sec upon the detergent addition. 
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Conclusion 
 Described above confocal microscopy studies of the effects of Bax onto the 
morphology of GUVs were undertaken with the goal of determining the feasibility and 
the experimental conditions for the FCCS measurements of Bax diffusion and self-
assembly in GUV membranes. As a result of these studies we determined that GUVs can 
be used as a source of free-standing lipid membranes in the FCCS experiments and that 
addition of 50 nM Bax and 4 nM cBid result in sufficient for the FCCS measurement 
amount of Bax accumulated in GUV membranes. In addition, for these Bax and cBid 
concentrations it was determined that GUVs maintain spherical shape and do not collapse 
for a period of 4-7 hours which is suitable for FCCS measurements. In addition, the 
functionality of the two forms of the  fluorescently labelled Bax, Bax-R and Bax-G, have 
been tested for their ability to form pores in LUVs and GUVs indicating that Bax-R and 
Bax-G can form pores in liposomes similar to the wild-type Bax.   
 
Experimentals 
Protein preparation, labeling and functionality check. Human cDNA for Bax, Bid and 
Bcl-xL were subcloned into pTYB1 vector (New England Biolabs). For production of the 
fluorescently labeled Bax two endogenous cysteines of Bax were substituted (C62S, 
C126A) and additional cysteine was engineered, S4C. All proteins were expressed in 
BL21(DE3) E. coli, and purified as an intein/chitin-binding domain fusion protein 
without use of detergents (See Appendix V for details). Purified proteins were estimated 
to be > 95% pure by Coomassie staining SDS-PAGE gels and stored at 4 °C. Bid was cut 
with recombinant caspase 8 to produce cBid. Mutant Bax with single cysteine was 
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labeled according to the manufacturer’s protocol with Alexa Fluor 488 maleimide 
(Invitrogen) and Atto 655 maleimide (AttoTech). Functional comparison of the 
fluorescently labeled Bax to the wild-type Bax was done using carboxyfluorescein assay 
from liposomes (See Chapter 3 for the method description). 
 
Preparation of giant unilamellar vesicles. GUVs were prepared by the electroformation 
method13 from a lipid mixture containing 80 mol% of 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC from Avanti Polar Lipids) and 20 mol% of bovine heart 
cardiolipin (Avanti Polar Lipids).  For the detailed protocol of GUV preparation see 
Appendix IV. For the confocal microscopy observation 50 µl of solution containing 
GUVs was transferred into a Lab-Tek observation chamber (Fisher Scientific) containing 
450 µl of 10 mM HEPES, pH 7.2, 100 mM KCl and a mixture of Bax, cBid and Bcl-xL. 
 
Confocal Microscopy was performed at 22 °C on a laser-scanning confocal microscope 
Meta 510 system (Carl Zeiss) using 40× NA 1.2 UV-Vis-IR C Apochromat water-
immersion objective. For excitation the 488 nm line of an Argon-ion laser (25 µW) and 
the 633 nm line of the HeNe laser (15 µW) were used. Collection and processing of 
images was done using Zeiss software provided with the microscope (AIM, version 4.2). 
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CHAPTER 6 
“Bax Mega-Pore: Line Tension Measurement” 
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Introduction 
The size of the Bax pore has become a controversy in the field of apoptosis. In 
fact, the Bax pore has not been observed in vivo by electron microscopy in mitochondria 
of cells undergoing apoptosis, where Bax appears to aggregate at the fission sites on the 
surface of the OMM1. Nonetheless, in vitro studies using electrophysiology and pore-
sizing techniques have shown that Bax forms pores of 2-5 nm in diameter2-6, while 
electron microscopy and AFM revealed the formation of 100-200 nm disruptions in 
liposomes and supported lipid bilayers incubated with Bax7, 8. In light of this controversy 
about the size of a Bax pore, the finding of the formation of 5-20 µm in diameter Bax 
mega-pores support the hypothesis that Bax is able to form pores of various sizes9.  
 In addition to extremely large diameters, Bax mega-pores also exhibited 
uncommonly long life times ranging from 10 min to hours. Based on the life time and 
size, these Bax mega-pores are very similar to the giant pores formed in GUVs by 
detergents or by the physical disruption of GUVs10-15. The latter two types of giant pores 
can be differentiated on the basis of the magnitude of the force responsible for closing a 
pore – the line tension10, 16. The line tension is the energy per unit length of the membrane 
contour at the pore edge, and it arises due to the exposure to water of the hydrophobic 
lipid tails in the rim of the pore. The line tension is the highest in the giant pores opened 
by physical disruption (10-20 pN)10, 15,  and it is two orders of magnitude lower in the 
giant pores stabilized by detergents (0.2 pN)10. Therefore, in order to characterize the Bax 
mega-pores with respect to the other two known types of giant pores, we used an 
established microscopy technique to measure the line tension in the rim of the Bax mega-
pore, which turned out to be two orders of magnitude lower than the line tension in the 
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rim of a detergent stabilized giant pore. Furthermore, using this line tension measurement 
together with other knowledge about the Bax interaction with lipid membranes, we 
propose a model of the formation, existence and closure of the Bax mega-pores. 
 
Results and Discussion 
Bax forms longed lived mega-pores in GUVs 
While using confocal microscopy to study Bax-R and Bax-G binding to GUVs in 
the presence of cBid, we were intrigued by the formation of giant Bax pores which we 
named Bax mega-pores (Fig. 6-1, 6-2). These pores ranged from 5-20 µm in diameter, 
appeared within 10 minutes of Bax addition to GUVs, and were extremely stable, with 
life times of 8 minutes up to many hours. Interestingly, all observed Bax mega-pores had 
increased Bax concentration in the rim of the pore, which did not expand or led to GUV 
collapse17. Although the mega-pores usually closed over the observation period of 1-2 
hours, the presence of a simple obstacle in the pore closure path, e.g. another liposome, 
was observed to arrest the closure process (Fig. 6-1c). For comparison, an impedimentary 
lipid vesicle present in the closure path of a giant pore opened by the stimulation with 
visible light was cut into two vesicles when the pore closed10. This observation shows 
that Bax reduces the line tension in the pore rim, thus resulting in the arrest of the pore 
closure by an impedimentary vesicle. Nonetheless, in GUVs where Bax mega-pore did 
close, the fluorescent Bax concentrated at the rim of the pore dispersed over the GUV 
surface producing a homogeneous Bax fluorescence signal. Additionally, GUVs which 
have gone through the process of the mega-pore formation and closure did not have 
another mega-pore open and appeared to be stable for hours afterwards. 
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 Figure 6-1. Bax mega-pore. a 3D reconstruction of the Bax mega-pore shown together 
with the confocal images used to produce this reconstruction. Values in µm indicate 
distance from the coverslip surface. b. Time series of opening, existence and closure of 
the Bax mega-pore. Arrow in the first image indicates the position at which mega-pore 
will open. Time stamps represent time since the opening of the pore. c. Other examples of 
giant Bax mega-pores.   
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 Figure 6-2. Time series of the opening and closure of a Bax mega-pore. These 
confocal images represent an overlay of three channels: red (Bax-R), green (Bax-G) and 
pink (Alexa 546). Time stamps indicate time after protein addition to GUVs. Scale bar is 
40µm. 
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Size distribution of Bax mega-pores. 
To determine whether there exists correlation between the size of a Bax mega-
pore and the size of a GUV, we performed the Pearson’s correlation test. In this test we 
compared the distribution of the diameters of the Bax mega-pores with the diameter of 
corresponding GUVs (Fig. 6-3). As a result only weak correlation was found between 
these two sets of values (with the Pearson correlation coefficient of 0.25). The maximum 
value for the Pearson correlation coefficient is 1, and it corresponds to the direct positive 
correlation between the two sets of values, i.e. increase in the value of one data set will 
lead to linear increase in the values of the other data set.   
a b 
Figure 6-3. Size distribution of Bax mega-pores.  a. Bar plot of GUV diameter (gray) 
and corresponding diameter of a Bax-mega pore (white). Data from 44 GUVs is 
presented. b. Same data as in a but plotted as a distribution on Bax mega-pore diameter 
versus the GUV diameter. As an additional evidence of weak correlation between the two 
data sets the linear fit of this data shown as a line (R=0.25). 
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Weak correlation between the diameter of a GUV and the diameter of a Bax 
mega-pore present in this GUV suggest that the Bax mega-pore formation is a stochastic 
process which most likely depends on the physical properties of the GUV membrane (i.e. 
elasticity and bending rigidity etc.). These physical properties of GUV membranes 
depend directly on the lipid composition of membranes. In Chapter 5 the heterogeneity of 
cardiolipin distribution among GUVs during the electroformation was discussed, and 
correlated with the heterogeneous binding of Bax to GUVs. Based on this, it can be 
concluded, that one of the reasons for the weak correlation between the diameters of Bax 
mega-pores and GUVs in which they occur is due to heterogeneous lipid distribution 
among GUVs.  We can also speculate, that the other reason for the weak correlation can 
be the fact that Bax mega-pores formed in GUVs larger than 50µm in diameter 
destabilize the GUV leading to its collapse (data not shown) which results in a skewed 
distribution of the Bax mega-pore diameters with GUV diameter. Finally, we should 
mention that the diameter values for this analysis were collected from a number of 
confocal images corresponding to the various experiments where concentration of the 
fluorescently labeled BAX was varied.  
 
Analysis of the line tension in the rim of Bax mega-pore 
Kinetics and thermodynamics of giant pores in GUVs can be explained by 
theoretical models 10, 13 where the energy  of a pore of radius rE r  can be described as 
        (Eqn. 1)  22 rrEr 
where, is the line tension while    is the surface tension. Interplay between line and 
surface tension allows opening, existence and closure of giant pores in GUVs. Following 
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model of Borchard-Wyart et al.14 the life of a pore in a GUV can be described in four 
steps: (i) pore opens due to the increase of the membrane surface tension ( ) which can 
be induced by application of an electrical field11, 18, or by insertion of molecules with 
non-zero spontaneous curvature such as detergents10, or by the insertion of the Bax-
derived α5 peptide 19; (ii) while surface tension term in Equation 1 is larger than the line 
tension term the pore expands to some critical radius ( ); (iii) while the surface tension 
and line tension terms in the equation 1 are equal (i.e. pore energy ) the pore exists 
in unstable equilibrium state; (iv) when the line tension begins to increase the pore begins 
to close. Using this theoretical framework the line tension in the rim of the pore during 
the pore closing stage can be calculated using  
cr
0 r
3
2k     (Eqn. 2) 
where,  is the slope of the  versus time plot and k )ln(2 rR  is the solution viscosity 
(1.035×10-3 Pa·s for 30 mM sucrose solution), R  is the radius of a GUV containing a 
pore of radius r . Examples of the evolution of the radius ( r ) of Bax mega-pore for three 
GUVs are shown in Figure 6-4. From these three plots we estimate the line tension in the 
rim of the Bax mega-pore to be 3.7±1.7 fN which is four orders of magnitude lower than 
the line tension of a pore opened by the intense illumination in a DOPC vesicle ( = 
20.7±3.5 pN)10 and two orders of magnitude lower than the line tension of a detergent 
stabilized giant pore (0.2 pN). 
The ability of the Bax to reduce the line tension of artificial lipid membranes have 
been reported previously but without a direct measurement of the line tension20. Here, we 
measured the line tension in the rim of the Bax mega-pore to be 3.7±1.7 fN which is two 
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to four orders of magnitude lower than the line tension in the rim of detergent stabilized 
or mechanically opened pores respectively. It is hypothesized, that the reason for the 
ability of the cone-shaped detergents to reduce the line tension in giant lipid pores is 
based on their propensity to partition to the high curvature regions in the edge a pore10, 16 
(Karatekin, May 2000 others). Therefore, the ability of Bax to reduce the line tension 
lower than that of  detergents indicates that Bax is a remarkable protein designed by 
evolution to stabilize edges of lipid membranes.  
Interestingly, the line tension generated by the full length Bax proteins is three 
orders of magnitude lower than the line tension generated by the pore-forming α5 peptide 
of Bax in a supported lipid bilayer ( = 3.8±0.4 pN)19.  The lower line tension value 
measured in the presence of the full length Bax protein indicates that the full length 
protein is able to stabilize the pore edge more efficiently than a single alpha helix of Bax 
indicating an additional role for the non-pore forming alpha helices of Bax. Previously 
the non-pore forming helices of Bax were given two major roles in the function of Bax: 
first, to prevent the pore-forming helices of Bax (α5 and α 6) from harming the cell by 
forming pores in various membranes; and second, to facilitate the communication 
between Bax and other proteins involved in the apoptosis decision such as BH3 domain 
interactions etc.  
 
The life time of Bax mega-pore 
The life time of a lipid pore in DOPC vesicle immersed in water solution is 
estimated to be 10-200 msec, and it can be extended by increasing the viscosity of 
solution13. Therefore, 66 % glycerol solution which has 30 times higher solution viscosity  
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a b
                                c                                                                     
 
Figure 6-4. Plots of the evolution of the radius of Bax mega-pore with time.  GUVs  
were mixed with 30 nM Bax-G, 25 nM Bax-R and 4 nM cBid. Movies of the Bax-R and 
Bax-G binding to GUVs as well as transformation of GUVs were taken immediately 
upon mixing. a. GUV initial radius was 40 µm while the slope of the  during the 
pore closing is = -22.8±2.5 µm2/sec. The opening and closing of a pore for this 
particular GUV is shown in Supp. Movie 1. b. GUV initial radius was 20 µm while the 
slope of the  during the pore closing is = -0.57±0.19 µm2/sec. c. GUV initial 
radius was 20 µm, while the slope of the during the pore closing is = -
0.93±0.14 µm2/sec. 
)ln(2 rR
k
ln(r)2R k
ln(2 )rR k
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than water is commonly used to measure the life time of giant lipid pores10, 12, 14. The 
reported life time of giant pores in glycerol ranges from seconds for the lipid pores 
opened by a physical method to minutes for lipid pores stabilized with detergent10 while 
the life time of Bax mega-pores is measured in water solution and ranges from 8 min to 
many hours. Hence, if the life time of all tree types of giant pores is compared in the 
same solution, the Bax mega-pore will have the longest life time, which is explained by 
the extremely low line tension measured in the rim of this pore. 
 
Proposed model of the Bax mega-pore formation, existence and closure 
We propose the following mechanism for Bax mega-pore opening, existence, and 
closure based on a GUV shown in Figures 6-1b and 6-2. In this mechanism Bax inserts 
into a lipid membrane from the outside of a GUV and transforms from a globular soluble 
protein21 to a membrane integrated protein with proposed extended structure shallowly 
inserted into the membrane22 (Fig. 6-5a). This produces a dramatic area increase in the 
outer membrane leaflet while the area of the inner leaflet remains unchanged (Fig. 6-5b). 
The localized area difference of the two membrane leaflets induces curvature frustration 
and increase in the surface tension of the membrane23, 24 (Δσ>0). When surface tension 
increases to a critical value the membrane structure ruptures and the mega-pore is 
formed. Once the pore is formed its line tension provides a force for reclosure of the 
mega-pore which counteracts the surface energy such that GUV continues to exist and 
does not collapse (See also Eqn. 1). However, now through the open mega-pore soluble 
Bax is able to accumulate in the lumen of the GUV and insert into the inner leaflet of the 
GUV membrane. This results in the area increase of the inner leaflet leading to the 
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increase in surface tension in this leaflet.  Meanwhile, membrane Bax has accumulated in 
the rim of the pore, reducing line tension and decreasing the rate of pore closure as 
surface energy of the inner and outer leaflets equilibrate (Fig. 6-2b).  As a result the Bax  
 
Figure 6-5. Model of Bax interaction with lipid membranes. a. Schematic of Bax 
binding, integration and oligomerization in a lipid membrane. b. Proposed mechanism of 
the Bax mega-pore opening and closure.  
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mega-pore closes very slowly over tens of minutes even though the surface energy of the 
two leaflets is the same. After the pore closure Bax in the form of monomers or small 
oligomers diffuses away from the position where the membrane resealed such that within 
seconds after pore closure no heterogeneities are observed on the GUV surface.  
 
Bax mega-pore: connection to physiology 
It is clear that the Bax mega-pore structures we observed in GUVs can not occur 
in vivo simply due to their size (5-20 µm) versus the size of mitochondria (0.2-1 µm). 
Furthermore Bax mega-pores scaled for the smaller size of mitochondria would also need 
to be scaled for the reported localization of Bax to the fission sites1. Finally, the simple 
lipid composition of GUVs (DOPC:cardiolipin, 80:20 mol %) compared to the 
complexity of mitochondrial outer membrane and the heterogeneous distribution of lipids 
and proteins on the mitochondrial surface all limit the space available for Bax pore 
formation to a submicroscopic size. Therefore, on the mitochondrial surface Bax has a 
limited membrane area to form a protein-membrane complex, while on the surface of 
GUV membrane the area available to Bax is many times greater and can generate the 
mega-pores that we observed. 
 
Conclusion 
 The existence of microscopic Bax mega-pores further supports the hypothesis that 
Bax can form a variety of pore sizes in artificial lipid membranes and that the Bax pore is 
a lipidic pore stabilized by the presence of the Bax protein in the pore rim5, 20. The 
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accumulation of Bax in the pore rim not only reduces the line tension to extremely low 
values but it also leads to the increase of the pore life time. 
Bax is not the first protein which is reported to form giant pores in GUVs. For 
example, protein talin and other FERM domain containing proteins have been shown to 
stabilize the edges of giant pores in GUVs but only in conditions of zero salt25, 26. At 
physiological salt concentrations these proteins do not promote the formation of giant 
pores. Furthermore, the physiological relevance of this pore stabilization ability of talin 
and other FERM domain containing proteins is not clear. In vivo the function of these 
proteins is to connect actin filaments to the cell membrane. In contrary to these proteins, 
Bax forms giant pores in physiologic salt conditions and is a bona fide pore-forming 
protein, whose pore forming activity is directly linked to its function in vivo, thus making 
the discovery of the ability of Bax to form mega-pores more significant. 
 
Experimentals 
Protein purification and labeling was done as described in Chapter 5 and Appendix V. 
Line tension analysis. Analysis of the line tension in the rim of a Bax mega-pore was 
done according to Karatekin et al.10 using time-lapse movies of the pore opening and 
closure collected using laser-scanning microscope Meta 510 system (Carl Zeiss). 
Diameter of an open Bax mega-pore together with the diameter of a GUV was measured 
using Zeiss LSM image browser software. Time dependent evolution plots of the pore 
diameter were fitted using linear square fit analysis in Origin 6.0 software (OriginLab 
Corp.). The value for the slope of this linear fit was used to calculate the line tension as 
described in Supplementary Information. 
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“FCCS Study of Bax Self-Assembly in Lipid Membranes” 
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Abstract 
It is widely accepted that during apoptosis, permeabilization of the outer mitochondrial 
membrane by the pore-forming members of the Bcl-2 protein family is a critical point 
after which the cell cannot be resuscitated. However, without   direct evidence of how 
they interact in bilayers the molecular mechanism of the mitochondrial permeabilization 
remains controversial. Here we have reconstituted the pore formation by protein Bax in 
giant vesicles and show that in this environment Bax can form a heterogeneous 
distribution of coexisting pore sizes ranging from 1 nm to 20 µm in diameter. Evidence is 
provided by directly examining oligomerization and mobility change of Bax molecules in 
GUVs by fluorescence cross-correlation spectroscopy and by studying the large 
complexes by confocal microscopy. We show that in the presence of Bcl-xL, an inhibitor 
of Bax pore formation, membrane bound Bax was primarily monomeric. We also show 
that, in the large length scale format of a GUV, Bax form structures that reveal its affinity 
for highly curved membranes, and that it dramatically reduces line tension while 
stabilizing its lipidic pores. Finally, our results demonstrate that Bax forms pores by 
increasing membrane surface energy and changing curvature of lipid membranes, thus 
manifesting an ability to sculpt lipid bilayers. 
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Introduction 
Bax is a pro-apoptotic member of the BCL-2 protein family and its paramount 
function is to permeabilize the OMM during apoptosis1, 2. Upon apoptotic stimulation 
Bax translocates to the OMM where it changes conformation, inserts as a monomer, and 
then undergoes in-membrane homo-oligomerization to form a pore. Once the Bax pore is 
formed, cytochrome c and other mitochondria-resident proteins escape into the cytoplasm 
where they activate the cascade of caspases that dismantle the cell. To date the structure 
of the inactive, cytoplasm-resident, form of Bax is known3; however, the structure of the 
active, membrane-integrated, form of Bax remains unsolved. The absence of a membrane 
structure for this protein has lead to a vigorous debate about:  the nature of the Bax pore 
(lipidic versus barrel-stave)4-6, the number of Bax monomers participating in the pore 
formation7-10, the possible molecular interactions formed among them in a pore11, 12, and  
the progression and variety of pores formed by Bax (i.e. dimer, tetramer and higher order 
polymers)5, 6, 13, 14. To address these questions we used two-focus two-color scanning 
FCCS15-17 to non-intrusively measure the mobility and self-association of the 
fluorescently-labeled Bax in a hydrated lipid membrane of GUVs for 5-7 hours after Bax 
insertion into the lipid membrane (See Chapter 5 for the confocal microscopy analysis of 
the fluorescent Bax binding to GUV). In these FCCS experiments the microscope output 
was multiplexed for simultaneous determination of the membrane diffusion coefficients 
and concentrations of Bax-R, Bax-G and Bax-RG complexes, and the analysis of the Bax 
pore activation. Using the membrane diffusion coefficients for the monomeric Bax-R and 
Bax-G proteins and for the Bax-RG complexes we estimated the hydrodynamic radius of 
these complexes in lipid membranes which is comparable to values reported in literature. 
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Furthermore, using the values for the membrane diffusion coefficient of Bax we were 
able to clearly differentiate between two monomeric species of Bax in lipid membranes – 
membrane associated and membrane integrated Bax. In support of this analysis we used 
cBid to activate Bax and Bcl-xL to inhibit the membrane integration and self-association 
of Bax. 
 
Results and Discussion 
Bax is monomeric in solution and oligomerizes only in lipid membranes 
It has been shown by a FRET study that Bax does not oligomerize prior to 
membrane binding14.  Using FCCS we observe similar result that Bax-R and Bax-G in 
the presence of cBid are monomeric and do not oligomerize in solution (Fig. 7-1b). In 
solution, diffusion coefficient for Bax-G is 114±6 µm2/sec (mean±s.e., n=3) and for Bax-
R it is 134±12 µm2/sec (mean±s.e., n=3) which is similar to that of monomeric tBid and 
Bcl-xL17. We observe oligomerization of Bax-R and Bax-G only in the environment of a 
lipid membrane as shown by the increased cross correlation in Fig. 7-1c (blue line). 
 
In a lipid membrane Bax forms a population of varying in size oligomers 
Two-color two-focus scanning FCCS allows simultaneous measurement of the 
fluorescent protein concentration, diffusion coefficient and self-association in a lipid 
membrane15-18. To study Bax self-association in a lipid membrane we used Bax-R and 
Bax-G proteins (50 nM total concentration) activated with 4 nM cBid (as was determined 
by the confocal microscopy experiments described in Chapter 5). 
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Figure 7-1. FCCS on Bax in solution and in a lipid membrane. b. Normalized auto-
correlation curves and cross-correlation curve (blue) for Bax-R and Bax-G in solution in 
the presence of cBid. c.   Normalized auto-correlation curves and cross-correlation curve 
(blue) for Bax-R and Bax-G in a lipid membrane in the presence of cBid. 
 
 
Figure 7-2. Confocal microscopy images of Bax binding to a GUV. Bax-R (25 nM), 
Bax-G (25 nM) and cBid (4 nM) were added to GUVs upon which collection of the time-
series of images was initiated. Time stamps represent the time after protein addition to 
GUVs. 
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After the establishment of sufficient fluorescent signal of Bax in GUV 
membranes (as shown in Fig. 7-2), the FCCS measurements were done on a population of 
GUVs (10 min measurement time per GUV) (Fig. 7-3 d, e). The FCCS analysis of 
membrane Bax produced a clear result that Bax protein complexes increased in size with 
time, as can be seen from the decrease in the average mobility of these Bax-RG 
containing complexes (Fig. 7-3 e, blue squares). At the same time, the number of 
membrane Bax particles (which include monomers and oligomers) was increasing, so it 
was clear that for the >6 hours of these experiments Bax was continuing to accumulate in 
the membrane.  Each time point on the Figure 7-3 d and 7-3 e represents an independent 
GUV measurement such that amount of Bax in the membrane and the average diffusion 
coefficient of the Bax particles is not uniform and reflects the variation in the vesicle 
lipid composition (See Chapters 2 and 5 for discussion). 
The average diffusion coefficient of Bax-RG complexes in GUV membranes 
incubated for five hours with 50 nM of the fluorescent Bax and 4 nM cBid is 2.0±0.4 
µm2/sec (mean±s.d., n=21). This diffusion coefficient is slower than the membrane 
diffusion coefficient of monomeric tBid and Bcl-xLΔC measured by the same technique 
(5 µm2/sec)17, suggesting formation of a bulky slowly-diffusing Bax-RG complex in a 
lipid membrane (Table 7-1). Since the diffusion coefficient of a particle in a lipid 
membrane depends on the in-membrane hydrodynamic diameter of the particle, we can 
use the value for the diffusion coefficient of Bax-RG complexes to determine their 
approximate in-membrane hydrodynamic diameter using a modified Saffman-Delbruck 
formula19 but for this the membrane diffusion coefficient of a Bax monomer should be  
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 Figure 7-3. Two-color two-focus scanning FCCS experiments on Bax. a and b 
represent FCCS results of Bax-R/Bax-G cross-correlation (50 nM total Bax 
concentration) in the presence of 50 nM  Bcl-xL and 4 nM cBid, while d and e represent 
similar results but in the absence of Bcl-xL. c. Schematic of various diffusion species of 
Bax in a lipid membrane. 
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known. The value for the diffusion coefficient of a Bax monomer will be used to ensure 
the accuracy of calculations. 
 
Bcl-xL prevents the self-assembly of Bax in lipid membranes. 
To determine the membrane diffusion coefficient of a Bax monomer, Bax self-
assembly and pore formation in a lipid membrane should be inhibited. This was 
accomplished by using full length human Bcl-xL protein, which is an anti-apoptotic 
member of the Bcl-2 family that inhibits Bax pore formation20. When GUVs were 
preincubated with Bcl-xL (50 nM) and cBid (4 nM) for one hour and then Bax (50 nM) 
was added, no binding of Bax to GUV membranes was observed (Fig. 5-3, Chapter 5), 
which does not allow for the FCCS measurements. However, this observation reflects the 
ability of Bcl-xL to sequester cBid in an inactive complex which is unable to activate and 
promote membrane integration of Bax14, 17, 20. Simultaneous addition to GUVs of 
Bax, cBid and Bcl-xL at these same concentrations resulted in sufficient membrane 
binding of Bax for the FCCS measurements but did not result in GUV permeabilization 
(Fig. 5-3, Chapter 5). Comparison of the fluorescence intensity of Bax-R accumulation in 
the GUV membranes in the presence and absence of Bcl-xL shows that in the presence of 
Bcl-xL the amount of Bax binding to the GUV membranes is lower than in the absence of 
Bcl-xL (Fig. 7-4).  
Based on the results of the FCCS experiments shown in Figures 7-3 a-c, in the 
presence of Bcl-xL the membrane concentration of Bax increased over 7 hours and its 
diffusion coefficient decreased from 8.3±1.0 µm2/sec (mean±s.d, n=6) to 5.2±0.7 µm2/sec 
(mean±s.d., n=26). The latter diffusion coefficient value is typical of a transmembrane  
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 Figure 7-4. Comparison of Bax-R binding to GUV membranes in the presence and 
absence of Bcl-xL.  a. Map of fluorescence intensity changes in a line scan through the 
GUV membrane (vertical direction) with time (horizontal direction). This membrane 
trace comes from a GUV exposed only to Bax-R protein and cBid. b. Change in 
cumulative fluorescence intensity in membranes of GUVs exposed to Bax-R and cBid in 
the absence and presence of Bcl-xL. The trace for the last point in each measurement is 
shown in a and c. c. Map of fluorescence intensity changes in a GUV exposed to Bax-R, 
cBid and Bcl-xL. In these experiments following protein and lipid concentrations were 
used: 25 nM Bax-R, 25 nM Bax-G, 50 nM Bcl-xL, 4 nM cBid, and 5 µM total lipid.  
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alpha-helical peptide21 and it is also similar to the in-membrane diffusion coefficient of 
monomeric membrane integrated tBid or C-terminal truncated Bcl-xL described by the 
Saffman-Delbruck model of membrane protein diffusion (Table 7-1)17, 22. In addition, we 
observed no cross-correlation between Bax-R and Bax-G at this concentration of Bcl-xL 
(Fig. 7-3b).  Based on these results we conclude that the diffusion coefficient of a 
membrane integrated Bax monomers is 5.2±0.7 µm2/sec. 
Furthermore, we propose that the gradual decrease in the membrane diffusion 
coefficient of Bax in the presence of inhibiting concentrations of Bcl-xL represents the 
transition of Bax from being a monomeric membrane-associated protein sliding on the 
membrane surface with fast diffusion to becoming a monomeric membrane-integrated 
protein with appropriately slower diffusion (Fig. 7-3c). However, we do not discount the  
 
Table 7-1. Comparison of the various diffusion coefficients of Bax with the diffusion 
coefficient of lipids. 
Type of molecule Diffusion 
coefficient, µm2/sec 
in-membrane 
diameter,  
nm 
in solution:   - 
     monomeric inactive Bax 114±5  
     monomeric tBid17 143±9  
     monomeric Bcl-xLΔC17 78±10  
in a lipid membrane:   
    lipids 10.0±0.5 1 
    monomeric membrane associated Bax 8.3±1.0 - 
    monomeric membrane integrated Bax 5.2±0.7  ~ 1  
    monomeric tBid17 5.0±0.3 - 
    monomeric Bcl-xLΔC17 4.8±0.7 - 
    Bax pore complex  
    (at 50 nM total Bax concentration ) 
2.0±0.4 53±12 
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 possibility that the monomeric integrated Bax forms hetero-dimers with Bcl-xL in lipid 
membranes20. In the Saffman-Delbruck theory scaling of the diffusion coefficient with 
the in-membrane diameter of the protein is logarithmic implying that integrated 
monomeric Bax would have membrane diffusion coefficient similar to that of a Bax/Bcl-
xL hetero-dimer. 
 
Calculation of the Bax pore complex diameter  
Traditionally the Saffman-Delbruck equation is used to calculate the 
hydrodynamic radius of a membrane inclusion from its diffusion coefficient21-25  (See 
Eqn. 1 in the Experimentals section). It has been shown, that Saffman-Delbruck equation 
faithfully describes diffusion of membrane inclusions traversing both leaflets of a lipid 
membrane in the case of small proteins, however, in the case of larger membrane 
inclusions (for example, such as lipid rafts) this theory underestimates the diameter of 
membrane inclusions. As a consequence of this, a modified version of a Saffman-
Delbruck equation has been developed by Petrov and Schwille  for the description of the 
diffusion of large membrane inclusions19 (See Eqn. 2 in the Experimentals section). 
In the case of Bax diffusion in lipid membranes, the diffusion coefficient of a Bax 
monomer (5.2±0.7 µm2/sec) is consistent with the Saffman-Delbruck theory, however, 
the diffusion coefficient of Bax-RG protein complex is two times slower than the 
diffusion of a Bax monomer, and thus according Petrov and Schwille the in-membrane 
hydrodynamic diameter of this complex should be calculated according to the modified 
Saffman-Delbruck formula. As a result the diameter of the Bax-RG protein complex 
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diffusing with diffusion coefficient of 2.0±0.4 µm2/sec is 53±12 nm. This value is one 
order of magnitude larger than the size of a Bax pore measured by the dextran blocking 
of a pore and by the electrophysiology methods13, 26. However, this value is consistent 
with the electron microscopy imaging of a Bax pore in liposomes and the AFM 
measurement of the Bax pores in supported lipid bilayers5, 27, where it has been shown 
that the diameter of a Bax pore can be 100-200 nm. 
It is worth noting here that the calculated hydrodynamic radius of a Bax-RG 
complex does not necessarily represent the size of a pore formed by this complex. In spite 
of the obvious connection between the calculated diameter of a Bax-RG complex and the 
electron microscopy and AFM experiments, it is still possible that the size of the pore is 
smaller than 53 nm and the rest of the size of the pore is occupied by the lipids trapped in 
the concerted motion of a lipidic pore. 
 
Titration of Bax in lipid membranes: mass action law 
We next asked a question, whether by increasing the amount of Bax in a lipid 
membrane we can control for the size and the concentration of Bax-RG complexes. For 
this purpose various amounts of total soluble Bax-R and Bax-G proteins were added to 
the constant concentration of GUVs, and the FCCS measurements were done on these 
GUV populations. In each case, Bax binding to GUVs was activated by the addition of 4 
nM cBid. As a result of these experiments we find that with the increasing concentration 
of total Bax added to the system the higher concentration of Bax particles is found in a 
lipid membrane (Fig 7-4, grey bars). It is important to note that these Bax particles 
include monomers and oligomers of Bax. Additionally, with increasing concentration of  
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 Figure 7-5. Titration of Bax. Bax-R and Bax-G were added to GUVs (5µM total lipid 
concentration) in the presence of cBid. FCCS measurements were done on a population 
of no less than 10 GUVs upon 1-2 hours after protein addition to GUVs. 
 
 
Table 7-2. FCCS results of the titration of Bax. Experimental conditions were the same 
as described in the legend to Figure 7-5. The hydrodynamic diameter was calculated 
using modified Saffman-Delbruck formula19. 
Total Bax 
concentration, 
nM 
Bax-RG 
complexes, 
particles/µm2 
measured diffusion 
coefficient, µm2/sec
calculated in-membrane 
hydrodynamic diameter, 
nm 
50 7.9 2.0±0.4 53.2 
83 8.8 1.5±0.4 102.2 
100 9.6 1.4±0.3 120 
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Bax particles in a lipid membrane, the greater number of the Bax-RG complexes was 
observed (Fig. 7-5, black bars). Analysis of the diffusion coefficients for the Bax-RG 
complexes formed at different total concentrations of Bax also showed an increase in the 
average size of these complexes (Table 7-2). Such correlation between the size and 
concentration of Bax-RG complexes with the total concentration of Bax in a system 
shows that Bax pore formation follows the mass action law. 
 
Moderating the activity of Bax with cBid 
To study the effects of increasing concentrations of cBid onto the distribution of 
Bax particles in a lipid membrane, we varied cBid concentrations in our FCCS 
experiments while keeping Bax and total lipid concentration constant.  As a result, we 
observed correlation between the increase of cBid concentration and the resulting 
concentration of Bax particles in the lipid membrane (Fig. 7-6). However, the 
concentration of Bax-RG complexes did not follow this correlation pattern.  
 
 
Figure 7-6. Effects of cBid titration on the distribution of the membrane forms of 
Bax. Results were obtained using two-color two-focus scanning FCCS analysis. 
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The concentration of Bax-RG complexes in a lipid membrane remained constant (within 
the margin of error) for all cBid concentrations (Fig. 7-6, blue bars). This observation 
indicates that cBid must be affecting only the kinetics of Bax integration into the lipid 
membranes without a significant effect on the resulting concentration of the Bax 
oligomers. 
 
Interactions among Bax, cBid, and Bcl-xL: rheostat model 
In Figure 7-3 we have shown that Bcl-xL inhibits oligomerization of Bax in a lipid 
membrane. However, we were intrigues to know whether the inhibitory effect of Bcl-xL 
on Bax can be rescued by the addition of excess cBid. According to the rheostat model 
proposed by Korsmeyer et al. the apoptosis decision in cells depends on the relative 
concentrations of pro- and anti-apoptotic proteins28. Therefore, in our minimal in vitro 
system we expect to observe an increase in the oligomerization of Bax in a lipid 
membrane containing Bcl-xL when cBid concentration is increased, due to the 
competition for cBid between Bax and Bcl-xL29.  
Simultaneous addition to GUVs of 50 nM Bax and Bcl-xL at 1:1 protein to protein 
ratio with 4 nM cBid resulted in complete inhibition of Bax oligomerization as can be 
seen from the absence of Bax-RG complex formation, while in the absence of Bcl-xL the 
same concentrations of Bax and cBid resulted in the formation of 16% of Bax-RG 
complexes (normalized to the total concentration of Bax particles in the membrane) (Fig. 
7-7). However, when excess of cBid is added, with 1:1:1 stoichiometry of Bax, Bcl-xL 
and cBid in the system, there is sufficient cBid for the interaction with both Bax and Bcl-
xL, and as a result we observe rescue of the Bax-RG complex formation (Fig. 7-7). These 
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observations are consistent with the rheostat model where cBid can interact with both 
Bax and Bcl-xL while having higher affinity for the interaction with Bcl-xL14, 17, 29 and 
thus when Bcl-xL is present majority of the cBid molecules is sequestered in the 
interaction with Bcl-xL (assuming 1:1 stoichiometry of protein binding) leaving few cBid 
molecules for the interaction with Bax. Therefore, using minimal in vitro system we were 
able to show that the outcome of the interaction among Bax, cBid and Bcl-xL can be 
described by the rationale of the rheostat model.   
 
 
Figure 7-7. Bax, cBid and Bcl-xL: rheostat model. Results were obtained using two-
color two-focus scanning FCCS analysis. 
 
Discussion 
For use with two-color two-focus FCCS we produced two forms of the 
fluorescently labeled full length Bax protein, Bax-R and Bax-G. These fluorescently 
labeled Bax proteins have been shown to have the pore formation activity similar to that 
of the recombinant wild type Bax (See Chapter 5 for details).  Furthermore, we show that 
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these two fluorescent forms of Bax are monomeric in solution and oligomerize only in 
lipid membranes (Fig. 7-1). 
 
Bax binding to lipid membranes: associated versus integrated Bax 
 Using two-color two-focus scanning FCCS we show that prior to oligomerization 
in a lipid membrane monomeric Bax associates with the lipid membrane, and then 
becomes membrane integrated. The transition between the membrane associated and 
integrated forms of Bax most likely occurs via a conformational change, which is aided 
by cBid protein already present in the membrane. We differentiate between these two 
monomeric forms of Bax based on their diffusion coefficient: membrane associate 
monomeric Bax, due to incomplete insertion into a lipid bilayer, has faster diffusion 
coefficient (8 µm2/sec) than the monomeric membrane integrated Bax (5 µm2/sec). It is 
important to note, that this transition from associated to integrated Bax could only be 
observed by scanning FCCS in the presence of Bcl-xL protein in GUV membranes. Bcl-
xL slows down membrane binding of Bax, and thus allowed us to observe this transition 
process. Bcl-xL have been proposed to inhibit the pore formation by Bax in three ways: 
by directly binding monomeric integrated Bax, by binding cBid protein and thus 
eliminating it as an activator of Bax, and by preventing Bax binding to a lipid 
membrane20, 30. However, the mechanism of a letter inhibition pathway is not clear. 
Therefore, Bcl-xL inhibition of Bax binding, oligomerization and pore formation in lipid 
membranes, which were observed in our experiments, agree with literature. 
 In the absence of Bcl-xL in the membrane, the association and integration of Bax 
is rapid, and can not be resolved by the scanning FCCS. In this case we observe the 
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decrease in the average diffusion coefficient of Bax from 5 µm2/sec to 2 µm2/sec, which 
is likely represents the transition form monomeric integrated Bax to a proteo-lipidic 
complex containing multiple Bax monomers. Furthermore, the time frame of the Bax 
transition from the associated to integrated protein in the presence of Bcl-xL is longer 
than the time frame of the transition from the monomeric membrane integrated protein to 
the proteo-lipid complex in the absence of Bcl-xL (Fig. 7-3 b and e), thus supporting our 
proposal that Bcl-xL slows down the process of Bax integration in a lipid membrane. Our 
observation of the transition from membrane integrated to membrane associated forms of 
Bax can be further supported by the SPR studies31 and by the studies of the conformation 
of Bax loosely associated with the lipid membrane of LUVs32.  
 
Self-assembly of Bax in lipid membranes 
It has been shown that in order to form a pore in artificial lipid membranes, Bax 
need to undergo self-assembly in the lipid membrane environment5, 10, 13, 14, 33, while in 
vivo, during apoptosis, Bax has also been shown to form large aggregates10, 34, 35. 
Therefore, our observation of the Bax-RG complex formation was expected. However, 
what was unexpected, is the progressive decrease in the diffusion coefficient of Bax upon 
membrane integration. According to the Saffman-Delbruck formula, diffusion of a 
membrane protein is primarily affected by the in-membrane hydrodynamic diameter of 
the protein. Therefore, dimerization and even tetramerization of a protein in a lipid 
bilayer would not result in a significant change in the diffusion coefficient of the resulting 
complex, compared to that of a monomer36, 37. Therefore, our observation of the 
significant decrease in the diffusion coefficient of Bax-RG complex compared to that of a 
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Bax monomer, indicates that Bax is not simply oligomerizing, but most likely is forming 
lipidic pores4, 5, 38. These lipidic pores involve lipids which contribute to the size of the 
in-membrane hydrodynamic diameter of a complex (See Fig. 7-3 c for a proposed model 
of a Bax lipidic pore). Therefore, our estimation of the diameter of these slowly diffusing 
Bax-RG proteo-lipidic complexes most likely over-estimates the size of pores formed by 
these complexes in a lipid bilayer. However, we do not have direct experimental evidence 
for the presence of pores in these complexes. The reason for our assumption, that these 
Bax-RG proteo-lipidic complexes contain a pore, is based on the transmission electron 
microsocopy and AFM measurement of the Bax pore diameters, which show that Bax is 
capable of forming pores with the diameter of 100-200 nm. Calculated in-membrane 
diameter of a Bax-RG complex falls into this range. 
 
Rheostat model: connection to physiology 
 The finding that pro- and anti-apoptotic proteins of the Bcl-2 family can 
heterodimerize, and that their relative concentrations to each other affects the decision 
whether a cell should undergo apoptosis, have lead to the proposal of the rheostat model 
by Korshmeyer et al28.  The results obtained using our model system of Bax pore 
formation in GUVs support this hypothesis (Fig. 7-7). These results show that, when 
equimollar concentrations of Bax and Bcl-xL are present in a lipid membrane together 
with low concentration of cBid, there is no oligomerization and pore formation by Bax. 
However, when cBid is added, such that there is approximately one cBid molecule for 
each Bax and Bcl-xL molecule, then oligomerization and pore formation by Bax is 
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rescued. Similarly, in the presence of low cBid concentration and the complete absence 
of Bcl-xL, Bax is able to oligomerize and form pores. 
 The results of scanning FCCS shown that Bax, cBid and Bcl-xL obey the law of 
mass action (Fig. 7-5, 7-6, 7-7). These results show that increase in the concentration of 
soluble protein leads to the concentration increase of the membrane bound protein, with a 
certain saturation limit. Results of the titration experiments with Bax-R and Bax-G show 
that not only the total concentration of membrane bound Bax monomers increases, but 
also that the distribution of Bax-RG proteo-lipidic complexes changes, resulting in the 
larger mean diameter of complexes (Table 7-2). 
 
Conclusions 
 The work presented in this chapter represents the first example of the application 
of two-color two-focus scanning FCCS to study oligomerization and pore formation by 
Bax in lipid membranes of GUVs. The results of this study provide an insight into the 
mechanism of Bax pore formation in lipid membranes and the regulation of this 
mechanism by the pro-apoptotic BH3-only protein cBid and anti-apoptotic protein Bcl-
xL. These results show that Bax binds lipid membranes containing cBid as a monomer, by 
first associating with the lipid membrane, likely via electrostatic interaction, and then 
undergoing conformational transition to become a membrane integrated protein, likely 
due to the interaction with cBid. Once in lipid membrane, integrated Bax monomers 
initiate self-association which leads to the formation of pores. Formation of pores reduces 
the concentration of monomeric Bax monomers in the lipid membrane, thus allowing for 
the integration of additional Bax proteins. This continual insertion of Bax monomers into 
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the lipid membrane leads to increase in the average Bax pore size resulting in the 
heterogeneous distribution of Bax pores. Increase in the number of Bax pores in the lipid 
membrane leads to the disruption of elastic forces of the lipid membrane, thus leading to 
the deformation and destruction of GUVs. 
 
Experimentals 
Protein purification and labeling was done as described in Chapter 5 and Appendix V. 
Sample preparation for the FCCS experiments. 
 For the FCCS experiments GUVs were prepared from a lipid mixture of 
DOPC:bovine heart cardiolipin (80:20 mol%) using the electroformation method 
described in Appendix IV. After the preparation 50 µl of GUVs were transferred to an 
observation well containing 450 µl of 1xEB buffer (10 mM Hepes, pH 7.2, 100 mM KCl) 
and a mixture of proteins (Bax, cBid, Bcl-xL) depending on the experiment.  For all 
experiments observation chambers (8 well LabTak, Nunc) were treated for at least one 
hour with a solution containing 4 mg/ml BSA. BSA treatment was done with the purpose 
to prevent protein adsorption to the plastic walls of the observations chamber.  All FCCS 
measurements were performed at room temperature (22 °C) in a dark room.  
 
Fluorescence cross-correlation spectroscopy.  
FCCS measurements were performed on a laser-scanning microscope Meta 510 
system (Carl Zeiss) using 40× NA 1.2 UV-Vis-IR C Apochromat water-immersion 
objective. For excitation the 488 nm line of an Argon-ion laser (25 µW) and the 633 nm 
line of the HeNe laser (15 µW) were used, while detection was done using a home-built 
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detection unit at the fiber output channel. A dichroic mirror and band-pass filters (D555, 
HQ520/40 and HQ700/75; AHF Analyze Technik) were used behind a collimating 
achromat to split the emission for the dual-color detection and to reject residual laser and 
background light. We then used achromats (LINOS Photonics) to image the internal 
pinhole onto the apertures of the fibers connected to the avalanche photodiodes (APD, 
PerkinElmer). The photon arrival times were recorded in the photon mode of the 
hardware correlator Flex 02-01D (http://correlator.com). 
For scanning FCCS, the detection volume was repeatedly scanned perpendicularly 
through the equator of a GUV. We controlled its movement directly with the Zeiss LSM 
operation software. We used the frame mode with Nx2 pixels to scan the two parallel 
lines. We measured their distance d by repeatedly scanning over a film of dried 
fluorophores and measuring the distance between the bleached traces in a high-resolution 
LSM image. 
Data analysis was performed with software written in MATLAB (MathWorks). 
For scanning FCCS, we binned the photon stream in bins of 2 µs and arranged it as a 
matrix such that every row corresponded to one line scan. Corrected for movements of 
the membrane was done by calculating the position of the maximum of a running average 
over several hundred line scans and shifting it to the same column. We fitted an average 
over all rows with a Gaussian and we added only the elements of each row between -2.5σ 
and 2.5σ to construct the intensity trace. We computed the auto- and cross-correlation 
curves of the resulting intensity traces with a multiple tau correlation algorithm and fitted 
them with a nonlinear least-squares fitting algorithm. In all FCCS data processing, we 
excluded from further analysis irregular curves resulting from major instabilities 
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identified by distortions of the curves and a systematic change in the intensity trace. For 
details of data fitting see Supplementary information. 
 
Calculation of the diameter for the Bax pore complex. 
According to the Saffman-Delbruck theory of the diffusion of particles in lipid 
membranes translational diffusion coefficient ( ) of the particle depends on the radius 
(
D
R ) of the particle in the following way 
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where mem  is membrane viscosity, sol  is solution viscosity, h is membrane thickness, 
T temperature,  is Boltzmann constant, and Bk   is Euler's constant (0.5772)22. 
Schematic representation of a diffusing particle in a lipid membrane is shown in Figure 7-
8. 
 
 
Figure 7-8. Schematic representation of the hydrodynamic model of a particle diffusing 
in a lipid membrane described by the Saffman-Delbruck equation (Eqn. 1). 
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 As was mentioned previously that Saffman-Delbruck formula describes well 
diffusion of small proteins is a lipid membrane, but it fails to describe the membrane 
diffusion of larger complexes such as lipid rafts19. Since Bax-RG proteo-lipidic 
complexes have diffusion coefficient two times smaller that the diffusion coefficient of a 
Bax monomer we used modified Saffman-Delbruck formula19 to determine the in-
membrane hydrodynamic radius of these complexes. In our analysis we made 
assumptions that membrane viscosity is 0.7 cP15, membrane thickness is 5 nm. The 
expression for the modified Saffman-Delbruck formula is following 
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where,   is the reduced radius, memsolR  2 , while , , , and  are constant 
( , , 
1c 2c 1b 2b
0.737611 c 0.521192 c 74819.21 b , 61465.02 b  ). 
To calculate the error for this value we used the fact that membrane viscosity is 
not very well defined and according to Ramadurai et al.15 it varies for a lipid membrane 
composed of DOPC/DOPG mixture from 0.6 cP to 0.8 cP. Using this uncertainty in the 
actual value for the membrane viscosity together with the fact that lipid composition used 
in our work has similar viscosity as the one used in Ramadurai et al. based on the 
measurements of translational lipid diffusion (see Appendix VI) we estimated that 
standard error for the diameter of the Bax pore complex is 12 nm. Therefore, we estimate 
that the diameter of the Bax pore complex in a lipid membrane is 53±12 nm. 
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Conclusions 
 Protein Bax, a member of the Bcl-2 family, participates in the apoptosis decision 
by forming pores in the mitochondrial outer membrane. In non dying cells, Bax is found 
in the cytoplasm, therefore, in order to form pores in the mitochondrial outer membrane it 
needs to undergo a conformational change, which is associated with the activation of 
Bax. The molecular mechanism of Bax activation is one of the major unanswered 
questions in the field of apoptosis. In addition to this question, there are other  questions 
about the pore formation mechanism of Bax, which remain unanswered due to the 
absence of the structure for membrane integrated active Bax, the form of Bax involved in 
the formation of pores. These questions include (i) the molecular mechanism of Bax 
integration into a lipid membrane; (ii) the details of molecular interactions between Bax 
monomers, leading to the formation of a pore; (iii) the progression, oligomeric state and 
the size of pores formed Bax; (iv) the nature of a Bax pore – lipidic versus barrel-stave; 
(v) the molecular interactions among monomers in a pore. To answer some of these 
questions we developed and used approaches to study fluorescently labeled Bax in three 
model in vitro systems –detergent micelles, LUVs and GUVs – using single-molecule 
sensitivity fluorescence techniques based on FCS. These single-molecule sensitivity 
techniques provide us with a non-invasive method to study the mechanism of Bax pore 
formation in lipid membranes. 
 
Determination of the oligomeric state of Bax in micelles of activating detergents 
 It has been observed that Bax can be activated via interaction with detergent 
micelles. Additional biochemical analysis of the complexes formed by Bax and detergent 
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micelles revealed that these proteo-micellar complexes have a hydrodynamic volume 
larger than the combined volumes of a Bax monomer and a single detergent micelle. Due 
to the propensity of Bax to oligomerize in the hydrophobic environment of a lipid 
membrane during pore formation, it was hypothesized that Bax oligomerizes in detergent 
micelles, and that this oligomerization leads to the activation of Bax. Additionally, it was 
proposed that the oligomer of detergent activated Bax (consisting of up to 8 monomers) 
binds lipid membranes and then leads to the formation of a pore. This is in contrast to the 
in vitro studies where it was shown that Bax binds the mitochondrial outer membrane as 
a monomer, and then undergoes oligomerization culminating in the formation of a pore. 
 Using a truncated version of Bax, BaxΔC, labeled with a single fluorophore per 
protein monomer, we determined the oligomeric state of Bax in the micelles of several 
activating detergents using the fluorescence intensity distribution analysis (FIDA). To 
show that the fluorescently labeled BaxΔC used in our study has similar pore forming 
ability to that of BaxΔC used in the preceding studies where it was shown to enlarge the 
size of detergent micelles, we compared the pore forming ability of the two proteins 
using the assay of dye release from liposomes. The results of this assay showed that the 
fluorescently labeled BaxΔC has similar but slightly reduced pore forming ability 
compared to unlabeled BaxΔC. We attribute this slight reduction in the pore forming 
activity of fluorescently labeled BaxΔC to the presence of the fluorescent label on this 
protein.  
 The detergents used in this study were n-octylglucoside, dodecylmaltocide, Triton 
X-100, Tween 20, and cholic acid, and the results of FIDA for all of these detergents 
showed that BaxΔC does enlarge the hydrodynamic volume of detergent micelles, but 
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there is only one protein monomer per detergent micelle. Cholic acid was an exception to 
the first part of this statement, since Bax did not enlarge the size of micelles of cholic 
acid. We ascribe the absence of enlargement of the micelles of cholic acid upon 
interaction with Bax to the fact that cholic acid is an ionic detergent, and it naturally 
forms extremely small micelles of 4 kDa (in comparison the size of Bax is 21 kDa while 
the size of Triton X-100 detergent micelles is 70-100 kDa). 
 The result, showing that BaxΔC is present as a monomer in the proteo-micellar 
complexes, provides a connection between the detergent activation of Bax in vitro and 
the physiologic pattern of Bax activation observed in vivo, showing that active Bax is a 
monomer prior to membrane binding, and oligomerizes only in the environment of a lipid 
membrane to form a pore. However, independent reviewers of our study pointed out that 
the use of the truncated version of Bax, BaxΔC, might be a problem. Furthermore, two 
recently published studies used micelles of Triton X-100 to study the homo-
oligomerization of full length Bax using cross-linking. The comment of the authors of 
these studies on our study was that the reason for difference in the observed results is the 
use of BaxΔC, which might have different oligomerization propensity than full length 
Bax. 
 BaxΔC has 19 amino acids truncated at the C-terminus, and thus lacks helix 9 
which is implicated in binding lipid membranes. When expressed in vivo, BaxΔC can 
release cytochrome c from mitochondria, thus showing that it has pore forming activity 
comparable to that of full length Bax. The reason why we chose to use BaxΔC in our 
studies is because the full length Bax in our hands forms visible by eye precipitates upon 
incubation with activating detergents, thus rendering it unusable in FIDA analysis. 
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However, we do agree that repeating FIDA with the full length fluorescently labeled Bax 
is one of the future experiments which need to be done. 
 
Imaging studies with fluorescently labeled Bax 
 Before continuing to the two-color two-focus scanning FCCS experiments on the 
fluorescently labeled full length Bax in lipid membranes, we performed confocal 
microscopy characterization of the interaction of fluorescent Bax with GUVs. In these 
confocal microscopy experiments we used cBid to promote Bax binding to GUVs, and 
we have made a number of informative observations: (i) permeabilization of GUVs by 
Bax is a stochastic process, i.e. GUVs exposed to the same concentration of solution Bax 
are not permeabilized simultaneously; (ii) after the initial permeabilization of a GUV, 
Bax continues to bind the GUV membrane until it saturates; (iii) shortly after the addition 
of Bax to GUVs, Bax is able to open stable giant pores in GUVs, which we named Bax 
mega-pores; (iv) Bax binding was not homogenous among the GUVs, i.e. some GUVs 
accumulated high membrane Bax concentrations than others, suggesting heterogeneity in 
the lipid composition of GUVs; (v) after prolonged incubation with GUVs Bax causes 
morphological changes in GUV structure, GUVs may form tubule-like structures, or have 
a potato-like shape, GUVs can form agglomerates or disintegrate; (vi) large, visible by 
confocal microscopy aggregates of Bax were observed in GUV membranes after 
prolonged incubation with Bax; (vii) the inhibitor of Bax pore formation, protein Bcl-xL, 
does not completely inhibit Bax binding to GUV membranes but it does inhibit 
permeabilization of GUVs by Bax; (viii) within 24 hours of Bax addition, the majority of 
GUVs are disintegrated and are unfit for FCCS measurements, while GUVs which were 
 187
not treated with Bax maintain their spherical shape and remained present in the 
observation chamber after 24 hours. The results of these confocal imaging studies not 
only allowed us to determine the optimal experimental conditions and the time frame for 
performing scanning FCCS measurement on Bax in GUV membranes, but also they 
showed that Bax binding changes the morphology of GUVs. 
 
Bax mega-pore 
 It has been observed that Bax forms a wide variety of pores in artificial lipid 
membranes and in isolated mitochondria, with the largest size of a Bax pore ranging 
between 100-200 nm in diameter. In contrast to these studies, we observed the formation 
of Bax mega-pores with diameters of 5-20 µm. All of these pores had fluorescent Bax 
concentrated at the rim of the pore which allowed us to perform 3D reconstructions of 
these pores.  
These Bax mega-pores spent an unusually long time in an open state ranging from 
10 minutes to hours. Giant pores of similar diameter can be opened in GUVs by 
application of detergents or by mechanical disruption, however, these only have a life 
time on the order of seconds and microseconds respectively. By analyzing the closure 
kinetics of Bax mega-pores, we have determined that the reason for such long lifetime of 
these pores compared to the other giant pores is explained by the extremely low line 
tension in the rim of the pore (3.7±1.7 fN), which is caused by the presence of Bax in the 
pore rim. Furthermore, the line tension in the rim of a Bax mega-pore formed by full 
length Bax is three orders of magnitude lower than that formed by the pore forming helix 
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5 of Bax, thus suggesting that the non-pore forming helices of Bax participate in the 
stabilization of a pore. 
The existence of Bax mega-pores shows that Bax can form pores spanning four 
orders of magnitude in size. However, it is not clear whether all of these Bax pores have 
similar molecular interactions among Bax monomers in the pore rim, suggesting for the 
need to further explore the formation mechanism of various Bax-containing pores.  
 
FCCS studies with Bax 
 For FCCS studies, we have produced two fluorescently labeled forms of Bax. One 
is labeled with Alexa Fluor 488 (Bax-G) and the other is labeled with Atto 655 (Bax-R). 
The pore forming activity of these proteins was identical to that of the wild-type full 
length Bax. Furthermore, these proteins behaved as monomers in solution and did not 
associate in solution in the absence of lipid membranes. Association of Bax-R and Bax-G 
resulted in the formation of a stable Bax-RG complex, and was observed only in GUV 
membranes using two-color two-focus scanning FCCS. Using this scanning FCCS 
technique, we have also observed that the diffusion of Bax-RG complexes decreases with 
time, suggesting a time dependent enlargement in the hydrodynamic in-membrane size of 
the complexes.  The size of these Bax-RG complexes ranged from 50-120 nm in 
diameter, which is consistent with the size of the Bax pores observed in LUVs by 
transmission electron microscopy (with maximal size of 10-200 nm  in diameter). 
However, it is important to mention that the in-membrane size of the Bax-RG complexes 
may not be the same as the size of pores possibly formed inside these complexes, since if 
the Bax pore is a lipidic pore, then lipids would be participating in the formation of the 
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pore, and their contribution to the diffusion of the Bax-RG complex would lead to a 
decrease in the overall diffusion coefficient of the complex, and thus lead to higher 
values in the estimation of the hydrodynamic diameter of the complex. 
 In the presence of Bcl-xL protein the oligomerization of Bax was inhibited and the 
amount of Bax binding to the lipid membrane was decreased. We have also found that the 
diffusion coefficient of Bax was changing with time from 8 µm2/sec to 5 µm2/sec. This 
change in the diffusion coefficient of monomeric Bax is consistent with the hypothesis 
that, during membrane integration, Bax transitions from being a membrane associated 
protein to being a membrane integrated protein, where the membrane associated Bax 
monomer would have fast diffusion coefficient, comparable to that of lipids (~10 
µm2/sec), while the membrane integrated Bax monomer would have a slow diffusion 
coefficient, similar to that of transmembrane monomeric proteins (~5 µm2/sec). This 
change in the diffusion coefficient of Bax in the presence of Bcl-xL occurred over two 
hours after protein addition to GUVs, while in the absence of Bcl-xL, Bax became 
oligomeric and reduced its diffusion coefficient to 3-4 µm2/sec after 40 min of addition to 
GUVs, thus indicating that Bcl-xL prevents pore formation by Bax not only by keeping it 
monomeric but by also keeping Bax mostly in the membrane associated state preventing 
the membrane integration of Bax. 
 Overall the results of scanning FCCS studies on Bax in GUV membranes provide 
direct observation that Bax binds lipid membranes as a monomer (membrane associated 
monomeric Bax), undergoes membrane insertion (membrane integrated monomeric Bax) 
and then undergoes in-membrane oligomerization and self-assembly into large complexes 
50-120 nm in diameter which we feel are proteo-lipid pores.  
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Future Directions 
Scanning FCCS can be used to study hetero-oligomerization among proteins of the 
Bcl-2 family  
To the best of our knowledge, the approach, implementation and data analysis 
presented in this dissertation of using single-molecule sensitivity fluorescence techniques 
to study the mechanism of pore formation by Bax, and in fact by any other pore forming 
protein, is the first of its kind. Therefore, we foresee further studies utilizing this 
approach to study other pore forming proteins and peptides, and in particular, Bax. Our 
scanning FCCS studies provided an initial characterization of the diffusion coefficients of 
various Bax species in a lipid membrane. However, since in vivo Bax is kept in check by 
other members of the Bcl-2 protein family, it is important to investigate in future 
experiments the effect of other Bcl-2 members on Bax. This can be done by studying not 
the homo-oligomeirzation of Bax, as was done in this dissertation, but the hetero-
oligomerization of Bax with other Bcl-2 family members. This type of hetero-
oligomerization studies by scanning FCCS in lipid membranes can, for example, provide 
information about the affinity of the interaction among various Bcl-2 family members, 
and in particular help to determine whether activator and de-repressor BH3-only proteins 
interact with Bax in the environment of a lipid membrane. Another set of hetero-
oligomerization experiments can address the question whether the major mechanism of 
inhibition of Bax pore formation by the anti-apoptotic proteins is by directly binding Bax 
in the lipid membrane or not.  Our preliminary evidence suggests that Bax and Bcl-xL do 
not form a stable complex in a lipid membrane; however, Bcl-xL did inhibit the pore 
formation by Bax in these experiments. Information obtained in the described above 
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experiments about the mechanisms of interaction among the Bcl-2 family members in 
lipid membranes can potentially be used to develop small molecules which can help 
modulate these Bcl-2 family interactions and thus can be used in cancer treatment of 
prevention of cell death after trauma or cardiac infarction. 
 
Cholic acid can be used to determine the structure of active Bax 
 Our FCS studies with the micelles of Bax activating detergents have shown that 
the majority of activating detergents form large proteo-micellar complexes with Bax. The 
large hydrodynamic size of these complexes prohibits NMR determination of the 
structure of active Bax contained inside these complexes. However, we have shown that 
cholic acid activates Bax without the formation of large hydrodynamic volume 
complexes, in fact, the size of Bax-cholic acid complexes is almost identical to the size of 
an inactive Bax monomer whose structure have been successfully determined by NMR. 
Therefore, we predict that cholic acid can be used to determine the structure of active Bax 
by NMR. 
 
Single-molecule TIRF can be used to study the sequence of interactions among 
proteins of the Bcl-2 family 
  Single-molecule TIRF microscopy allow to study interactions among individual 
molecules near a surface. Supported lipid bilayers can form such a surface, and thus they 
have been used in single-molecule TIRF experiments. We hypothesize that single-
molecule TIRF can be used to study homo- and heterotypic interactions among proteins 
of the Bcl-2 family, provided that these proteins are fluorescently labeled. These types of 
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studies would provide information about the sequence of interactions among the proteins 
of the Bcl-2 family, since such information can not be easily obtained using scanning 
FCCS technique used in this dissertation.  
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Appendix I 
 
Structural information on human α Bax protein  
 
Amino acid sequence: 
 
MDGSGEQPRG GGPTSSEQIM KTGALLLQGF IQDRAGRMGG EAPELALDPV PQDASTKKLS  
 
        70         80         90        100        110        120  
ECLKRIGDEL DSNMELQRMI AAVDTDSPRE VFFRVAADMF SDGNFNWGRV VALFYFASKL  
 
       130        140        150        160        170        180  
VLKALCTKVP ELIRTIMGWT LDFLRERLLG WIQDQGGWDG LLSYFGTPTW QTVTIFVAGV  
 
       190  
LTASLTIWKK MG  
 
Number of amino acids: 192 
 
Molecular weight: 21184.4 
 
Theoretical pI: 5.08 
 
Amino Acid composition: 
Ala (A)  14   7.3% 
Arg (R)  11   5.7% 
Asn (N)   3  1.6% 
Asp (D)  13   6.8% 
Cys (C)   2   1.0% 
Gln (Q)   9   4.7% 
Glu (E)  10  5.2% 
Gly (G)  21  10.9% 
His (H)   0   0.0% 
Ile (I)   9   4.7% 
Leu (L)  22  11.5% 
Lys (K)   9   4.7% 
Met (M)   8   4.2% 
Phe (F)  10   5.2% 
Pro (P)   8   4.2%  
Ser (S)  11   5.7% 
Thr (T)  13  6.8%  
Trp (W)   6    3.1%  
Tyr (Y)   2    1.0%  
Val (V)  11    5.7% 
 
Total number of negatively charged residues (Asp + Glu): 23 
Total number of positively charged residues (Arg + Lys): 20 
Extinction coefficients: 
 
 
Ext. coefficient    35980 M-1 cm-1, at 280 nm measured in water. 
 
Abs 0.1% (=1 g/l)   1.698, assuming all Cys residues are reduced 
 
 195
Appendix II 
 
Protocol for the preparation of large unilamellar vesicles 
 
For my thesis I have used the reverse phase method of LUV preparation (ref). The other 
existing method for the LUV preparation is the freeze-thaw method (ref). Using either of 
these methods it is possible to prepare LUVs in various aqueous buffer solutions. In my 
thesis research I mainly prepared two types of LUV: filled with quenched concentration 
of carboxyfluorescein or filled with buffer solution. In order to prepare LUVs by either 
method lipids have to be dried in a glass vial/tube. 
Drying lipids: 
1. Deposit lipids dissolved in chloroform into a glass tube (1x10 cm, diameter x 
height). The total amount of lipids per tube can be from 0.5 – 10 mg. 
2. Dry lipids using a stream of nitrogen gas. Dried lipids are extremely vulnerable to 
oxidation by the oxygen in the atmosphere, therefore, care must be taken to keep 
the dry lipids either under 100% nitrogen or 100% argon atmosphere. 
3. To remove the chloroform from lipids completely the liophilization vacuum 
system is used for 2 hours. 
4. At this points glass tubes with dried lipids can be stored at -20 °C under 100% 
nitrogen or 100% argon atmosphere. For convenience 50 ml disposable plastic 
conical tubes can be used. In this form lipids can be stored for 1-2 months. 
LUV preparation by reverse phase method: 
1. Defrost a container containing the glass tube/tubes with dried lipids by leaving it 
on a bench at room temperature for 5-10 minutes.  
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2. Return the rest of the glass tubes to -20 °C. 
3. To the glass tube with dried lipids add 1 ml of diethyl ether to dissolve the lipids. 
Make sure that all lipids are dissolved by checking for the white residue of dry 
lipids on the sides of a glass tube.  (Note, a bottle of diethyl ether which is over 1 
year old is dangerous since it can be explosive due to the formation of diethyl 
ether hydroperoxide).  
4. Next, add 0.5 ml of buffer which will be incorporated into the interior of the 
liposomes (for example, 1x EB* or 50 mM rarboxyfluorescein in 1x EB). At this 
point the ether and water phases will be separated with ether phase being on top 
of the water phase. 
5. Sonicate the water-ether solution using a table top, water bath sonicator for 10-30 
seconds. At this point the solution in the glass tube should become homogeneous 
and milky. If the solution is not homogeneous repeat the sonication cycle. 
6. The milky solution in a tube is an emulsion of aqueous buffer in ether. 
7. Transfer the emulsion to a bulb-like vial and connect it to a rotary evaporator to 
evaporate the ether from the emulsion. Slow evaporation of ether forces lipids in 
solution to organize into lipid bilayers of liposomes. At this point liposomes 
would be non-unilamellar (i.e. there would be daughter liposomes inside of a 
larger mother liposome) and would have diameters anywhere between 600 nm 
and 50-30 nm. 
8. To form unilamellar liposomes of a 200 nm to 100 nm in diameter the liposomes 
from the Step 7 should be extruded 7-21 times through a membrane with pore of a 
specified diameter. 
 197
9. At this point dynamic light scattering can be used to asses the quality of the 
extrusion process. 
10. Depending on the lipid composition resulting extruded LUVs can be stored for 1 
month. For example, extruded LUVs made with lipids containing tow oleoyl 
carbon tails can be store at room temperature for 1 month. 
 
Preparation of LUVs filled with quenched carboxyfluorescein: 
1. Prepare a 50 mM carboxyfluorescein solution in a buffer of choice. Keep 7.0 pH.  
2. Follow steps 1-3 of the above LUV preparation protocol. 
3. Add 0.5 ml of 50 mM carboxyfluoresceine in 1x EB to the glass tube containing 
lipids dissolved in ether. Separation of the aqueous and ether pahses would be 
clearly visible. 
4. Sonicate the buffer-ether solution using a table top, water bath sonicator for 10-30 
seconds. At this point the solution in the glass tube should become homogeneous 
and milky. If the solution is not homogeneous repeat the sonication cycle. 
5. The milky solution in a tube is an emulsion of aqueous buffer in ether. 
6. Transfer the emulsion to a bulb-like vial and connect it to a rotary evaporator to 
evaporate the ether from the emulsion. Slow evaporation of ether forces lipids in 
solution to organize into lipid bilayers of liposomes. At this point liposomes 
would be non-unilamellar (i.e. there would be daughter liposomes inside of a 
larger mother liposome) and would have diameters anywhere between 600 nm 
and 50-30 nm. 
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7. To form unilamellar liposomes of a 200 nm to 100 nm in diameter the liposomes 
from the Step 7 should be extruded 7-21 times through a membrane with pore of a 
specified diameter. 
8. To separate the extruded LUVs filled with the carboxyfluoresceien from the 
carboxyfluoresceine present outside the LUVs use a Sephadex G-25 column. The 
appropriate dimentions of such Sephadex G-25 column should be 1 cm x 30 cm 
(diameter versus length) to enshure clear separation of the liposomes filled with 
the carboxyfluorescein from free carboxyfluoresceine in solution. 
9. After the gel filtration thotuhg the Spehadex G-25 column perform dynamic light 
scattering on the sample of LUVs to ensure the correct size. 
10. To ensure that the liposomes are filled with quenched carboxyfluorescein use a 
small sample of liposomes (5-10 µl) in a clear ependorf tube (note the brightness 
of the sample) then add 5 µl of 20% Triton X-100 to the sample. Triton X-100 is a 
detergent which when added to the liposomes would solubilize the liposomes 
releasing their content into solution. If the sample changes brightness this would 
mean that the liposomes are filled with qunenched carboxyfluoresceien and are 
ready for use. The same type of control can be sone using a plate reader or a 
conventional fluorimeter. 
11. Liposomes filled with quenched carboxyfluoresceine and filtered throught he 
Sphadex G-25 column can be used only over a 5 day period due to the gradual 
leakage of carboxyfluoresceine from liposomes.  
 
* 1x EB – equilibration buffer containing 10 mM HEPES pH 7.2, 100 mM KCl 
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Appendix III 
Protocol for preparation of giant unilamellar vesicles 
Giant unilamellar vesicles (GUVs) used in all experiments described in this dissertation 
were prepared by the electroformation method2, 3. In this method chloroform mixture of 
lipids (1-2 mg/ml of total lipid) is deposited onto the surface of two parallel platimun 
wires (5 µl of mixture per wire). Deposition of lipid mixture onto the platinum wires is 
done using a plastic gel-loading pipette tip. Lipids are allowed to dry on the surface of the 
wires after which the wires are immersed into the di-ionized water solution of 300 mM 
sucrose. The platinum wires and the sucrose solution are contained in a Teflon chamber 
(Fig. A1a). Next, wires are connected to an AC function generator set to sine wave-
shaped output of AC current with 10 Hz, 2V for 1-2 hours (Fig. A1b, A1c). During this 
1-2 hour time period GUVs are formed on the surface of the platinum wires (like grapes 
on a wine). After that the frequency of the AC current is changed to 2 Hz for another 30 
min to 1 hour. This leads to detachment of GUVs from the platinum wires into the 
sucrose solution resulting in GUVs ready for use in an experiment. While pipetting the 
GUVs care must be taken not to rupture them by cutting the tip of 200 µl pipette tip (this 
increases the diameter of the pipette opening and results in a smaller shear forces 
experienced by GUVs while passing through the opening during pipetting). 
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a 
 
 
 
b 
 
 
c 
 
 
Figure A1. Illustrations to the method of GUV electroformation. a. Electroformation 
chamber made of Teflon with two platinum wires. b. Function generator; this figure 
shows for function generators. c. Assembled electroformation chambers connected to the 
function generator. 
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Appendix IV 
Protocol of protein purification and labeling.  
Human full length Bax, BaxΔC, BaxΔC(G40C), Bid, Bcl-xL, and mutant Bax_S4C were 
expressed in BL21(DE3) E. coli, and purified as an intein/chitin-binding domain fusion 
protein without use of detergents. Briefly, bacterial cultures were grown at 37 °C in 
Terrific Broth4 to an A600 of 1.5–2.0, and then the cultures were induced with 0.1 mM 
isopropyl 1-thio-D-galactopyranoside (Research Products International. Corp.), and the 
temperature was changed to 25 °C. After 12–15 h, bacteria were collected via 
centrifugation; the resulting pellet was resuspended in lysis buffer (phosphate-buffered 
saline, pH 7.2, 1mM EDTA, 0.25 mM phenylmethylsulfonyl fluoride), and cells were 
broken by four passages through a microfluidizer (Microfluidics) at the pressure of 1000 
bar. Lysate was clarified by centrifugation, and the supernatant containing protein of 
interest was incubated with chitin affinity resin (New England Biolabs) overnight at 4 °C 
on a rocker. Resin was subjected to a high salt wash and then equilibrated in cleavage 
buffer (10 mM HEPES/NaOH, pH 8.0, 100 mM NaCl, 50mM dithiothreitol) and 
incubated for 48 h at 4 °C. The purity of the proteins was assessed by SDS-PAGE. 
Bax_S4C was labeled with either Alexa Flupr 488 maleimide (Invitrogen) or Atto 655 
maleimide (AttoTech) according to the manufacturer’s protocol. Labeled protein was 
separated from the free dye using a Sephadex G-25 column. The degree of protein 
labeling was determined using a Nano-Drop spectrophotometer (Thermo Scientific) by 
measuring absorbance at 280 nm (for protein concentration) and 488 nm (for Alexa Fluor 
488 concentration) and 655 nm (for Atto 655 concentration). Resulting proteins Bax-R 
and Bax-G were 80% and 100% labeled respectively and were stored in EB buffer (10 
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mM HEPES/KOH, pH 7.2, 100 mM KCl) at 4 °C. Proteins were used within one month 
of purification and labeling.  
Bid was cut with recombinant caspase 8 to produce cBid.  
 
Protein functionality check: fluorescently labeled Bax is functional. To determine 
whether fluorescent labeling and mutagenesis of the human  full length Bax protein 
(Figure 1B) interferes with the capacity of Bax to form pores the experiments of 
carboxyfluorescein release from liposomes 5, 6 were performed. In these experiments the 
ability to form pores in liposomes of the wild-type Bax and the two forms of the 
fluorescently labeled Bax (Bax-G labeled with Alexa 488 and Bax-R labeled with Atto 
655) were compared. As a result, identical kinetics of carboxyfluorescein release was 
observed for the wild-type Bax and for Bax-R and Bax-G which implies that fluorescent 
labeling and mutagenesis of Bax did not interfere with its pore forming ability. In these 
experiments 100 nM Bax was activated by the activator protein cBid (20 nM). To show 
that the wild-type Bax as well as Bax-R and Bax-G can be inhibited by the full-length 
Bcl-xL we also performed carboxyfluorescein releases in the presence of 100 nM Bcl-xL 
(Supplementary Fig. 2b-d). For these experiments liposomes were prepared from the lipid 
mixture of DOPC and bovine heart cardiolipin (80:20 mol%). Lipids were purchased 
from Avanti Polar Lipids. 
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Appendix V 
Lipid diffusion in DOPC versus DOPC:CL (80:20 mol%) lipid bilayer.  
 To determine whether lipid diffusion and viscosity of a lipid membrane is 
affected by the presence of cardiolipin in a lipid bilayer we have measured the lipid 
diffusion in GUVs formed from DOPC or DOPC:CL (80:20 mol%) lipid mixtures. We 
have also compared the results using dual-focus scanning FCS versus static volume FCS 
which is normally done in a fixed position at the top a GUV (See Chapter 3 for the 
description of FCS in lipid membranes). The results of our analysis show no difference in 
diffusion of classic lipidic probes (DiO and DiD) in DOPC versus DOPC:CL lipid 
membranes (Table A1) indicating the presence of cardiolipin does not affect lipid 
diffusion and the viscosity of a lipid membrane.  
 
Table A1. Comparison of lipid diffusion in GUVs prepared from lipid mixture of DOPC 
and DOPC:CL (80:20 mol%). The lipid probe used was DiO or DiD (Invitrogen, 
Molecular Probes). Comparison was also done with regard to the dual focus scanning 
FCS versus static volume FCS7 which was done using Zeiss Confocor 2 instrument. 
 
Membrane 
composition 
Probe D, 
µm2/sec 
Number 
of GUVs 
measured 
Method 
DOPC:CL (80:20 
mol%) 
DiO, 
DiD 
10.0±0.5 9 dual focus scanning FCS  
 
DOPC DiD 10.9±1.9 12 static volume FCS (single 
point measurement at the top 
of a GUV) 
DOPC:CL (80:20 
mol%) 
DiO 10.6±2.9 10 static volume FCS (single 
point measurement at the top 
of a GUV) 
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